Publicacions - Fundació Institut d'Investigació en Ciències de la

ANNEX 2 

Relació detallada de la producció 

científica per serveis i plataformes 

tecnològiques. 

Relación detallada de la producción 

científica por servicios y plataformas 

tecnológicas. 

List of publications classified by 

hospital services and technological 

platforms

PROJECTES PUBLICACIONS 

FACTOR 

D'IMPACTE 

ANÀLISIS CLÍNIQUES 15 34,384 

ANATOMIA PATOLÒGICA 1 24 71,334 

ANESTESIOLOGIA I REANIMACIÓ 14 20,533 

ANGIOLOGIA I CIRURGIA VASCULAR 1 

APARELL DIGESTIU 7 60 197,502 

BADALONA SERVEIS ASSITENCIALS (BSA) 7 8,888 

CARDIOLOGIA 6 42 136,999 

CEEISCAT 6 13 91,267 

CENTRE D'EXPERIMENTACIÓ ANIMAL 4 14,474 

CIRURGIA CARDIACA 6 0,927 

CIRURGIA GENERAL I DIGESTIVA 3 7 12,491 

CIRURGIA TORÀCICA 3 21,263 

DERMATOLOGIA 15 10,119 

ENDOCRINOLOGIA I NUTRICIÓ 2 11 27,754 

EPIDEMIOLOGIA CLÍNICA 1 

FARMÀCIA HOSPITALÀRIA 1 8 8,8 

FARMACOLOGIA CLÍNICA 1 11 20,375 

FUNDACIÓ DE LLUITA CONTRA LA SIDA 2 21 86,413 

FUNDACIÓ IRSICAIXA 9 70 362,322 

HEMATOLOGIA I HEMOTERÀPIA 4 24 130,108 

HEMODINÀMICA 10 15,963 

IMMUNOLOGIA IGTP 4 

IMPPC 17 114,515 

INSTITUT GUTTMANN 22 62,617 

Laboratori d'Immunobiologia per a la Recerca i les Aplicacions 

7 20 36,734 

Diagnòstiques (LIRAD) 

MEDICINA INTENSIVA 5 12,095 

MEDICINA INTERNA 4 113,165 

MEDICINA INTERNA - DESINTOXICACIÓ 2 5 14,462 

MEDICINA INTERNA - DOMICILIÀRIA 

MEDICINA INTERNA - HOSPITALITZACIÓ 1 28 127,280 

MEDICINA INTERNA - MALALTIES INFECCIOSES 2 4 12,451 

MEDICINA INTERNA - VIH 2 38 204,747 

MEDICINA NUCLEAR 1 5 3,697 

MICROBIOLOGIA 14 32 110,27 

NEFROLOGIA 5 10 24,047 

NEUROCIRURGIA 1 2 1,584 

NEUROLOGIA 14 34 143,108 

OBSTETRÍCIA I GINECOLOGIA 4 10,816 

OFTALMOLOGIA 4 9,848 

ONCOLOGIA MÈDICA 6 35 158,695 

ONCOLOGIA RADIOTERÀPICA 2 5,943 

PEDIATRIA 1 25 58,445 

PNEUMOLOGIA 9 28 75,219 

PSIQUIATRIA 1 2,157 

RADIODIAGNÒSTIC 6 6,922 

REHABILITACIÓ 2 2,523 

RESSONÀNCIA MAGNÈTICA 1 4,744 

REUMATOLOGIA 13 32,236 

SCIENTIFIC DIRECTION 1 

UNITAT D’URGÈNCIES 1 1,413 

UNITAT D'AL·LÈRGIA 1 6,297 

UNITAT DE GENÒMICA 1 1 3,134 

UNITAT DE GENÒMICA FUNCIONAL 1 

UNITAT DE PATOLOGIA MAMÀRIA 7 22,964 

UNITAT DE TUBERCULOSI EXPERIMENTAL (UTE) 3 7,711 

UNITAT D'INNOVACIÓ 2 

UNITAT FUNCIONAL INTERDISCIPLINÀRIA SOCIOSANITÀRIA 3 3,866 

UNITAT POLIVALENT D'INVESTIGACIÓ CLÍNICA (UPIC) 2 3,572 

UROLOGIA 2 6 3,805 

Pàgina 2 de 148


ANÀLISIS 

CLÍNIQUES 

Publicacions 

Factor d’impacte total: 34,384 

Audi L, Fernández-Cancio M, Carrascosa A, Andaluz P, Torán N, Piró C, Vilaró E, Vicens-Calvet E, 

Gussinyé M, Albisu MA, Yeste D, Clemente M, Hernández de la Calle I, Del Campo M, Vendrell T, 

Blanco A, Martínez-Mora J, Granada ML, Salinas I, Forn J, Calaf J, Angerri O, Martínez-Sopena 

MJ, Del Valle J, García E, Gracia-Bouthelier R, Lapunzina P, Mayayo E, Labarta JI, Lledó G, 

Sánchez Del Pozo J, Arroyo J, Pérez-Aytes A, Beneyto M, Segura A, Borrás V, Gabau E, Caimarí 

M, Rodríguez A, Martínez-Aedo MJ, Carrera M, Castaño L, Andrade M, Bermúdez de la Vega JA; 

Grupo de Apoyo al Síndrome de Insensibilidad a los Andrógenos (GrApSIA). 

Novel (60%) and Recurrent (40%) Androgen Receptor Gene Mutations in a Series of 59 Patients 

with a 46,XY Disorder of Sex Development 

J CLIN ENDOCR METAB 2010; APR, 95 (4) 1876-1888 

IF: 6,495 

Fuentes X, Castiñeiras MJ, Jardí A, Martínez Casademont M, Miró J, Pastor MC, Trujillo G, 

Vilanova A. 

Consideracions tècniques sobre els laboratoris clínics públics de Catalunya. 

IN VITRO VERITAS 2010; 11:64-67. 

Galan A, Curos A, Valle V. 

Biomarkers for detection and prediction in acute coronary syndrome. 

MED CLIN-BARCELONA 2010 Apr 17;134(11):499-504. Epub 2009 May 21. 

IF: 1,413 

Lucas A, Julián MT, Cantón A, Castell C, Casamitjana R, Martínez-Cáceres EM, Granada ML 

Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean 

population. 

ENDOCRINE 2010 Dec;38(3):391-6. Epub 2010 Oct 23. 

IF: 1,373 

Miquel, M; Bartoli, R; Odena, G; Serafin, A; Cabre, E; Galan, A; Barba, I; Cordoba, J; Planas, R 

Rat CCl4-induced cirrhosis plus total portal vein ligation: a new model for the study of 

hyperammonaemia and brain oedema 

LIVER INT 2010 Aug;30(7):979-87. Epub 2010 May 21. 

IF: 3,84 

Pellitero S, Reverter JL, Pizarro E, Granada ML, Aguilera E, Sanmarti A. 

Usefulness of pulse oximetry in screening of carotid atherosclerosis in patients with type 2 

diabetes mellitus. 

MED CLIN-BARCELONA 2010 Jun 5;135(1):15-20. Epub 2010 Mar 6. 

IF: 1,413 


Pérez V, Sánchez A, Bayés B, Navarro-Muñoz M, Lauzurica R, Pastor MC, Romero R. 

Effect of paricalcitol on the urinary peptidome of kidney transplant patients. 

TRANSPL P 2010 Oct;42(8):2924-7. 

IF: 0,993 

Perez-Romero, N; Serra, A; Granada, ML; Rull, M; Alastrue, A; Navarro-Diaz, M; Romero, R; 

Fernandez-Llamazares, J 

Effects of Two Variants of Roux-en-Y Gastric Bypass on Metabolism Behaviour: Focus on Plasma 

Ghrelin Concentrations Over a 2-Year Follow-up 

OBES SURG 2010; MAY, 20 (5) 600-609 

IF: 3,078 

Ricardo Lauzurica, Mari Cruz Pastor, Beatriz Bayés, Cristian Morales, Maribel Troya, Susana 

Malumbres, María Doladé, Ramón Romero. 

Immflamation, Metalloproteinases and Growth Factors in the development of Carotid 

Atherosclerosis in Renal transplant (RT) Patients. 

AM J TRANSPLANT 2010 (S4), 10: 242. 

IF:6,048 

Ricós C., Perich C., Doménech MV., Fernández P., Biosca C., Minchinela J., Simón M., Cava F., 

Álvarez V., Jiménez CV., Garcia Lario JV. 

Variación biológica. Revisión desde una perspectiva práctica. 

REV LAB CLIN 3(4):192-200 

Ruiz R, Llopis MA, Biosca C, Trujillo G, Llovet MI, Tarrés E, Ibarz M, Alsina MJ, Alvarez V, 

Busquets G, Doménech 

MV, Figueres C, Minchinela J, Pastor RM, Perich C, Ricós C, Sansalvador M, Simón M. 

Indicators and quality specifications for strategic and support processes related to the clinical 

laboratory: four years' experience. 

CLIN CHEM LAB MED 2010 Jul;48(7):1015-9. 

IF: 2,069 

Sancho A, Pastor MC, Bayés B, Sánchez A, Morales-Indiano C, Doladé M, Romero R, Lauzurica R. 

Posttransplant inflammation associated with onset of chronic kidney disease. 

TRANSPL P 2010 Oct;42(8):2896-8 

IF:,993 

Vilanova A, Fuentes X, Castiñeiras MJ, Jardí A, Martínez Casademont M, Miró J, Pastor MC. 

Guia per La verificació dels sistemes de mesura de magnituds biològiques ordinals per a 

l’acreditació segons la norma ISO 15189. 

IN VITRO VERITAS 11:60-63. 

Zamora E, Lupón J, Simó R, Galán A. 

Myostatin Serum levels in heart failure. 

EUR J HEART FAIL 2010 Dec;12(12):1379 

IF: 4,512 


Zamora E, Simó R, Lupón J, Galán A, Urrutia A, González B, Mas D, Valle V. 

Serum myostatin levels in chronic heart failure. 

REV ESP CARDIOL 2010 Aug;63(8):992-6. 

IF: 2,157 


ANATOMIA 

PATOLÒGICA 



Beyer K, Domingo-Sàbat M, Santos C, Tolosa E, Ferrer I, Ariza A. 

The decrease of {beta}-synuclein in cortical brain areas defines a molecular subgroup of dementia with 

Lewy bodies 

BRAIN 2010 Dec;133(Pt 12):3724-33 

IF: 9,23 

Boada A, Bielsa I, Fernández-Figueras MT, Ferrándiz C.Perniosis. 

Clinical and histopathological analysis. 

AM J DERMATOPATH 2010 Feb;32(1):19-23 

IF: 1,263 

Canadas, MP; Videla, S; Darwich, L; Tarrats, A; Pinol, M; Garcia-Cuyas, F; Llatjos, M; Alcalde, C; 

Fernandez, I; Sirera, G; Clotet, B 

Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women 

J CLIN VIROL 2010; JUL, 48 (3) 198-201 

IF: 4,023 

Cañadas MP, Darwich L, Sirera G, Bofill M, Piñol M, Garcia-Cuyas F, Llatjos M, Corbasi P, Clotet B, Videla 

S; HIV-HPV Can Ruti Study Group 

Human Papillomavirus 16 Integration and Risk Factors Associated in Anal Samples of HIV-1 Infected 

Men. 

SEX TRANSM DIS 2010 May;37(5):311-5 

IF: 3,268 

Cañadas MP, Darwich L, Sirera G, Cirigliano V, Bofill M, Clotet B, Videla S; on behalf of the HIV-HPV Study 

Group. 

New molecular method for the detection of human papillomavirus type 16 integration. 

CLIN MICROBIOL INFEC 2010 Jul;16(7):836-42 

IF: 4,784 

Climent, F; Soler, MT; Catala, I; Castella, E; Corominas, JM; Walsh, PM 

Breast Cancer OncoGuia: surgical pathology report guidelines 

CLIN TRANSL ONCOL 2010; FEB, 12 (2) 138-141 

IF: 1,254 

Espinet, B; Salaverria, I; Bea, S; Ruiz-Xiville, N; Balague, O; Salido, M; Costa, D; Carreras, J; Rodriguez- 

Vicente, AE; Garcia, JL; Hernandez-Rivas, JM; Calasanz, MJ; Siebert, R; Ferrer, A; Salar, A; Carrio, A; Polo, 

N; Garcia-Marco, JA; Domingo, A; Gonzalez-Barca, E; Romagosa, V; Marugan, I; Lopez-Guillermo, A; 

Milla, F; Mate, JL; Luno, E; Sanzo, C; Collado, R; Oliver, I; Monzo, S; Palacin, A; Gonzalez, T; Sant, F; 

Salinas, R; Ardanaz, MT; Font, L; Escoda, L; Florensa, L; Serrano, S; Campo, E; Sole, F 

Incidence and Prognostic Impact of Secondary Cytogenetic Aberrations in a Series of 145 Patients with 

Mantle Cell Lymphoma 

GENE CHROMOSOME CANC 2010; MAY, 49 (5) 439-451 


IF: 3,99 

Fernandez-Figueras MT, Michal M, Kazakov DV. 

Mammary-type tubulolobular carcinoma of anogenital mammary-like glands with prominent stromal 

elastosis 

AM J SURG PATHOL 2010 Aug;34(8):1224-6 

IF: 4,106 

Fernández-Figueras MT, Puig L, Cannata P, Cuatrecases M, Quer A, Ferrándiz C, Ariza A 

Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases. 

AM J DERMATOPATH 2010 May 6. [Epub ahead of print] 

IF: 1,263 

Garcia-Olivé I, Monsó E, Andreo F, Sanz-Santos J, Taron M, Molina-Vila MA, Llatjós M, Castellà E, Moran 

T, Bertran-Alamillo J, Mayo-de-Las-Casas C, Queralt C, Rosell R. 

Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations. 

EUR RESPIR J 2010 Feb;35(2):391-5. Epub 2009 Jul 30. 

IF: 5,922 

Gil, O; Diaz, I; Vilaplana, C; Tapia, G; Diaz, J; Fort, M; Caceres, N; Pinto, S; Cayla, J; Corner, L; Domingo, M; 

Cardona, PJ 

Granuloma Encapsulation Is a Key Factor for Containing Tuberculosis Infection in Minipigs 

PLOS ONE 2010; APR 6, 5 (3) -e10030 

IF: 4,411 

Gómez Vázquez M, Navarra Amayuelas R, Martin-Urda MT, Abellaneda Fernández C, Tapia G. 

Subungual squamous cell carcinoma. Presentation of two cases 

ACTAS DERMOSIFILIOGR 2010 Sep;101(7):654-6. 

Juncà J, Moreno M, Mate JL, Milla F 

Concomitant diagnosis of acute mieloide leucemia and chronic lymphoproliferative disorder with AA 

amiloidosis asa final event 

MED CLIN-BARCELONA 2010 Jun 19;135(3):136-7 

IF: 1,413 

Kazakov DV, Requena L, Kutzner H, Fernandez-Figueras MT, Kacerovska D, Mentzel T, Schwabbauer P, 

Michal M. 

Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 

6 cases and review of the literature 

AM J DERMATOPATH 2010 Jun;32(4):340-7 

IF: 1,263 

Manchon P, Borràs JM, Ferro T, Espinàs JA; Breast Cancer OncoGuia Group. (Arellano A, Llatjós M) 

Breast Cancer OncoGuia 

CLIN TRANSL ONCOL 2010 Feb;12(2):113-38 

IF: 1,254 

Margeli, M; Cirauqui, B; Castella, E; Tapia, G; Costa, C; Gimenez-Capitan, A; Barnadas, A; Ronco, MS; 

Benlloch, S; Taron, M; Rosell, R 

The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast 


Cancer PLOS ONE 2010; mar-03, 5 (3) -e9499 

IF: 4,411 

Mendioroz M, Fernández-Cadenas I, Del Río-Espinola A, Rovira A, Solé E, Fernández-Figueras MT, García- 

Patos V, Sastre-Garriga J, Domingues-Montanari S, Alvarez-Sabín J, Montaner J. 

A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population 

NEUROLOGY 2010 Nov 30;75(22):2033-5 

IF: 8,017 

Mertz KD, Pfaltz M, Junt T, Schmid M, Fernandez Figueras MT, Pfaltz K, Barghorn A, Kempf W. 

Merkel cell polyomavirus is present in common warts and carcinoma in situ of the skin 

HUM PATHOL 2010 Oct;41(10):1369-79 

IF: 2,998 

Motlló C, Grau J, Juncà J, Ruiz N, Mate JL, Orna E, Navarro JT, Vives S, Sancho JM, Esteban D, Granada I, 

Feliu E, Ribera JM, Millá F 

Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. 

CANCER GENET CYTOGEN 2010 Dec;203(2):328-32. 

IF: 1,551 

Navarro, JT; Hernandez, A; Rodriguez-Manzano, J; Mate, JL; Grau, J; Morgades, M; Martro, E; Tural, C; 

Ribera, JM; Matas, L 

Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected 

patients 

MED CLIN-BARCELONA 2010 Oct 9;135(11):485-90. Epub 2010 Jul 31. 

IF: 1,413 

Sanz-Santos J, Andreo F, Sánchez D, Castellá E, Llatjós M, Bechini J, Guasch I, López De Castro P, Roca J, 

Parra I, Monsó E. 

Usefulness of a lung cancer rapid diagnosis specialist clinic. Contribution of ultrasound bronchoscopy. 

ARCH BRONCONEUMOL 2010 Dec;46(12):640-5. 

Tomasa TM, Castellà E, Homs M, Chico C, Lecumberri J, Cubells C, Klamburg J 

Amniotic fluid embolism diagnosed by fibre-optic bronchoscopy. 

ANAESTHESIA 2010 Dec;65(12):1230-1. doi: 10.1111/j.1365-2044.2010.06549.x. 

IF: 3,008 

Vallejos V, Barnadas A, Margelí M, Cirauqui B, Mariscal A, Sanchez MC, Castellà E, Julián FJ, Luna MA, 

Fraile M. 

Monitorización de la respuesta a la terapia neoadyuvante en el carcinoma de mama localmente 

avanzado mediante métodos de imagen. 

Senología Patol Mam 2010; 23;141-151 

Xicoy, B; Ribera, JM; Mate, JL; Tapia, G; Morgades, M; Navarro, JT; Sanz, C; Ariza, A; Feliu, E 

Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma 

with or without human immunodeficiency virus infection 

LEUKEMIA LYMPHOMA 2010; NOV, 51 (11) 2063-2069 

IF: 2,492 


Projectes 

BEYER , KATRIN 

Instituto de Salud Carlos III - Núm. Exp.: CP09/00102 

Expresión diferencial de isoformas de beta-sinucleína en cerebro y su detección en sangre como posible 

biomarcador diagnóstico para la enfermedad de Parkinson. 

Durada: 3 anys - (2009-2012) 

Import Concedit: 44.900 € 


ANESTESIOLOGIA 

I REANIMACIÓ 



Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J, Sabaté S, Mazo V, Briones Z, Sanchis J; on behalf 

of the ARISCAT Group.Prediction of Postoperative Pulmonary Complications in a Population-based 

Surgical Cohort. 

ANESTHESIOLOGY 2010 Dec;113(6):1338-1350 

IF: 5,486 

Canet J, Mazo V. 

Postoperative pulmonary complications. 

MINERVA ANESTESIOL 2010 Feb;76(2):138-43. 

IF: 2,581 

Comisión Nacional de la Especialidad de Anestesiología y Reanimación. Navia J, Monedero P, Echevarría 

M, CanetJ, Aguilera L, Gómez Herreras JI, Gómez M, Álvarez J, Abengoechea JM, Hernández J, Romero 

AJ.Analysis of the report on the commom health sciences training requirements]. 

REV ESP ANESTESIOL REANIM 2010 Oct;57(8):525-7. 

Escudero A, Sariñena MT, Jiménez-Carrión A, De Paz S. 

Gastric dilatation secondary to the migration of an osteosynthesis screw. 

REV ESP ANESTESIOL REANIM 2010 Mar;57(3):196 

García-Aguado R, Charco Mora P, Cortiñas Díaz J, Ortiz de la Tabla González R, Viñoles Pérez J, Planas 

Roca A, Pérez Cajaraville J, Valero R, Massó Lago E, López A, Fabregat López J, Santos P, López Alvarez S, 

Zaballos JM, Cuchillo Sastriques JV, Panadero Sánchez A; Sociedad Española de Anestesiología, 

Reanimación y Tratamiento del Dolor. 

Recommendations for managing the difficult airway using supraglottic devices in the adult patient 

undergoing ambulatory surgery. 

REV ESP ANESTESIOL REANIM 2010 Aug-Sep;57(7):439-53. 

Gómez-Arnau JI, Aguilar JL, Bovaira P, Bustos F, De Andrés J, de la Pinta JC, García-Fernández J, López- 

Alvarez S, López-Olaondo L, Neira F, Planas A, Pueyo J, Vila P, Torres LM; Grupo de Trabajo de NVPO de 

la Sociedad Españolade Anestesiología y Reanimación 

Postoperative nausea and vomiting and opioid-induced nausea and vomiting: guidelines for prevention 

and treatment. 

REV ESP ANESTESIOL REANIM 2010;57: 508-24. 

Martinez-Barenys C, Busquets J, de Castro PE, Garcia-Guasch R, Perez J, Fernandez E, Mesa MA, 

Astudillo J. 

Randomized double-blind comparison of phrenic nerve infiltration and suprascapular nerve block for 

ipsilateral shoulder pain after thoracic surgery. 

EUR J CARDIO-THORAC 2010 Dec 7. [Epub ahead of print] 

IF: 2,293 

Mendez E, Moret E, LLubia C, Sanz J, Lopez de Castro PE, Ruyra X 


Abordaje multidisciplinar en el tratamiento de una hemoptisis grave con amenaza vital 

REV ESP ANESTESIOL REANIM 2010; 57: 667-670 

Monerris M. M. , M. Homs, D. Samper.. 

Dolor músculo-esquelético en el que se requieren dosis altas de tramadol. 

DOLOR 2010; 25: 43-9 

Navia J, Monedero P, Echevarría M, Canet J, Aguilera L, Gómez-Herreras JI, Gómez-Sancho M, Puig M, 

Abengoechea JM, Hernández J, Romero AJ. 

Health-care workload and instructional capacity of Spanish hospitals accredited to train residents in 

anesthesiology. 

REV ESP ANESTESIOL REANIM 2010 Jun-Jul;57(6):341-50. 

R. García-Guasch, C. Martínez, J. Busquets, A. Flo, A. Martí 

Comparison of frenic nerve infiltration and supraescapular nerve blockade for ipsilateral shoulder pain 

after thoracotomy in patients receiving thoracic epidural analgesia 

EUR J ANAESTH 2010; (27)47:219-20 

IF: 1,679 




IF: 3,008 

Vallès J, Guilera M, Briones Z, Gomar C, Canet J, Alonso J; ARISCAT Group. 

Validity of the Spanish 8-item short-form generic health-related quality-of-life questionnaire in surgical 

patients: a population-based study. 

ANESTHESIOLOGY 2010 May;112(5):1164-74. 

IF: 5,486 

Vila Caral P, Castillo R, Llubiá C. 

Tracheal laceration during intubation with a Frova introducer. 

REV ESP ANESTESIOL REANIM 2010 Nov;57(9):599-602. 


ANGIOLOGIA I 

CIRURGIA VASCULAR 


Martorell, A; Vallejos, V; Esteban, C; Mila, M; Callejas, JM; Fraile, M 

Lymphoscintigraphy study of oedema after femoropopliteal segment surgery 

Cirugía Española 2010 Jul;88(1):36-40. Epub 2010 May 8 


APARELL 

DIGESTIU 



Abulí A, Bessa X, González JR, Ruiz-Ponte C, Cáceres A, Muñoz J, Gonzalo V, Balaguer F, Fernández- 

Rozadilla C, González D, de Castro L, Clofent J, Bujanda L, Cubiella J, Reñé JM, Morillas JD, Lanas A, Rigau 

J, García AM, Latorre M, Saló J, Fernández Bañares F, Argüello L, Peña E, Vilella A, Riestra S, Carreño R, 

Paya A, Alenda C, Xicola RM, Doyle BJ, Jover R, Llor X, Carracedo A, Castells A, Castellví-Bel S, Andreu M; 

Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. (Gassull MA.) 

Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype. 

GASTROENTEROLOGY 2010 Sep;139(3):788-96, 796.e1-6. Epub 2010 Jun 2. 

IF: 12,032 

Boix, J; Lorenzo-Zuniga, V 

Seeking for the quality in colonoscopy. 

MED CLIN-BARCELONA 2010 Jan 30;134(2):68-9. Epub 2009 Nov 6. 

IF: 1,413 

Bruguera M, Barrio JL, Bayas JM, Campins M, Esteban R, Gatell JM, Martínez M, Monés J, Plans A, Planas 

R, Segura A, Serra C, Torres M, Tural C, Villalbí JR 

Com actuar quan un metge és portador del virus de la immunodeficiència humana o dels virus de 

l’hepatitis B o C (Segona Edició del Quadern de la Bona Praxi, núm. 7). 

QUADERNS DE LA BONA PRAXI 2006;21:1-14. 

Bujanda L, Sarasqueta C, Hijona E, Hijona L, Cosme A, Gil I, Elorza JL, Asensio JI, Larburu S, Enríquez- 

Navascués JM, Jover R, Balaguer F, Llor X, Bessa X, Andreu M, Paya A, Castells A; Gastrointestinal 

Oncology Group of the Spanish Gastroenterological Association. (Gassull MA.) 

Colorectal cancer prognosis twenty years later. 

WORLD J GASTROENTERO 2010 Feb 21;16(7):862-7 

IF: 2,24 

Cabre, E 

Irritable bowel syndrome: can nutrient manipulation help? 

CURR OPIN CLIN NUTR 2010; SEP, 13 (5) 581-587 

IF: 4,333 

Carrion, S; Marin, I; Lorenzo-Zuniga, V; De Vega, VM; Boix, J 

Appropriateness of colonoscopy indications according to the new EPAGE II criteria 

GASTROENTEROL HEPATOL 2010; AUG-SEP, 33 (7) 484-489 

Diez-Quevedo C, Masnou H, Planas R, Castellví P, Giménez D, Morillas RM, Martín-Santos R, Navinés R, 

Solá R, Giner P, Ardévol M, Costa J, Diago M, Pretel J. 

Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in 

hepatitis c: a 12 week, randomized, double-blind, placebo-controlled trial. 

J CLIN PSYCHIAT 2010 Oct 5. [Epub ahead of print] 

IF: 5,023 


Domènech E, Carrión S, Garcia-Planella E, Mañosa M, Gordillo J, Concepción M, Guarner C, Cabré E. 

Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. 

INFLAMM BOWEL DIS 2010. DOI: 10.1002/ibd.21456 

IF: 4,613 

Domènech E, López San Román A, Garcia-Planella E. 

How long should combined therapy with biological and immunomodulatory agents be maintained in 

inflammatory bowel disease? 

GASTROENTEROL HEPATOL 2010; 33:471-472 

Domenech E, Zabana Y, Garcia-Planella E, Lopez San Roman A, Nos P, Ginard D, Gordillo J, Martinez-Silva 

F, Beltran B, Mañosa M, Cabre E, Gassull MA. 

Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective studybefore and 

after infliximab availability. 

ALIMENT PHARM THER 2010 Jan15;31(2):233-9. 

IF: 3,861 

Domènech E, Zabana Y, Mañosa M, Garcia-Planella E, Cabré E, Gassull MA. 

Infliximab reintroduction is not associated to a higher rate of immune-related adverse effects in patients 

with inflammatory bowel disease initially treated with a three-infusion induction regimen. 

J CLIN GASTROENTEROL 2010 Jan;44(1):34-7. 

IF: 2,752 

Fernandez-Rodriguez, CM; Alonso, S; Martinez, SM; Forns, X; Sanchez-Tapias, JM; Rincon, D; Rodriguez- 

Caravaca, G; Barcena, R; Serra, MA; Romero-Gomez, M; Fernandez, I; Garcia-Samaniego, J; Fuente, J; 

Sola, R; Moreno-Otero,R; Planas, R 

Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: Outcomes and 

factors predicting response 

AM J GASTROENTEROL 2010 Oct;105(10):2164-72; quiz 2173. Epub 2010 Aug 10 

IF: 6,882 

Fernández-Rozadilla C, de Castro L, Clofent J, Brea-Fernández A, Bessa X, Abulí A, Andreu M, Jover R, 

Xicola R, LlorX, Castells A, Castellví-Bel S, Carracedo A, Ruiz-Ponte C; Gastrointestinal Oncology Group of 

the Spanish Gastroenterological Association. 

Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish 

cohort. 

PLOS ONE 2010 Sep 9;5(9). pii: e12673. 

IF: 4,411 

Fernández-Rozadilla C, Tarrío R, Clofent J, de Castro L, Brea-Fernández A, Bessa X, Abulí A, Andreu M, 

Jover R, Xicola R, Llor X, Castells A, Castellví-Bel S, Carracedo A, Ruiz-Ponte C; Gastrointestinal Oncology 

Group of the Spanish Gastroenterological Association. 

Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect lowpenetrance 

variants in humans: a two-stage case-control study. 

CANCER EPIDEM BIOMAR 2010 Feb;19(2):619-23. 

IF: 4,19 

Garcia-Retortillo M, Morillas RM, Miquel M, Rodríguez-López O, Cirera I, Vergara M, Sala M, Giménez 

MD, Cañete N, Gallach M, Ardèvol M, Alvárez MA, Montoliu S, Romero-Gómez M, Planas R, Solà R. 

Factors predictius de desposta virològica sostinguda en pacients amb desposta virológica precoç 

completa al tractament de l’hepatitis C 


SUPLEMENTS ANNALS DE MEDICINA Vol.93-Supl 1- Enero 2010:S1-47 (29). 

Garcia-Retortillo M, Morillas RM, Miquel M, Rodríguez-López O, Cirera I, Vergara M, Sala M, Giménez 

MD, Cañete N, Gallach M, Ardèvol M, Alvárez MA, Montoliu S, Romero-Gómez M, Planas R, Solà R. 

Factores predictivos de respuesta virológica sostenida en pacientes con respuesta virológica precoz 

completa al tratamiento de la hepatitis C 

GASTROENTEROL HEPATOL 2010; 33: 165 (P-80) 

Gassull MA. 

Nutrition and gastrointestinal tract: still a long way to go, after 10 years. 

CURR OPIN CLIN NUTR 2010 Sep;13(5):552-3. 

IF: 4,333 

Ginés P, Wong F, Watson H, Terg R, Bruha R, Zarski JP, Dudley F, NormoCAT Study Investigators (Planas 

R).Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor 

antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, 

double-blind, placebo controlled study. 

ALIMENT PHARM THER 2010 Apr;31(8):834-45. Epub 2010 Jan 22. 

IF: 3,861 

Gonzalo V, Lozano JJ, Muñoz J, Balaguer F, Pellisé M, Rodríguez de Miguel C, Andreu M, Jover R, Llor X, 

Giráldez MD, Ocaña T, Serradesanferm A, Alonso-Espinaco V, Jimeno M, Cuatrecasas M, Sendino O, 

Castellví-Bel S, CastellsA; Gastrointestinal Oncology Group of the Spanish Gastroenterological 

Association. (Gassull MA.) 

Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. 

PLOS ONE 2010 Jan 19;5(1):e8777 

IF: 4,411 

Grupo Español para el Estudio de la Motilidad Digestiva, Azpiroz F, Baudet JS, Benages A, Canga F, 

Carrasco J, Ciriza C, Cucala M, Domínguez E, Faro V, Garrigues V, Giganto F, Herrerías JM, Iglesias J, 

Lacima G, López P, Llabrés M, Mearin F, Mínguez M, Monés J, Mora F, Muñoz C, Pérez de la Serna J, 

Ponce J, Rodríguez-Téllez M, Romero MJ, 

Normal values in ambulatory oesophageal pH monitoring at two levels in Spain. 

REV ESP ENFERM DIG 2010; 102: 406-12 

IF: 1,13 

Guevara, M; Baccaro, ME; Rios, J; Martin-Llah, M; Uriz, J; del Arbol, LR; Planas, R; Monescillo, A; 

Guarner, C; Crespo, J; Banares, R; Arroyo, V; Gines, P 

Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of 

serum sodium concentration 

LIVER INT 2010 Sep;30(8):1137-42. Epub 2010 Jun 29. 

IF: 3,84 

Hernando-Harder A, Serra J, Azpiroz F, Mila M, Aguade S, Malagelada C, Tremolaterra F, Villoria A, 

Malagelada J-R. 

Colonic responses to gas loads in subgroups of patients with abdominal bloating. 

AM J GASTROENTEROL 2010 Apr;105(4):876-82. Epub 2010 Feb 23. 

IF: 6,882 

Leal C, Serra J. 

Espasmo esofágico difuso. 


GH continuada 2010; 9: 281-284 

Lorenzo-Zúñiga V, Moreno de Vega V, Boix J. 

The diagnostic value of colonoscopic biopsies in patients with chronic diarrhea. 

EUR J GASTROEN HEPAT 2010; 22(3):378-9 

IF: 1,598 

Lorenzo-Zúñiga V, Moreno de Vega V, Domènech E, Cabré E, Mañosa M, Boix J 

Impact of Capsule Endoscopy Findings in the Management of Crohn’s Disease 

DIGEST DIS SCI 2010 Feb;55(2):411-4. Epub 2009 Mar 3. 

IF: 2,06 

Lucena MI, García-Martín E, Andrade RJ, Martínez C, Stephens C, Ruiz JD, Ulzurrun E, Fernández MC, 

Romero-Gómez M, Castiella A, Planas R, Durán JA, Melcón A, Guarner C, Soriano G, Borraz Y, Agundez 

JA. 

Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-liver injury. 

HEPATOLOGY 2010 Jul;52(1):303-12. 

IF: 10,885 

Manchon Walsh P, Borras J M, Ferro T, Espinas J A. Colorectal Cancer OncoGuia Group. Moreno de Vega 

V in colaborators. 

Colorectal Cancer OncoGuia. 

CLIN TRANSL ONCOL 2010 Mar;12(3):188-210. 

IF: 1,254 

Mañosa M, Naves JE, Leal C, Cabré E, Moreno V, Lorenzo-Zuñiga V, Boix J, Domènech E. 

Does methotrexate induce mucosal healing in Crohn's disease? 

INFLAMM BOWEL DIS 2010 Mar;16(3):377-8 

IF: 4,613 

Marin-Gallen S, Clemente-Casares X, Planas R, Pujol-Autonell I, Carrascal J, Carrillo J, Ampudia R, 

Verdaguer J, Pujol-Borrell R, Borràs FE, Vives-Pi M. 

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. 

CLIN EXP IMMUNOL 2010 May;160(2):207-14. Epub 2009 Dec 17 

IF: 3,134 

Miquel, M; Bartoli, R; Odena, G; Serafin, A; Cabre, E; Galan, A; Barba, I; Cordoba, J; Planas, R 

Rat CCl4-induced cirrhosis plus total portal vein ligation: a new model for the study of 

hyperammonaemia and brain oedema 

LIVER INT 2010 Aug;30(7):979-87. Epub 2010 May 21. 

IF: 3,84 

Montoliu S, Ballesté B, Planas R, Álvarez MA, Rivera M, Miquel M, Masnou H, Cirera I, Morillas RM, Coll 

S, Sala M,García-Retortillo M, Cañete N, Solà R. 

Incidence and prognosis of the different types of functional renal failure in cirrhotic patients with 

ascites. 

CLIN GASTROENTEROL H 2010 Jul;8(7):616-22; quiz e80. Epub 2010 Apr 24. 

IF: 5,286 

Morillas RM, Garcia-Retortillo M, Miquel M, Pardo A, Cañete N, Gallach M, Ardèvol M, Coll S, Sala M, 

Dalmau B, Quer JC, Planas R, Solà R. 


Eficàcia d’entecavir en el tractament de l’hepatitis crònica B en la práctica diaria 

SUPLEMENTS DELS ANNALS DE MEDICINA Vol.93-Supl 1- Enero 2010:S1-59 (66). 

Morillas RM, Planas R. 

Prescripción de fármacos en la insuficiencia hepática. 

FMC 2010;17:427-434 

Morillas RM, Sala M, Masnou H, Planas R. 

Tratamiento de la hepatitis C ¿Qué hacer con los no respondedores? 

GASTROENTEROL HEPATOL 2010; in press 

Morillas RM, Sala M, Planas R. 

Criterios clásicos frente a simplificados en el diagnóstico de la hepatitis autoinmune. 

GH Continuada 2010;9:243-246 

Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española 

para el Estudio del Hígado (AEEH). (Planas R.) 

Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult co-infected 

patient with hiv and hepatitis A, B and C virus. 

ENFERM INFEC MICR CL 2010 Jan;28(1):31.e1-31.e31. 

IF: 1,656 

Planas R 

XXXI Congreso Anual de la Fundación y Asociación Española para el Estudio del Hígado 

HEPATITIS HOY 2006;2:69-74. 

Planas R, Carrillo J, Sanchez A, de Villa MC, Nuñez F, Verdaguer J, James RF, Pujol-Borrell R, Vives-Pi M. 

Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at 

clinical onset and in long-standing diabetes. 

CLIN EXP IMMUNOL 2010 Jan;159(1):23-44. Epub 2009 Nov 11. 

IF: 3,134 

Planas R, Marín I, Sala M, Morillas RM. 

Hepatitis autoimmunitàries. 

ANALES DE MEDICINA 2010(Supl1):31-34-S1-38 

Planas R, Sala M, Masnou H, Morillas RM. 

Estrategias de mejora en el tratamiento de la hepatitis crónica C. 

GASTROENTEROL HEPATOL 2010;33(Espec Congr1).46-52. 

Planas R. 

XXX Congreso Nacional de la Asociación Española para el Estudio del Hígado 

HEPATITIS HOY 2005;2:81-88 

Planas, R; Pujol-Borrell, R; Vives-Pi, M 

Global gene expression changes in type 1 diabetes: Insights into autoimmune response in the target 

organ and in the periphery 

IMMUNOL LETT 2010 Oct 30;133(2):55-61. Epub 2010 Aug 11. 

IF: 2,511 

Rabanal M, Gaspar MJ, Casanovas T, Forns X, Planas R i Solà P del Consell Assessor del Tractament 


Farmacològic deles Hepatitis Víriques del Departament de Salut. 

Análisis dels casos d’hepatitis C crònica tractats a Catalunya durant el període 2001-2005. 

Butlletí epidemiològic de Catalunya 2007;10:145-150. 

Saludes V, Bracho MA, Valero O, Ardèvol M, Planas R, González-Candelas F, Ausina V, Martró E. 

Baseline prediction of combination therapy outcome in Hepatitis C Virus 1b infected patients by 

discriminant analysis using viral and host factors. 

PLOS ONE 2010 Nov 30;5(11):e14132 

IF: 4,411 

Sanjuan X, Salas A, Lloreta J, Manchon Walsh P, Colorectal Cancer OncoGuia Group. Moreno de Vega V 

in colaborators. 

Colorectal Cancer OncoGuia: surgical pathology report guidelines. 

CLIN TRANSL ONCOL 2010 Mar;12(3):211-3. 

IF: 1,254 

Santaolalla R, Mañé J, Pedrosa E, Lorén V, Fernández-Bañares F, Mallolas J, Carrasco A, Salas A, Rosinach 

M, Forné M, Espinós JC, Loras C, Donovan M, Puig P, Mañosa M, Gassull MA, Viver JM, Esteve 

M.Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory 

Crohn's disease. 

INFLAMM BOWEL DIS 2010 Nov 8. [Epub ahead of print] 

IF: 4,613 

Serra I, Marín I, Morillas RM, Domènech E. 

Visceral leishmaniasis in a patient with autoimmune hepatitis on combined immunosuppressant 

therapy. 

MED CLIN-BARCELONA 2010 Feb 20;134(5):234-5. Epub 2009 Apr 8. 

IF: 1,413 

Serra J, Villoria A, Azpiroz F, Lobo B, Santos J, Accarino A, Malagelada JR. 

Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel 

syndrome. 

NEUROGASTROENT MOTIL 2010 Apr;22(4):401-6, e91-2. Epub 2009 Dec 28. 

IF: 3,349 

Serra J. 

Distensión abdominal y flatulencias. 

7DM 2010; 824: 17-21 

Serra, I; Oller, B; Manosa, M; Naves, JE; Zabana, Y; Cabre, E; Domenech, E 

Systemic amyloidosis in inflammatory bowel disease: Retrospective study on its prevalence, clinical 

presentation, and outcome J CROHNS COLITIS 2010; SEP, 4 (3) 269-274 

IF: 2,628 

Serra, J 

Levosulpiride in the management of functional dyspepsia and delayed gastric emptying 

GASTROENTEROL HEPATOL 2010 Oct;33(8):586-90. Epub 2010 Sep 17. 

Soldevila B, Alonso N, Martínez-Arconada MJ, Morillas RM, Planas R, Sanmartí AM, Martínez-Cáceres 

EM. 

A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and 


egulatory CD4 (+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during 

pegylated interferon alpha2a plus ribavirin treatment. 

J VIRAL HEPATITIS 2010 May 10. doi: 10.1111/j.1365-2893.2010.01317.x. [Epub ahead of print] 

IF: 3,502 

Travis S, Van Assche G, Dignass A, Cabré E, Gassull MA. 

On the second ECCO Consensus on Crohn's disease.J CROHNS COLITIS 2010 Feb;4(1):1-6. 

IF: 2,628 

Usón J, Sánchez FM, Sória F, Boix J, Fernández M, Latorre R, Climent S, Tejedo V. 

Empleo del modelo animal en la formación en endoscopia diagnóstica y terapéutica de la vía biliar 

Educ. Med 2010; 13(3): 171-176 

Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler 

G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E; European Crohn's and Colitis Organisation 

(ECCO).(MA Gassull)The second European evidence-based Consensus on the diagnosis and management 

of Crohn's disease: Definitionsand diagnosis. 

J CROHNS COLITIS 2010 Feb;4(1):7-27. Epub 2010 Jan 15. 

IF: 2,628 

Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, 

Dotan I, Marteau P, Ardizzone A, Baumgart DC, D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm 

J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G, 

Reinshagen M. 

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: 

Special situations. 

J CROHNS COLITIS 2010 Feb;4(1):63-101. Epub 2009 Dec 21. 

IF: 2,628 

VanZyl B, Planas R, Ye Y, Foulis AK, deKrijger RR, Butler PC, Nelson JL, Gale EAM, Vives-Pi M, Gillespie KM 

Why are levels of maternal microchimerism higher in type 1 diabetes pancreas? 

CHIMERISM 2010 Oct;1(2):45-50 

Yukihide Momozawa,Myriam Mni,Kayo Nakamura,Wouter Coppieters,Sven Almer,Leila 

Amininejad,Isabelle Cleynen,Jean-Frédéric Colombel,Peter de Rijk,Olivier Dewit,Yigael Finkel, Miquel A 

Gassull, Dirk Goossens,Debby Laukens,Marc Lémann,Cécile Libioulle,Colm O'Morain,Catherine 

Reenaers,Paul Rutgeerts,Curt Tysk,Diana Zelenika,Mark Lathrop,Jurgen Del-Favero,Jean-Pierre 

Hugot,Martine de Vos, Denis Franchimont, Severine Vermeire, Edouard Louis & Michel Georges et al. 

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against 

inflammatory bowel disease. 

NAT GENET 2010; doi:10.1038/ng.733 Received03 August 2010Accepted18 November 2010Published 

online12 

IF: 36,377 

Zabana Y, Domènech E, Mañosa M, Garcia-Planella E, Bernal I, Cabré E, Gassull MA. 

Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in 

clinical practice. 

ALIMENT PHARM THER 2010 Mar;31(5):553-60. Epub 2009 Nov 30. 

IF: 3,861 

Zeuzem S, Sulkowski MS, Lawitz EJ, Rustgi VK, Rodriguez-Torres M, Bacon BR, Grigorescu M, Tice AD, 


Lurie Y, Cianciara J, Muir AJ, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-1 

Study Team. (Planas R.) 

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients 

With Chronic Hepatitis C Virus Genotype 1 

GASTROENTEROLOGY 2010 Oct;139(4):1257-66. Epub 2010 Jun 27. 

IF: 12,032 

Projectes 

ARMENGOL NIELL, CAROLINA 

Instituto de Salud Carlos III - Núm. Exp.: PI10/02082 

Estudio proteómico integral del cáncer de hígado: identificación de factores diagnóstico y pronóstico, vías 

de señalización clave y nuevas dianas terapéuticas 

Durada: 3 anys - (2010-2013) 


CABRE GELADA, EDUARD 

FIS - Núm. Exp.: PS09/01294 

Perfil genético funcional en la enfermedad de CROHN. Efecto sobre el desarrollo de recurrencia postquirúrgica 

Durada: 3 anys - (2009-2012) 


LORENZO-ZUÑIGA GARCIA, VICENTEInstituto de Salud Carlos III - Núm. Exp.: PI10/00132 

Desarrollo de apósitos de colon para prevenir las complicaciones de las escaras tras terapéutica 

endoscópica 

Durada: 3 anys - (2010-2013) 


MORILLAS CUNILL, ROSA MARIA 

FIS - Núm. Exp.: EC08/00259 

Estudio multicéntrico, aleatorizado, doble-ciego, controlado con placebo, sobre la eficacia del tratamiento 

con beta-bloqueantes (nadolol o carvedilol según respuesta hemodinámica) para la prevención de la 

descompensación en pacientes con cirrosis compensada y gradiente de presión portal superior a 10 

mmHg. 

Durada: 3 anys - (2008-2011) 


PLANAS VILA, RAMON 

FIS - Núm. Exp.: PI080809 

Bloqueo del receptor de endocanabinoides CB1 por SR141716A en ratas cirróticas con ascitis. Efecto 

sobre la progresión a cirrosis, la hipertensión portal, translocación bacteriana y encefalopatía. 

Durada: 3 anys - (2008-2011) 


SALA LLINÀS, MARGARITA 

FIS - Núm. Exp.: PS09/00751 

Identificación de marcadores diagnóstico y pronóstico en plasma de cáncer hepático mediante análisis 

proteómico. 


Durada: 3 anys - (2009-2012) 


SERRA PUEYO, JORDI 


Efecto de los cambios fisico/quimicos en el contenido intestinal sobre la sensibilidad visceral y los 

síntomas abdominales en los trastornos funcionales digestivos. 

Durada: 3 anys - (2010-2013) 



BADALONA 

SERVEIS ASSISTENCIALS 



Ortega G, Castellà C, Martín-Cantera C, Ballvé JL, Díaz E, Saez M, Lozano J, Rofes L, Morera C, Barceló A, 

Cabezas C, Pascual JA, Pérez-Ortuño R, Saltó E, Valverde A, Jané M; BIBE Study Group. 

Passive smoking in babies: The BIBE study (Brief Intervention in babies. Effectiveness). 

BMC PUBLIC HEALTH 2010 Dec 20;10:772. 

IF: 2,364 

Sicras A, Galera J, Muñoz G, Navarro R 

Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill 

fixeddose combinations for the treatment of hypertension. 

MED CLIN-BARCELONA 2010 Nov 23;136(5):183-191 

IF: 1,413 

Sicras-Mainar A, Blanca-Tamayo M, Gutiérrez-Nicuesa L, Salvatella-Pasant J, Navarro-Artieda R. 

Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a 

longitudinal study in a population setting. 

GAC SANIT 2010 Jan-Feb;24(1):13-9. Epub 2009 Jul 30. 

IF: 1,114 

Sicras-Mainar A, Blanca-Tamayo M, Gutiérrez-Nicuesa L, Salvatella-Pasant J, Navarro-Artieda R. 

Clinical validity of a population database definition of remission in patients with major depression. 

BMC PUBLIC HEALTH 2010 Feb 11;10:64. 

IF: 2,364 

Sicras-Mainar A, Fernández de Bobadilla J, Navarro-Artieda R, Rejas-Gutiérrez J. 

All-cause mortality and incidence of major cardiovascular events in hypertensive patients with ASCOTtype 

profile in a Spanish population setting. 

ATEN PRIM 2010 Aug;42(8):420-30. Epub 2010 Feb 8. 

IF: 0,619 

Sicras-Mainar A, Fernández-De-Bobadilla J, Navarro-Artieda R, Sánchez-Maestre C. 

Comorbidity and health resources use in smokers. An analysis from a primary care setting 

REV CLIN ESP 2010 Mar;210(3):109-17. Epub 2010 Feb 11 

IF: 0,762 

Tomas, S; Gimena, I 

Patient safety in emergency care 

AN SIST SANIT NAVAR 2010; , 33 () 131-148 

IF: 0,252 


CARDIOLOGIA 


Alegret JM, Subirana MT, Marcuello E, Bayes-Genis A, Ferres P, Torner M. 

Afectación valvular tricuspídea y pulmonar en un caso de síndrome carcinoide 

REV ESP CARDIOL 1997;50:532-534. 

IF: 2,157 


Artom G, Koren-Morag N, Spodik DH, Brucato A, Guindo J, Bayes de Luna A, Brambilla G, Finkelstein Y, 

Granel B, Bayes-Genis A, Scwammenthal E, Adler Y 

Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent 

pericarditis: a multi-centre all-case analysis 

EUR J HEART FAIL 2005;26:723-7 

IF: 4,512 

Baggish AL, van Kimmenade RR, Pinto Y, Richards AM, Lainchbury J, Bayes-Genis A, Santaló M, Ordonez- 

Llanos J, Januzzi JL. 

New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart 

failure prognosis. 

BIOMARKERS 2010 Jun;15(4):307-14. 

IF: 2,09 

Bayes Genis A 

The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute 

shortness of breath. 

REV ESP CARDIOL 2005 Oct;58(10):1142-4 

IF: 2,157 

Bayes-Genis A, Pascual-Figal D, Januzzi JL, Maisel A, Casas T, Valdés Chávarri M, Ordóñez-Llanos J. 

Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart 

failure. 

REV ESP CARDIOL 2010 Oct;63(10):1171-8. 

IF: 2,157 

Bayes-Genis A, Soler-Botija C, Farré J, Sepúlveda P, Raya A, Roura S, Prat-Vidal C, Gálvez-Montón C, 

Montero JA, Büscher D, Belmonte JC. 

Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. 

J MOL CELL CARDIOL 2010 Nov;49(5):771-80. Epub 2010 Aug 14. 

IF: 5,499 

Bayes-Genis A. 

Natriuretic peptides: new indications? 


IF: 1,413 

Bellera MN, Ortiz JT, Caralt MT, Pérez-Rodon J, Mercader J, Fernández-Gómez C, Paré C, Heras M. 

(Bayes-Genis A.in collaborators) 


Magnetic resonance reveals long-term sequelae of apical ballooning syndrome. 

INT J CARDIOL 2010 Feb 18;139(1):25-31. Epub 2008 Sep 19. 

IF: 6,802 

Ciompi F, Pujol O, Gatta C, Rodríguez-Leor O, Mauri-Ferré J, Radeva P. 

Fusing in-vitro and in-vivointravascular ultrasound data for plaque characterization. 

INT J CARDIOVAS IMAG 2010 Oct;26(7):763-79. Epub 2009 Nov 29. 

IF: 2,539 

F.Ciompi, O.Pujol, E.Fernandez-Nofrerias, J.Mauri, P.Radeva 

Conditional Random Fields for image segmentation in Intravascular Ultrasound 

MICCAT 2010 

Farré J, Roura S, Prat-Vidal C, Soler-Botija C, Llach A, Molina CE, Hove-Madsen L, Cairo JJ, Godia F, Bragos 

R, Cinca J, Bayes-Genis A 

FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells. 

GROWTH FACTORS 2007;25:71-6 

IF: 2,8 

Ferrer E., Delgado L, López-Ayerbe J, Vallejo N, Gual F, Ribas N, Masmitja S, Bosch C, Teis A, Ruyra X. 

Cirugía reparadora de la insuficiencia mitral degenerativa. Análisis, resultado y seguimiento de 100 

pacientes. 

CIR CARDIOV 2010; 17(4) : 301-9 

Galan A, Curos A, Valle V. 

Biomarkers for detection and prediction in acute coronary syndrome. 

MED CLIN-BARCELONA 2010 Apr 17;134(11):499-504. Epub 2009 May 21. 

IF: 1,413 

Garcia-Garcia, C; Sanz, G; Valle, V; Molina, L; Sala, J; Subirana, I; Marti, H; Marrugat, J; Bruguera, J; 

Masia, R; Elosua, R 

Trends in In-Hospital Mortality and Six-Month Outcomes in Patients With a First Acute Myocardial 

Infarction. Change Over the Last Decade 

REV ESP CARDIOL 2010; OCT, 63 (10) 1136-1144 

IF: 2,157 

Garcia-Ortega P, Marin A, Quilez E, Rodriguez-Leor O. 

New tools for allergy diagnosis and clinical advice after immediate reactions to ICM. 

BRIT J RADIOL 2010 Jul;83(991):632-3. 

IF: 2,062 

Gatta C, Balocco S, Ciompi F, Hemetsberger R, Rodriguez Leor O, Radeva P. 

Real-time gating of IVUS sequences based on motion blur analysis: method and quantitative validation. 

MED IMAGE COMPUT COMPUT ASSIST INTERV 2010;13(Pt 2):59-67. 

Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, van Es GA, Kolatkar NS, Kravitz BG, 

Miller DM,Huang C, Fitzgerald PJ, Nesto RW; APPROACH Study Group.(Mauri F, Valle Tudela V, 

Rodriguez-Leor O in collaborators) 

Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes 

mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone 

on atherosclerosis in diabetes patients with cardiovascular history trial. 


CIRCULATION 2010 Mar 16;121(10):1176-87. Epub 2010 Mar 1. 

IF: 14,429 

Gual-Capllonch, F; Arce, J; Seres, L; Vallejo, N; Ferrer, E; Fernandez, C; Lopez-Ayerbe, J; Teis, A 

Left atrial intramural haematoma associated with mitral annular calcification 

EUR J ECHOCARDIOGR 2010 Jun;11(5):E18. Epub 2009 Dec 11 

IF: 2,117 

Heras M, Avanzas P, Bayes-Genis A, Pan M, de Isla LP, Sanchis J. 

Unplanned redundant publication. A consequence of too many cardiovascular journals? 

HEART 2010 Nov;96(21):1780. Epub 2010 Aug 23. 

IF: 4,706 

Heras M, Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J. 

Annual Summary 2010: Bibliometric Data, Activities, and New Production of the Journal. 

REV ESP CARDIOL 2010 Dec;63(12):1501-9. 

IF: 2,157 

Heras M, Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J. 

A new editorial phase with new projects. 

REV ESP CARDIOL 2010 Jul;63(7):865-8. 

IF: 2,157 

Heras M, Bayes-Genis A, Bermejo J, Pérez de Isla L, Sanchis J, Segovia J, Alfonso F. 

Introduction. Current topics on cardiology 2009. 

REV ESP CARDIOL 2010 Jan;63 Suppl 1:1-2. 

IF: 2,157 

Hernandez, JMDT; Alfonso, F; Gimeno, F; Diarte, JA; Lopez-Palop, R; de Prado, AP; Rivero, F; Sanchis, J; 

Larman, M;Diaz, JF; Elizaga, J; Moreiras, JM; Jaume, AG; Hernandez, JM; Mauri, J; Recalde, AS; Bullones, 

JA; Rumoroso, JR; delBlanco, BG; Baz, JA; Bosa, F; Botas, J; Hernandez, F 

Thrombosis of Second-Generation Drug-Eluting Stents in Real Practice Results From the Multicenter 

Spanish Registry ESTROFA-2 (Estudio Espanol Sobre Trombosis de Stents Farmacoactivos de Segunda 

Generacion-2) 

JACC-CARDIOVASC INTE 2010; SEP, 3 (9) 911-919 

IF: 5,862 

Hung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, McMurray JJ, Velazquez EJ, Kober L, 

Pfeffer MA, Solomon SD; VALIANT investigators. 

Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial 

infarction. 

J AM COLL CARDIOL 2010 Nov 23;56(22):1812-22. 

IF: 14,292 

Jiménez-Navarro MF, Ramirez-Marrero MA, Anguita-Sánchez M, Castillo JC; BADAPIC Investigators. 

(Lupón Roses J) 

Influence of gender on long-term prognosis of patients with chronic heart failure seen in heart failure 

clinics. 

CLIN CARDIOL 2010 Mar;33(3):E13-8. 

IF: 1,807 


Labovsky V, Hofer EL, Feldman L, Fernández Vallone V, García Rivello H, Bayes-Genis A, Hernando Insúa 

A, Levin MJ, Chasseing NA. 

Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from 

neonatal rat cardiomyocytes. 

DIFFERENTIATION 2010 Feb;79(2):93-101. Epub 2009 Nov 18. 

IF: 3,069 

Manzano-Fernández S, Januzzi JL, Boronat-García M, Pastor P, Albaladejo-Otón MD, Garrido IP, Bayes- 

Genis A, Valdés M, Pascual-Figal DA. 

Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in 

patients with acute heart failure. 

CONGEST HEART FAIL 2010 Sep-Oct;16(5):214-20. doi: 10.1111/j.1751-7133.2010.00153.x. 

Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, Januzzi JL Jr. 

Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from 

the International Collaborative of NT-proBNP Study. 

CIRC-HEART FAIL 2010 May;3(3):354-61. Epub 2010 Mar 23. 

IF: 4,315 

Ng J, Borodyanskiy AI, Chang ET, Villuendas R, Dibs S, Kadish AH, Goldberger JJ. J 

Measuring the complexity of atrial fibrillation electrograms. 

J CARDIOVASC ELECTR 2010 Jun 1;21(6):649-55. Epub 2010 Feb 1. 

IF: 3,288 

Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M. 

Summary of the clinical studies reported in the Annual Scientific Sessions of the American College of 

Cardiology (Atlanta, GA. USA, March 14-16, 2010). 

REV ESP CARDIOL 2010 Jun;63(6):695-707. 

IF: 2,157 

Pérez de Isla L, Bayes-Genis A, Sanchis J, Heras M. 

Summary of the clinical studies reported in the annual scientific sessions of the American Heart 

Association (Orlando, United States, November 14-18, 2009). 

REV ESP CARDIOL 2010 Feb;63(2):190-9. 

IF: 2,157 

Pons, F; Lupon, J; Urrutia, A; Gonzalez, B; Crespo, E; Diez, C; Cano, L; Cabanes, R; Altimir, S; Coll, R; 

Pascual, T; Valle, V 

Mortality and Cause of Death in Patients With Heart Failure: Findings at a Specialist Multidisciplinary 

Heart Failure Unit 

REV ESP CARDIOL 2010; MAR, 63 (3) 303-314 

IF: 2,157 

Pujadas S, Vidal-Perez R, Hidalgo A, Leta R, Carreras F, Barros A, Bayes-Genis A, Subirana MT, Pons-Llado 

G. 

Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic 

cardiomyopathy: a cardiac magnetic resonance imaging study. 

EUR J RADIOL 2010 Aug;75(2):e88-91 

IF: 2,941 


Rigol M, Solanes N, Farré J, Roura S, Roqué M, Berruezo A, Bellera N, Novensà L, Tamborero D, Prat- 

Vidal C, Huzman MA, Batlle M, Hoefsloot M, Sitges M, Ramírez J, Dantas AP, Merino A, Sanz G, Brugada 

J, Bayés-Genís A, Heras M. 

Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of 

administration. 

J CARD FAIL 2010 Apr;16(4):357-66. Epub 2010 Feb 9 

IF: 3,595 

Roura S, Farré J, Hove-Madsen L, Prat-Vidal C, Soler-Botija C, Gálvez-Montón C, Vilalta M, Bayes-Genis A. 

Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived 

mesenchymal stem cells. 

BASIC RES CARDIOL 2010 May;105(3):419-30. Epub 2010 Jan 21. 

IF: 6,128 

Scollan DF, Alcalde O, Zado E, Marchlinski F. (Bayes A. in collaborators) 

Avoidance of left phrenic nerve injury during endocardial ventricular tachycardia substrate modification. 

HEART RHYTHM 2010;7(2):266-8. Epub 2009 Oct 30. 

IF: 4,246 

Teis-Soley, A; Fernandez-Nofrerias, E; Rodriguez-Leor, O; Tizon, H; Salvatella, N; Valle, V; Mauri, J 

Coronary Artery Perforation by Intracoronary Guide Wires: Risk Factors and Clinical Outcomes 

REV ESP CARDIOL 2010; JUN, 63 (6) 730-734 

IF: 2,157 

Vallejo N, Ferrer E, Fernández-Nofrerías E, Mauri J. 

Postpneumonectomy dyspnea: improvement after transcatheter closure. 

REV ESP CARDIOL 2010 Apr;63(4):498-9. 

IF: 2,157 

Zamora E, Lupón J, Simó R, Galán A. 

Myostatin Serum levels in heart failure. 

EUR J HEART FAIL 2010 Dec;12(12):1379 

IF: 4,512 

Zamora E, Lupón J, Urrutia A, Bayes-Genis A. 

Obesity and long-term prognosis in heart failure: the paradox persists. 

REV ESP CARDIOL 2010 Oct;63(10):1210-2 

IF: 2,157 




IF: 2,157 

Zuazagoitia A, Grandes G, Torcal J, Lekuona I, Echevarria P, Gómez MA, Domingo M, de la Torre MM, 

Ramírez JI, Montoya I, Oyanguren J, Pinilla RO; EFICAR Group (Ejercicio Físico en la Insuficiencia 

Cardiaca). 

Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise 

program to improve the quality of life of patients with heart failure in primary care: The EFICAR study 

protocol. (Ejercicio Físico en la Insuficiencia Cardiaca). 


BMC PUBLIC HEALTH 2010 Jan 25;10:33. 

IF: 2,364 

Projectes 

BAYES GENIS, ANTONI 

Fundación Privada Daniel Bravo Andreu - Núm. Exp.: 

Administración intramiocárdica de células progenitoras cardíacas y factores angiogénicos mediante 

biomatrices activas. Seguimiento en linea de la regeneración cardíaca 

Durada: 3 anys - (2010-2013) 



Ministerio de Sanidad y Politica Social - Núm. Exp.: TRA-150 

Estudio aleatorizado y doble‐ciego para valorar el beneficio del tratamiento con testosterona en pacientes 

deficientes con IC avanzada (TIC) (EudraCT number 2009‐016498‐13) 

Durada: 1 anys - (2010-2011) 

Import Concedit: 55.902,12 € 


Fundació La Marató de TV3 - Núm. Exp.: 080330 

Desenvolupament de matrius biològiques per a reparar la cicatriu postinfart: alliberament local de 

cèl·lules mare, factos angiogènics i seguiment en línia de la regeneració miocàrdica. 

Durada: 3 anys - (2008-2011) 



Ministerio de Educación y Ciencia - Núm. Exp.: SAF2008-05144-C02-01 

Células madre derivadas de grasa cardíaca para regeneración miocárdica. Caracterización in vitro y 

estudios pre-clínicos en los modelos murino y porcino. 

Durada: 3 anys - (2008-2011) 



Comissió Europea - Núm. Exp.: RECATABI 229239 

Regeneration of Cardiac Tissue Assisted by Bioactive Implants. RECATABI 

Durada: 3 anys - (2010-2013) 


RODRIGUEZ LEOR, ORIOL 


Valoración semicuantitativa de la perfusión miocárdica en el infarto agudo de miocardio a partir del 

análisis angiográfico. Valor pronóstico en pacientes tratados con angioplastia primaria. 

Durada: 4 anys - (2007-2011) 



CEEISCAT 



Barczyk J, García J, Casabona J. 

The potential contribution of small-scale intervention projects in the field to the national health 

information system for HIV and sexually transmitted infections: a case study of a multilevel intervention 

in Guatemala. 

INT J PUBLIC HEALTH 2010 Dec;55(6):693-9. Epub 2010 Aug 12. 

IF: 2,241 

Calmet M., Juvé R., Alberny M., Andreu A., Loureiro E., Matas L., Vilamala A. Casabona J. 

Recursos diagnósticos para las infecciones de transmisión sexual en los laboratorios de Cataluña 

(España). 

GAC SANIT 2009 348-350 

IF: 1,114 

Corbeto EL, Lugo R, Martró E, Falguera G, Ros R, Avecilla A, Coll C, Saludes V, Casabona J. 

Epidemiological features and determinants for Chlamydia trachomatis infection among women in 

Catalonia, Spain. 

INT J STD AIDS 2010 Oct;21(10):718-22 

IF: 1,082 

Fernàndez L, Rifà B, Pujol F, Becerra J, Pérez M, Merono M, Zaragoza,K, Rafael A, Diaz O, Avellaneda A, 

Casado, MJ, Giménez A, Casabona J 

Impact of the introduction of rapid HIV testing in the Voluntary Counseling and Testing sites network of 

Catalonia,Spain 

INT J STD AIDS 2010 Jun;21(6):388-91. 

IF: 1,082 

Folch C, Casabona J, Muñoz R, González V, Zaragoza K. 

Increase in the prevalence of HIV and in associated risk behaviors in men who have sex with men: 12 

years of behavioral surveillance surveys in Catalonia (Spain) 

GAC SANIT 2010 Jan-Feb;24(1):40-6. Epub 2009 Dec 4. 

IF: 1,114 

Folch, C; Esteve, A; Zaragoza, K; Munoz, R; Casabona, J 

Correlates of intensive alcohol and drug use in men who have sex with men in Catalonia, Spain 

EUR J PUBLIC HEALTH 2010 Apr;20(2):139-45. Epub 2009 Jun 29. 

IF: 2,267 

Gill J, May M, Lewden C, Saag M, Mugavero M, Reiss P, Ledergerber B, Mocroft A, Harris R, Fux CA, 

Justice A, Costagliola D, Casabona J, Hogg RS, Khaykin P, Lampe F, Vehreschild J, Sterne JA, Gill J, Lewden 

C, Saag M, Egger M, Mugavero M, Reiss P, Ledergerber B, Mocroft A, Harris R, May M, Sterne JA, Brodt 

HR, Casabona J, Chene G, 

Causes of Death in HIV-1-Infected Patients Treated with Antiretroviral Therapy, 1996 - 2006: 

Collaborative Analysis of 13 HIV Cohort Studies. 


CLIN INFECT DIS 2010 May 15;50(10):1387-96 

IF: 8,186 

HIV-CAUSAL Collaboration, Ray M, Logan R, Sterne JA, Hernádez-Díaz S, Robins JM, Sabin C, Bansi L, van 

Sighem A,de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, 

Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, 

Hernán MA 

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. 

AIDS 2010 Jan 2;24(1):123-37 

IF: 6,348 

Huntington, S; Folch, C; Gonzalez, V; Merono, M; Ncube, F; Casabona, J 

Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among 

injecting drug users in Catalonia 

ENFERM INFEC MICR CL 2010 Apr;28(4):236-8. Epub 2009 Aug 19. 

IF: 1,656 

Marshall, V; Martro, E; Labo, N; Ray, A; Wang, DA; Mbisa, G; Bagni, RK; Volfovsky, N; Casabona, J; 

Whitby, D 

Kaposi Sarcoma (KS)-Associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European 

AIDS-KS Case Control Study 

J INFECT DIS 2010; oct-01, 202 (7) 1126-1135 

IF: 6,288 

Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV 

Epidemiological Research Europe (COHERE), Lodwick R, Costagliola D, Reiss P, Torti C, Teira R, Dorrucci 

M, Ledergerber B, Mocroft A, Podzamczer D, Cozzi-Lepri A, Obel N, Masquelier B, Staszewski S, García F, 

De Wit S, 

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. 

ARCH INTERN MED 2010 Mar 8;170(5):410-9 

IF: 10,639 

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, Lodwick RK, Sabin CA, 

Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, 

Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri 

P, Guest JL. 

Death rates in HIV-positive antiretroviral-naive patients with with CD4 count greater than 350 cells per 

μL in Europe and North America: a pooled cohort observational study. 

LANCET 2010 Jul 31;376(9738):340-5. Epub 2010 Jul 15. 

IF: 33,633 

Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chêne G, Mussini C, Porter K, Bucher HC; CASCADE 

Collaboration Members. 

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating 

antiretroviral therapy – The CASCADE Collaboration: A collaboration of 23 cohort studies. 

PLOS MED 2010 Feb 23;7(2):e1000239. 

IF: 15,617 


Projectes 

CASABONA BARBARA, JORDI 

FIPSE - Núm. Exp.: 36787/08 

Impacto del diagnóstico de VIH en las conductas sexuales. Indicadores, determinantes y evolución 

temporal en la cohorte PISCIS. 

Durada: 3 anys - (2008-2011) 



AGAUR - Agència de Gestió d'Ajuts Universitaris i de Recerca - Núm. Exp.: 2008ARAF1-00012 

Diagnosi de situació de salut sexual i reproductiva de treballadors/res del sexe immigrants de Catalunya. 

Durada: 2 anys - (2008-2010) 



COMISSIÓ EUROPEA - Núm. Exp.: COBATEST 20091211 

HIV community-based testing practices in Europe. HIV-COBATEST. 

Durada: 3 anys - (2010-2013) 


FOLCH TODA, CINTA 

COMISSIÓ EUROPEA - Núm. Exp.: 2008 12 14 EMIS 

European MSM Internet Survey on HIV and STI. (DG Sanco) (EMIS) 

Durada: 3 anys - (2008-2011) 


FOLCH TODA, CINTA 

Comissió Europea - Núm. Exp.: SIALON II 20101211 

SIALON II. Capacity building in combining targeted prevention with meaningful HIV surveillance among 

MSM. 

Durada: 2 anys - (2010-2012) 


MASIP MASIP, JOAN 

FIPSE - Núm. Exp.: 36721/08 

Estudio clínico-epidemiológico de las parejas madre-hijo expuestas al VIH y/o a los fármacos 

antirretrovirales. 

Durada: 3 anys - (2008-2011) 



CENTRE 

D’EXPERIMENTACIÓ 

ANIMAL 



Dorado, L; Millan, M; de la Ossa, NP; Guerrero, C; Gomis, M; Lopez-Cancio, E; Ricciardi, AC; Davalos, A 

Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke 

after intravenous thrombolysis 

EUR J NEUROL 2010 Feb;17(2):301-6. Epub 2009 Nov 12. 

IF: 3,765 


Cardona, PJ 


PLOS ONE 2010; APR 6, 5 (3) -e10030 

IF: 4,411 

Vilaplana C, Montané E, Pinto S, Barriocanal AM, Domenech G, Torres F, Cardona PJ, Costa J. 

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous 

vaccine RUTI. 

VACCINE 2010 Jan 22;28(4):1106-16. Epub 2009 Oct 22 

IF: 3,572 

Vilaplana C., Cardona PJ 

Tuberculin immunotherapy: its history and lessons to be learned. 

MICROBES INFECT 2010 Feb;12(2):99-105. Epub 2009 Nov 4. 

IF: 2,726 


CIRURGIA 

CARDÍACA 


Colli A, D'Amico R, Mestres CA, Pomar JL, Cámara ML, Ruyra-Baliarda X., Mulet J. 

Is early antithrombotic therapy necessary after tissue mitral valve replacement? 

J HEART VALVE DIS 2010 Jul;19(4):405-11. 

IF:,927 


Ferrer E., Delgado L, López-Ayerbe J, Vallejo N, Gual F, Ribas N, Masmitja S, Bosch C, Teis A, Ruyra-Baliarda 

X. 

Cirugía reparadora de la insuficiencia mitral degenerativa. Análisis, resultado y seguimiento de 100 

pacientes. 

CIR CARDIOV 2010; 17(4) : 301-9 

Mendez E, Moret E, LLubia C, Sanz J, Lopez de Castro PE, Ruyra-Baliarda X. 

Abordaje multidisciplinar en el tratamiento de una hemoptisis grave con amenaza vital 

REV ESP ANESTESIOL REANIM 57: 667-670 

Romero B, Delgado L, Fernandez M, Fernandez C, Colli A, Camara ML, Ruyra X 

Ruptura traumàtica de la vàlvula mitral 

CIR CARDIOVASC 17(1): 97-100 

Ruyra-Baliarda X. 

Preliminary experience with the no prolapse system. A new device for ensuring the proper length of 

artificial chordae in mitral valve repair. 

Interact cardiovasc thorac surg 2010 Feb;10(2):165-7. Epub 2009 Nov 12. 

Teis A, Cámara ML, Ferrer E, Romero-Ferrer B. 

Critical stenosis of pulmonar Homograft Induced by surgical in Ross procedure. 

Asian Cardiovasc Thorac Ann 2010 Aug;18(4):382-3 


CIRURGIA 

GENERAL I 

DIGESTIVA 


Argelagués MR, Pallarès MG, Castillo JM, Ubiergo MS, Rodríguez JF. 

Unusual subcutaneous manifestation of severe acute pancreatitis. 

REV ESP ENFERM DIG 2010 Feb;102(2):139-40. 

IF: 1,13 


Balibrea del Castillo, JM; Arias-Diaz, J; Martin, MCG; Vives-Pi, M; Perez, JCG; Cid, RC; Ameigeiras, EV; 

Cantero, JLB 

Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation 

by acute rejection cytokines 

Cirugía Española 2010 Jun;87(6):372-7. Epub 2010 May 10. 





IF: 4,023 




Men. SEX TRANSM DIS 2010 May;37(5):311-5 

IF: 3,268 

Esteban, C; Perez, P; Fernandez-Llamazares, J; Surinach, JM; Camafort, M; Martorell, A; Monreal, M 

Clinical Outcome in Patients With Peripheral Artery Disease and Renal Artery Stenosis 

ANGIOLOGY 2010 Feb-Mar;61(1):58-65. Epub 2008 Dec 18. 

IF: 0,992 

Perez-Romero, N; Serra, A; Granada, ML; Rull, M; Alastrue, A; Navarro-Diaz, M; Romero, R; Fernandez- 

Llamazares, J 

Effects of Two Variants of Roux-en-Y Gastric Bypass on Metabolism Behaviour: Focus on Plasma Ghrelin 

Concentrations Over a 2-Year Follow-up 

OBES SURG 2010; MAY, 20 (5) 600-609 

IF: 3,078 


Fraile M. 





Projectes 

BALIBREA DEL CASTILLO, JOSÉ MARÍA 

FIS - Núm. Exp.: PS09/00759 

Estudio comparativo de la respuesta inflamatoria local y sistémica tras gastrectomía abierta o 

laparoscópica por cáncer 

Durada: 3 anys - (2009-2012) 


JULIAN IBAÑEZ, JUAN FRANCISCO 

CIDEM - Núm. Exp.: VALTEC09-2-0098 

Ús de gel de plaquetes per a la cirurgia restitutiva de volum de la mama (PRP) 

Durada: 2 anys - (2009-2011) 


PACHA GONZALEZ, MIGUEL ANGEL 

Grupo CTO - Núm. Exp.: 

Modelos experimentales para el estudio del hipoesplenismo. 

Durada: 1 anys - (2010-2011) 



CIRURGIA 

TORÀCICA 



Felip E, Rosell R, Maestre JA, Rodríguez-Paniagua JM, Morán T, Astudillo J, Alonso G, Borro JM, 

González-Larriba JL, Torres A, Camps C, Guijarro R, Isla D, Aguiló R, Alberola V, Padilla J, Sánchez- 

Palencia A, Sánchez JJ, Hermosilla E, Massuti B; Spanish Lung Cancer Group. 

Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery 

Alone in Early-Stage Non-Small-Cell Lung Cancer 

J CLIN ONCOL 2010; jul-01, 28 (19) 3138-3145 

IF: 18,97 

Martinez-Barenys C, Busquets J, de Castro PE, Garcia-Guasch R, Perez J, Fernandez E, Mesa MA, 

Astudillo J. 

Randomized double-blind comparison of phrenic nerve infiltration and suprascapular nerve block for 

ipsilateral shoulder pain after thoracic surgery. 

EUR J CARDIO-THORAC 2010 Dec 7. [Epub ahead of print] 

IF: 2,293 






DERMATOLOGIA 


Boada A, Bielsa I, Fernández-Figueras MT, Ferrándiz C. 

Perniosis. Clinical and histopathological analysis. 

AM J DERMATOPATH 2010 Feb;32(1):19-23 

IF: 1,263 


Carretero G, Puig L, Dehesa L, Carrascosa JM, Ribera M, Sánchez-Regaña M, Daudén E, Vidal D, Alsina M, 

Muñoz-Santos C, López-Estebaranz JL, Notario J, Ferrandiz C, Vanaclocha F, García-Bustinduy M, 

Taberner R, Belinchón I, Sánchez-Carazo J, Moreno JC. 

Guidelines on the use of methotrexate in psoriasis. 

ACTAS DERMOSIFILIOGR 2010 Sep; 101: 600-13 

Fernández-Figueras MT, Puig L, Cannata P, Cuatrecases M, Quer A, Ferrándiz C, Ariza A 

Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases. 

AM J DERMATOPATH 2010 May 6. [Epub ahead of print] 

IF: 1,263 

Ferrándiz C, Carrascosa JM 

Transición de tratamientos sistémicos clásicos a etanercept. 

ACTAS DERMOSIFILIOGR 2010; 101 (Supl.1) 45-49 

Ferrandiz C, Carrascosa JM, Boada A 

A new era in the management of psoriasis? The biologics: facts and controvèrsies 

CLIN DERMATOL 2010 Jan-Feb;28(1):81-7. 

IF: 2,424 

Ferrándiz-Pulido C, Ferrándiz C. 

Molluscum Contagiosum. 

Piel 2010; 25: 203-210 

Fuente MJ 

El resurgir de la sífilis 

ACTAS DERMOSIFILIOGR 2010; 101(10): 817-9 

Guinovart MR, Carrascos JM, Ferrándiz C. 

Leucemia cutis desarrollada en la zona de inoculación de una dosis de recuerdo de la vacuna del 

tétanos. 

ACTAS DERMOSIFILIOGR 2010; 101: 727-28 

Mangas C, Paradelo C, Puig S, Gallardo F, Marcoval J, Azon A, Bartralot R, Bel S, Bigatà X, Curcó N, 

Dalmau J, Del Pozo LJ, Ferrándiz C, Formigón M, González A, Just M, Llambrich A, Llistosella E, Malvehy J, 

Martí RM, Nogués ME,Pedragosa R, Rocamora V, Sàbat M, Salleras M. 

Initial evaluation, diagnosis, staging, treatment, and follow-up of patients with primary cutaneous 

malignant melanoma. Consensus statement of the network of Catalan and Balearic Melanoma Centers. 


ACTAS DERMOSIFILIOGR 2010 Mar; 101(2): 129-142 

Masferrer E, Vicente MA, Bassas-Vila J, Rovira C, González-Enseñat MA. 

Porokeratotic eccrine ostial and dermal duct naevus: report of 10 cases. 

J EUR ACAD DERMATOL 2010 Jul;24(7):847-51 

IF: 3,309 

Morell L, Bassas-Vila J, Ferrándiz C. 

El síndrome de las uñas amarillas. 

Piel 2010; 25: 504-506 

Puig L, Daudén E, Carrascosa JM 

Comentario a las directrices Europea y Británica para el tratamiento de psoriasis 

ACTAS DERMOSIFILIOGR 2010; 101(4): 285-90 

Rodríguez-Caruncho C, Bielsa I. 

Dermatitis granulomatosa intersticial. 

Semin Fund Esp Reumatol 2010; 11: 64-9 

Ruiz MA, Heras F, Alomar A, Conde-Salazar L, de la Cuadra J, Serra E, Regalado F, Halbach R; GEIDAC 

Group (Carrascosa M) 

Development and validation of a questionnaire on Satisfaction with dermatological treatment of hand 

eczema. 

HEALTH QUAL LIFE OUT 2010; Nov 5, 8: 127 

IF: 1,86 

Sánchez-Regaña M, Dilmé E, Puig L, Bordas X, Carrascosa JM, Ferran M, Herranz P, García-Bustinduy M, 

López Estebaranz JL, Alsina M, Rodríguez MA, Ribera M,Fernández-López E, Moreno JC, Belinchón 

Romero I, Vidal D; Grupo Español de Psoriasis de la Academia Española 

Efectos adversos observados durante la terapia biologica en la psoriasis. Resultados de una encuesta al 

Grupo Espanol de Psoriasis 

ACTAS DERMOSIFILIOGR 2010 Mar; 101(2): 156-63 


DIRECCIÓ 

CIENTÍFICA 

Projectes 

GASSULL DURO, MIQUEL ANGEL 

CIDEM - Núm. Exp.: VALCON08-2-0008 

Avaluació de la cartera de projectes de l'IGTP. 

Durada: 1 anys - (2009-2010) 



ENDOCRINOLOGIA 

I NUTRICIÓ 



Alonso N, Granada ML, Soldevila B, Salinas I, Joaquin C, Reverter JL, Juncà J, Martínez Cáceres EM, 

Sanmartí A. 

Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 

diabetes mellitus: a 5-year prospective study. 

J ENDOCRINOL INVEST 2010 Jun 4. [Epub ahead of print] 

IF: 1,476 

Audi L, Fernández-Cancio M, Carrascosa A, Andaluz P, Torán N, Piró C, Vilaró E, Vicens-Calvet E, Gussinyé 

M, Albisu MA, Yeste D, Clemente M, Hernández de la Calle I, Del Campo M, Vendrell T, Blanco A, 

Martínez-Mora J, Granada ML, Salinas I, Forn J, Calaf J, Angerri O, Martínez-Sopena MJ, Del Valle J, 

García E, Gracia-Bouthelier R, Lapunzina P, Mayayo E, Labarta JI, Lledó G, Sánchez Del Pozo J, Arroyo J, 

Pérez-Aytes A, Beneyto M, Segura A, Borrás V, Gabau E, Caimarí M, Rodríguez A, Martínez-Aedo MJ, 

Carrera M, Castaño L, Andrade M, Bermúdez de la Vega JA; Grupo de Apoyo al Síndrome de 

Insensibilidad a los Andrógenos (GrApSIA). 

Novel (60%) and Recurrent (40%) Androgen Receptor Gene Mutations in a Series of 59 Patients with a 

46,XY Disorder of Sex Development 

J CLIN ENDOCR METAB 2010; APR, 95 (4) 1876-1888 

IF: 6,495 

Gómez Candela C, Cantón Blanco A, Luengo Pérez LM, Fuster GO 

Efficacy, cost-effectiveness, and effects on quality of life of nutritional supplementation. 

NUTR HOSP 2010 Oct;25(5):781-92. 

IF: 0,926 





IF: 1,373 

Pellitero S, Reverter JL, Pizarro E, Granada ML, Aguilera E, Sanmarti A. 

Usefulness of pulse oximetry in screening of carotid atherosclerosis in patients with type 2 diabetes 

mellitus. 

MED CLIN-BARCELONA 2010 Jun 5;135(1):15-20. Epub 2010 Mar 6 

IF: 1,413 

Pellitero, S; Reverter, JL; Tassies, D; Pizarro, E; Monteagudo, J; Salinas, I; Aguilera, E; Sanmarti, A; 

Reverter, JC 

Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid 

atherosclerosis in type 2 diabetes. 

THROMB HAEMOSTASIS 2010; MAR, 103 (3) 630-637 

IF: 4,701 


Puig-Domingo M, Resmini E, Gomez-Anson B, Nicolau J, Mora M, Palomera E, Martí C, Halperin I, Webb 

SM. 

Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after 

surgical failure 

J CLIN ENDOCR METAB 2010 Nov;95(11):4973-8. Epub 2010 Aug 25. 

IF: 6,495 

Reverter JL, Colomé E, Halperin I, Julián T, Díaz G, Mora M, Sanmartí A, Puig-Domingo M. 

Comparative study of historical series of differentiated thyroid carcinoma in two tertiary hospitals in 

Spain versus North American series. 

Endocrinol Nutr 2010 Oct;57(8):364-9. Epub 2010 Sep 16. 

Reverter JL, Colomé E, Puig Domingo M, Julián T, Halperin I, Sanmartí A. 

Clinical endocrinologists' perception of the deleterious effects of TSH suppressive therapy in patients 

with differentiated thyroid carcinoma. 

Endocrinol Nutr 2010 Oct;57(8):350-6. Epub 2010 May 24. Spanish. 

Reverter, JL; Colome, E; Holgado, S; Aguilera, E; Soldevila, B; Mateo, L; Sanmarti, A 

Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine 

treatment for differentiated thyroid carcinoma 

ENDOCRINE 2010 Jun;37(3):467-72. Epub 2010 Apr 16. 

IF: 1,373 


EM. 


regulatory CD4 (+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during 

pegylated interferonalpha2a plus ribavirin treatment. 


IF: 3,502 

Projectes 

AGUILERA HURTADO, EVA 

Associació Catalana Diabetes - Núm. Exp.: 

Estudi de la malaltia coronària silent en pacients assimptomàtics afectes de Diabetis tipus 1. 

Durada: 2 anys - (2010-2012) 


SOLDEVILA MADORELL, BERTA 

Societat Catalana d'Endocrinologia i Nutrició - Núm. Exp.: 

Mecanismes patogènics implicats en l’aparició de malaltia autoimmunitària tiroïdal en pacients amb 

melanoma maligne tractats amb interferó-alfa. Paper de les cèl·lules T reguladores. 

Durada: 1 anys - (2009-2010) 



EPIDEMIOLOGIA 

CLÍNICA 







FARMÀCIA 

HOSPITALÀRIA 



AlberoIa I, Alonso RM, Domínguez A, EspuñesJ, Giner P, À. Hernández, Navarro D, Obradors J, Pi-Sunyer 

T, Romans J, Sora M, Torrens Ll 

La neteja als centres sanitaris 

BUTLLETÍ DEL MEDICAMENT - HOSPITAL GERMANS TRIAS I PUJOL 1ª edició: Barcelona, 2010 

Bonafont X, Bosch M, Martin A, Costa J 

Interaccions farmacològiques dels agents antimicrobians 

BUTLLETÍ DEL MEDICAMENT - HOSPITAL GERMANS TRIAS I PUJOL 12 (54) 2010 

Bonafont X, Bosch M, Martin A, Costa J. 

Interaccions farmacològiques amb els antibacterians 

BUTLLETÍ D'INFORMACIÓ TERAPÈUTICA 2010; 22:48-55 

Bosch M, Martin A, Cardona G, Costa J, Portabella E, Bonafont X 

Revisió dels canvis de seguretat durant l´ any 2010. 

REVISIÓ DELS CANVIS DE SEGURETAT DURANT L'ANY 2010 12 (55) 2010 






IF: 5,023 

Martin-Cantera, C; Prieto-Alhambra, D; Roig, L; Valiente, S; Perez, K; Garcia-Ortiz, L; Bel, J; Marques, F; 

Mundet, X; Bonafont, X; Birules, M; Soldevila, N; Briones, E 

Risk levels for suffering a traffic injury in primary health care. The LESIONAT project 

BMC PUBLIC HEALTH 2010; mar-16, 10 () -136 

IF: 2,364 

Morillas RM, Garcia-Retortillo M, Miquel M, Pardo A, Cañete N, Gallach M, Ardèvol M, Coll S, Sala M, 

Dalmau B, Quer JC, Planas R, Solà R. 

Eficàcia d’entecavir en el tractament de l’hepatitis crònica B en la práctica diaria 

SUPLEMENTS DELS ANNALS DE MEDICINA Vol.93-Supl 1- Enero 2010:S1-59 (66). 

Negredo E, Rey-Joly C. 

Cardiovascular risk and human immunodeficiency virus infection: A new clinical challenge 

MED CLIN-BARCELONA 2010 Jul 10;135(5):209-11 

IF: 1,413 


Projectes 

BONAFONT PUJOL, XAVIER 

Ministerio de Sanidad y Politica Social - Núm. Exp.: EC10-094 

Estudio multicéntrico hospitalario del uso de medicamentos en situaciones especiales. Análisis de las 

pruebas científicas, de los resultados clínicos y de los costes. 

Durada: 1 anys - (2010-2011) 



FARMACOLOGIA 

CLÍNICA 



Almirall J, Bolíbar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, 

Torres A; Community-Acquired Pneumonia in Catalan Countries. (Costa J; Ruiz-Manzano J. in 

collaborators) 

Inhaled drugs as risk factors for community-acquired pneumonia. 

EUR RESPIR J 2010 Nov;36(5):1080-7. Epub 2010 Jun 4. 

IF: 5,922 

Bonafont X, Bosch M, Martin A, Costa J 

Interaccions farmacològiques dels agents antimicrobians 

BUTLLETÍ DEL MEDICAMENT - HOSPITAL GERMANS TRIAS I PUJOL 12 (54) 2010 

Bonafont X, Bosch M, Martin A, Costa J. 

Interaccions farmacològiques amb els antibacterians 

BUTLLETÍ D'INFORMACIÓ TERAPÈUTICA 2010; 22:48-55 

Bosch M, Martin A, Cardona G, Costa J, Portabella E, Bonafont X 

Revisió dels canvis de seguretat durant l´ any 2010. 

REVISIÓ DELS CANVIS DE SEGURETAT DURANT L'ANY 2010 12 (55) 2010 

Costa Pagès J, Polanco Allué I, Rodrigo Gonzalo de Liria C. 

Guía de práctica clínica: Gastroenteritis aguda en el niño. Guía multidisciplinar. 

SEGNHP-SEIP 2010 






IF: 5,023 

López A, Montané E. 

Practical aspects for the assessment of clinical trials with prophylactic vaccines against infectious 

diseases. 

MED CLIN-BARCELONA 2010 Nov 20;135(15):707-12. Epub 2010 Oct 15 

IF: 1,413 

Montané E, Barriocanal A, Portabella E, García F, Bel J, Just M, Lezcano C, Morató L, Muga R, Pintanel T, 

Santesmases J, Valls RM, Vilar D, Costa J. 

Farmacovigilancia: Reaccions adverses a medicaments (RAM). 

BUTLLETÍ DEL MEDICAMENT - HOSPITAL GERMANS TRIAS I PUJOL 12(53) 2010 

Montané E, Lecumberri J, Pedro-Botet ML. 


Influenza A, pregnancy and neuraminidase inhibitors. 

MED CLIN-BARCELONA 2010 Apr 22. [Epub ahead of print] 

IF: 1,413 

Ruiz-Antorán B, Agustí Escasany A, Vallano Ferraz A, Danés Carreras I, Riba N, Mateu Escudero S, Costa J, 

Sánchez Santiago MB, Laredo L, Durán Quintana JA, Castillo JR, Abad-Santos F, Payares Herrera C, 

Sádaba Díaz de Rada B, Gómez Ontañón E. 

Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital 

protocol. 

EUR J CLIN PHARMACOL 2010 Jun;66(6):633-41 

IF: 3,032 



vaccine RUTI. 


IF: 3,572 

Projectes 

COSTA PAGES, JOAN 

FIS - Núm. Exp.: EC08/00266 

Estudio prospectivo multicéntrico de la incidencia, relevancia clínica, factores de riesgo y preventibilidad 

del ingreso hospitalario por fracaso renal agudo asociado al uso de fármacos inhibidores del sistema 

renina-angiotensina. 

Durada: 3 anys - (2008-2011) 



FUNDACIÓ 

IRSICAIXA 



Achhra AC, Amin J, Law MG, Emery S, Gerstoft J, Gordin FM, Vjecha MJ, Neaton JD, Cooper DA; INSIGHT 

ESPRIT & SILCAAT study groups. (Clotet B. in collaborators) 

Immunodeficiency and the risk of serious clinical endpoints in a wellstudied cohort of treated HIVinfected 

patients. 

AIDS 2010 Jul 31;24(12):1877-86. 

IF: 6,348 

Aparicio, E; Parera, M; Franco, S; Perez-Alvarez, N; Tural, C; Clotet, B; Martinez, MA 

IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-alpha and Ribavirin Therapy 

Treatment Failure in HCV/HIV-1 Coinfected Patients 

PLOS ONE 2010; oct-29, 5 (10) -e13771 

IF: 4,411 

Armand-Ugón M, Moncunill G, Gonzalez E, Mena M, Ballana E, Clotet B, Esté JA. 

Different selection patterns of resistance and cross-resistance to HIV-1 agents targeting CCR5. 

J ANTIMICROB CHEMOTH 2010 Mar;65(3):417-24. Epub 2010 Jan 12. 

IF: 4,659 

Aucher A, Puigdomènech I, Joly E, Clotet B, Hudrisier D, Blanco J. 

Could CD4 capture by CD8+ T cells play a role in HIV spreading? 

J BIOMED BIOTECHNOL 2010;2010:907371. Epub 2010 Mar 25. 

IF: 1,225 

Ballana, E; Senserrich, J; Pauls, E; Faner, R; Mercader, JM; Uyttebroeck, F; Palou, E; Mena, MP; Grau, E; 

Clotet, B; Ruiz, L; Telenti, A; Ciuffi, A; Este, JAZNRD1 (Zinc Ribbon Domain-Containing 1) 

Is a Host Cellular Factor That Influences HIV-1 Replication and Disease Progression 

CLIN INFECT DIS 2010; APR 1, 50 (7) 1022-1032 

IF: 8,186 

Betancor G, Puertas MC, Nevot M, Garriga C, Martínez MA, Martinez-Picado J, Menéndez-Arias L. 

Mechanisms Involved in the Selection of HIV-1 Reverse Transcriptase Thumb Subdomain Polymorphisms 

Associated with Nucleoside Analogue Therapy Failure. 

ANTIMICROB AGENTS CH 2010 Nov;54(11):4799-811. Epub 2010 Aug 23. 

IF: 4,672 

Bonjoch A, Bayés B, Riba J, Puig J, Estany C, Perez-Alvarez N, Clotet B, Negredo E. 

Validation of estimated renal function measurements compared with the isotopic glomerular filtration 

rate in an HIV-infected cohort. 

ANTIVIR RES 2010 Dec;88(3):347-54 

IF: 4,439 

Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L, di Gregorio S, Puig J, Gómez G, 


Clotet B, Negredo E; Osteoporosis Study Group. 

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal 

cohort study. 

AIDS 2010 Nov 27;24(18):2827-33 

IF: 6,348 

Buzón MJ, Dalmau J, Puertas MC, Puig J, Clotet B, Martinez-Picado J. 

The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary 

virus isolates. 

AIDS 2010 Jan 2;24(1):17-25 

IF: 6,348 

Buzón MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, 

Sharkey M, Palmer S, Stevenson M, Clotet B, Blanco J, Martinez-Picado J. 

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed 

subjects. 

NAT MED 2010 Apr;16(4):460-5 

IF: 25,43 



Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women J CLIN 

VIROL 2010; JUL, 48 (3) 198-201 

IF: 4,023 






IF: 3,268 


Group. 



IF: 4,784 

Caro-Murillo AM, Gil Luciano A, Navarro Rubio G, Leal Noval M, Blanco Ramos JR; Cohorte de la Red de 

Investigación en Sida (CoRIS). (in collaborators Clotet B, Tural C, Ruiz L, Muga R, Tor J, Sanvisens A, 

Blanco J) 

[HIV infection in different age groups: Potential implications for prevention. CoRIS Cohort, Spain, 2004- 

2008]. 

MED CLIN-BARCELONA 2010 Apr 24;134(12):521-7. Epub 2010 Mar 6. 

IF: 1,413 

Clotet B, Clumeck N, Katlama C, Nijs S, Witek J. 

Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from 

the Phase III DUET trials. 

J ANTIMICROB CHEMOTH 2010 Nov;65(11):2450-4. Epub 2010 Aug 27. 

IF: 4,659 


Codoñer FM, Pou C, Thielen A, García F, Delgado R, Dalmau D, Santos JR, Buzón MJ, Martínez-Picado J, 

Alvarez-Tejado M, Clotet B, Ruiz L, Paredes R. 

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure 


IF: 4,439 

Cunyat, F; Ruiz, L; Marfil, S; Puig, T; Bofill, M; Blanco, J; Clotet, B; Cabrera, C 

Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant 

combination of atazanavir and amprenavir 

ANTIVIR THER 2010; , 15 (3) 431-436 

IF: 4,322 

Demetriou, VL; van de Vijver, DAMC; Kousiappa, I; Balotta, C; Clotet, B; Grossman, Z; Jorgensen, LB; 

Lepej, SZ; Levy, I; Nielsen, C; Paraskevis, D; Poljak, M; Roman, F; Ruiz, L; Schmidt, JC; Vandamme, AM; 

Van Laethem, K; Vercauteren, J; Kostrikis, LG 

Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in 

Newly-Diagnosed Patients in Europe 

PLOS ONE 2010; jun-08, 5 (6) -e10976 

IF: 4,411 

Dollard, SC; Butler, LM; Jones, AMG; Mermin, JH; Chidzonga, M; Chipato, T; Shiboski, CH; Brander, C; 

Mosam, A; Kiepiela, P; Hladik, W; Martin, JN 

Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights 

on the origin of the "Kaposi's sarcoma Belt" 

INT J CANCER 2010; nov-15, 127 (10) 2395-2401 

IF: 4,926 

Dore GJ, Soriano V, Rockstroh J, Kupfer B, Tedaldi E, Peters L, Neuhaus J, Puoti M, Klein MB, Mocroft A, 

Clotet B, Lundgren JD; SMART INSIGHT study group. 

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following 

antiretroviral therapy interruption. 

AIDS 2010 Mar 27;24(6):857-65. 

IF: 6,348 

Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portilla J, Prieto A, López JC, Rubio R, 

Mariño A, Pedrol E, Viladés C, del Arco A, Moreno A, Bravo I, López-Blazquez R, Pérez-Alvarez N, Clotet 

B. 

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with 

abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study 

(Lake Study) 

ANTIVIR RES 2010 Feb;85(2):403-8. Epub 2009 Nov 24. 

IF: 4,439 

Esté JA, Cihlar T. 

Current status and challenges of antiretroviral research and therapy. 

ANTIVIR RES 2010 Jan;85(1):25-33. Epub 2009 Dec 16. 

IF: 4,439 

Franco S. et al. 

Impact of antiretroviral therapy interruption on HCV diversity in patients co-infected with HCV and HIV- 


1: a substudy of the TIBET trial 

AIDS 2010 

IF: 6,348 

Frentz D, Boucher CA, Assel M, De Luca A, Fabbiani M, Incardona F, Libin P, Manca N, Müller V, O 

Nualláin B, Paredes R, Prosperi M, Quiros-Roldan E, Ruiz L, Sloot PM, Torti C, Vandamme AM, Van 

Laethem K, Zazzi M, van deVijver DA. 

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes 

over time. 

PLOS ONE 2010 Jul 9;5(7):e11505 

IF: 4,411 

Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk 

O, Phillips A, Sabin CA, Lundgren JD, Law MG; DAD study group. (R. Paredes as member of the EuroSIDA 

Study Group) 

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse 

effects of anti-HIV drugs study 

EUR J CARDIOV PREV R 2010 Oct;17(5):491-501 

IF: 2,633 

Garcia-Prado J, Prendergast A, Thobakgale C, Molina C, Tudor-Williams G, Ndung'u T, Walker BD, 

Goulder P. 

Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is 

associated with pediatric disease progression rate. 

J VIROL 2010 Jan;84(1):492-502. Epub . 

IF: 5,189 

Gatell JM, Katlama C, Grinsztejn B, Eron JJ, Lazzarin A, Vittecoq D, Gonzalez CJ, Danovich RM, Wan H, 

Zhao J, Meibohm AR, Strohmaier KM, Harvey CM, Isaacs RD, Nguyen BY; Protocol 005 Team. (Blanco J, 

Clotet B in collaborators) 

Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment 

options in a Phase II study. 

JAIDS-J ACQ IMM DEF 2010 Apr 1;53(4):456-63. 

IF: 4,262 

González-Ortega E, Mena MP, Permanyer M, Ballana E, Clotet B, Esté JA. 

ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block the fusion-active gp41 core 

formation. 

ANTIMICROB AGENTS CH 2010 Oct;54(10):4487-92. Epub 2010 Jul 19 

IF: 4,672 

Gonzalez, E., M. P. Mena, M. Armand-Ugon, E. Ballana, B. Clotet, and J. Este. 2010. 

Development of Resistance to the Natural HIV-1 Entry Virus Inhibitory Peptide (VIRIP) 

ANTIVIR RES 2010.02.375|65 

IF: 4,439 

Hill AM, Clotet B, Johnson M, Stoll M, Bellos N, Smets E. 

Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy 

in Highly Pretreated Patients: The POWER Experience. 

PHARMACOECONOMICS 2010 Dec 23;28 Suppl 1:69-81. doi: 10.2165/11587460-000000000-00000. 

IF: 3,44 


International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, 

Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge 

RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, 

Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, 

Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, 

Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, 

Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, 

Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos 

K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, 

Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch 

C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, 

Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, 

Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, 

Cornelson B, Cox DT, Cristofano MV, Cuchural G Jr, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, 

Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo 

H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant 

JE, Gandhi RT, Garcia E, Garmon D, Gathe JC Jr, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, 

Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins 

TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert 

MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, 

Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, 

Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, 

Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, 

Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin 

HL Jr, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, 

Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, 

Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, 

Oldfield EC 3rd, Olender SA, Ostrowski M, Owen WF Jr, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, 

Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch 

M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC 3rd, Rosenberg 

ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, 

Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM 

Jr, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, 

Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, 

Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, 

Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, 

Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, 

Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M 

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. The 

International HIV Controllers Study. 

SCIENCE 2010 Dec 10;330(6010):1551-7. Epub 2010 Nov 4. 

IF: 31,364 

Izquierdo-Useros N, Naranjo-Gómez M, Erkizia I, Puertas MC, Borràs FE, Blanco J, Martinez-Picado J. 

HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? 

PLOS PATHOG 2010 Mar 26;6(3):e1000740 

IF: 9,079 

Johnson, V.A., Brun-Vézinet, F., Clotet, B., Günthard, H.F., Kuritzkes, D.R., Pillay, D., Schapiro, J.M., 

Richman, D.D., 


International AIDS Society–USA. 

Topics in HIV Medicine 156. Special Contribution. Update of the Drug Resistance Mutations in HIV-1: 

December 2010. 

Top HIV Medicine 2010 Dec;18(5):156-63 

Joseph, J; Fernandez-Lloris, R; Pezzat, E; Saubi, N; Cardona, PJ; Mothe, B; Gatell, JM 

Molecular Characterization of Heterologous HIV-1gp120 Gene Expression Disruption in Mycobacterium 

bovis BCG Host Strain: A Critical Issue for Engineering Mycobacterial Based-Vaccine Vectors 

J BIOMED BIOTECHNOL 2010;2010:357370. Epub 2010 Jun 27. 

IF: 1,225 

Julg B, Pereyra F, Buzón MJ, Piechocka-Trocha A, Clark MJ, Baker BM, Lian J, Miura T, Martinez-Picado J, 

Addo MM, Walker BD. 

Infrequent recovery of HIV from, but robust exogenous infection of activated CD4+ T-cells from HIV elite 

controllers 

CLIN INFECT DIS 2010 Jul 15;51(2):233-8 

IF: 8,186 

Katlama C, Clotet B, Mills A, Trottier B, Molina JM, Grinsztejn B, Towner W, Haubrich R, Nijs S, 

Vingerhoets J, Woodfall B, Witek J. 

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the 

DUET-1 and DUET-2 trials. 

ANTIVIR THER 2010;15(7):1045-52 

IF: 4,322 

Leslie, A; Matthews, PC; Listgarten, J; Carlson, JM; Kadie, C; Ndung'u, T; Brander, C; Coovadia, H; Walker, 

BD; Heckerman, D; Goulder, PJR 

Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection 

J VIROL 2010 Oct;84(19):9879-88. Epub 2010 Jul 21. 

IF: 5,189 

Llibre JM, Antela A, Arribas JR, Domingo P, Gatell JM, López-Aldeguer J, Lozano F, Miralles C, Moltó J, 

Moreno S, Ortega E, Riera M, Rivero A, Villalonga C, Clotet B. 

Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy. 

ENFERM INFEC MICR CL 2010 Nov;28(9):615-20 

IF: 1,656 

Llibre JM, Schapiro JM, Clotet B. 

Clinical Implications of Genotypic Resistance to the Newer Antiretroviral Drugs in HIV-1-Infected 

Patients with Virological Failure. 

CLIN INFECT DIS 2010 Mar 15;50(6):872-81 

IF: 8,186 

Malan N, Su J, Mancini M, Yang R, Wirtz V, Absalon J, McGrath D; CASTLE Study Team (Clotet B) 

Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV 

1-infected patients: data from the CASTLE study. 

AIDS CARE 2010 Jun;22(6):677-86. 

Martin-Iguacel R, Llibre JM, Nielsen H, Heras E, Matas L, Lugo R, Clotet B, Sirera G. 

Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in 

industrialised countries. 


EUR J CLIN MICROBIOL 2010 Aug;29(8):917-25 

IF: 2,631 

Martinez, E; Larrousse, M; Llibre, JM; Gutierrez, F; Saumoy, M; Antela, A; Knobel, H; Murillas, J; 

Berenguer, J; Pich,J; Perez, I; Gatell, JM 

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL 

study 

AIDS 2010; JUL, 24 (11) 1697-1707 

IF: 6,348 

Más A, López-Galíndez C, Cacho I, Gómez J, Martínez MA. 

Unfinished Stories on Viral Quasispecies and Darwinian Views of Evolution. 

J MOL BIOL 2010 Apr 9;397(4):865-77 

IF: 4,008 

Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, 

Lundgren JD; EuroSIDA Study Group. (R. Paredes as member of the EuroSIDA Study Group) 

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive 

patients. 

AIDS 2010 Jul 17;24(11):1667-78 

IF: 6,348 

Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, Gatell J, Rakhmanova A, Johnson 

M, Kirk O, Lundgren J; EuroSIDA Study Group. (R. Paredes as member of the EuroSIDA Study Group) 

Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. 

JAIDS-J ACQ IMM DEF 2010 Oct 1;55(2):262-70 

IF: 4,262 

Moltó J, Deig E, Valle M, Llibre JM, Miranda C, Cedeño S, Valero S, Negredo E, Clotet B 

Effect of Nevirapine on the Steady-State Trough Concentrations of Atazanavir in HIV-Infected Patients 

Receiving Atazanavir/Ritonavir. 

THER DRUG MONIT 2010 Feb;32(1):93-6 

IF: 3,127 

Moltó J, Sanz-Moreno J, Valle M, Cedeño S, Bonal J, Bouarich H, Clotet B. 

Minimal Removal of Raltegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease. 

ANTIMICROB AGENTS CH 2010 Jul;54(7):3047-8 

IF: 4,672 

Moltó J, Valle M, Santos JR, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Clotet B. 

Efficacy and Safety of Ritonavir Dose Reduction Based on the Tipranavir Inhibitory Quotient in HIV- 

Infected Patients on Salvage Antiretroviral Therapy With Tipranavir/Ritonavir 

AIDS RES HUM RETROV 2010 Nov;26(11):1191-6. Epub 2010 Sep 23. 

IF: 2,082 

Moltó J, Valle M, Santos JR, Mothe B, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Barbanoj MJ, 

Clotet B. 

Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in 

heavily pretreated HIV-infected patients. 

ANTIVIR THER 2010;15(2):219-25 

IF: 4,322 


Munoz-Moreno, JA; Fumaz, CR; Prats, A; Ferrer, MJ; Negredo, E; Perez-Alvarez, N; Molto, J; Gomez, G; 

Garolera, M; Clotet, B 

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental 

to neurocognitive functioning? 

J NEUROVIROL 2010; JUN, 16 (3) 208-218 

IF: 2,243 

Papagno, L., Alter, G., Assoumou, L., Murphy, R.L., Garcia, F., Clotet, B., Larsen, M., Braibant, M., 

Marcelin, A.G., Costagliola, D., Altfeld, M., Katlama, C., Autran, B., the ORVACS Study Group. 2011. 

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic 

immunization with ALVAC-HIV vaccine 

INFECT DIS CLIN N AM 2010;2;25(1):27-36 

IF: 3 

Paredes R, Cheng I, Kuritzkes DR, Tuomala RE; Women and Infants Transmission Study (WITS) Group. 

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited 

antiretroviral therapy. 

AIDS 2010 Jan 2;24(1):45-53. 

IF: 6,348 

Paredes R, Clotet B.Clinical management of HIV-1 resistance. 

ANTIVIR RES 2010 Jan;85(1):245-65. Epub 2009 Oct 4. Review. 

IF: 4,439 

Paredes R, Lalama CM, Ribaudo HJ, Schackman BR, Shikuma C, Giguel F, Meyer WA 3rd, Johnson VA, 

Fiscus SA, D'Aquila RT, Gulick RM, Kuritzkes DR; AIDS Clinical Trials Group (ACTG) A5095 Study Team. 

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment 

failure. 

J INFECT DIS 2010 Mar;201(5):662-71 

IF: 6,288 

Patricia E, Domingo P, Gutierrez M, Gracia M, Fuster M, Molto J, Puig J, Perez-Alvarez N, Clotet B, 

Negredo E. 

Saquinavir/Ritonavir Monotherapy as a New Nucleoside-Sparing Maintenance Strategy in Long-Term 

Virologically Suppressed HIV-Infected Patients. 

CURR HIV RES 2010 Sep 1;8(6):467-70 

IF: 1,923 

Permanyer M, Ballana E, Esté JA. 

Endocytosis of HIV: anything goes. 

TRENDS MICROBIOL 2010 Dec;18(12):543-51 

IF: 7,5 

Pettersson S, Pérez-Nueno VI, Mena MP, Clotet B, Esté JA, Borrell JI, Teixidó J. 

Novel Monocyclam Derivatives as HIV Entry Inhibitors: Design, Synthesis, Anti-HIV Evaluation, and Their 

Interaction with the CXCR4 Co-receptor. 

CHEMMEDCHEM 2010 Aug 2;5(8):1272-81 

IF: 3,306 

Pineda, JA; Gonzalez, J; Ortega, E; Tural, C; Macias, J; Griffa, L; Burgos, A 


Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in 

HIV/hepatitis C virus-coinfected patients 

J VIRAL HEPATITIS 2010 Oct;17(10):714-9. doi: 10.1111/j.1365-2893.2009.01229.x. 

IF: 3,502 

Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV 

Epidemiological Research Europe (COHERE), Lodwick R, Costagliola D, Reiss P, Torti C, Teira R, Dorrucci 

M, Ledergerber B, Mocroft A, Podzamczer D, Cozzi-Lepri A, Obel N, Masquelier B, Staszewski S, García F, 

De Wit S, Castagna A, Antinori A, Judd A, Ghosn J, Touloumi G, Mussini C, Duval X, Ramos J, Meyer L, 

Warsawski J, Thorne C, Masip J, Pérez-Hoyos S, Pillay D, van Sighem A, Lo Caputo S, Günthard H, Paredes 

R, De Luca A, Paraskevis D, Fabre-Colin C, Kjaer J, Chêne G, Lundgren JD, Phillips AN. 

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. 

ARCH INTERN MED 2010 Mar 8;170(5):410-9 

IF: 10,639 

Radi M, Angeli L, Franchi L, Contemori L, Maga G, Samuele A, Zanoli S, Armand-Ugon M, Gonzalez E, 

Llano A, Esté JA, Botta M. 

Towards novel S-DABOC inhibitors: synthesis, biological investigation, and molecular modeling studies. 

BIOORG MED CHEM LETT 2008 Nov 1;18(21):5777-80. Epub 2008 Sep 23. 

IF: 2,661 

Reekie J, Kosa C, Engsig F, Monforte A, Wiercinska-Drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, 

Lundgren JD, Mocroft A; EuroSIDA Study Group. (Clotet B.) 

Relationship between current level of immunodeficiency and non-acquiredimmunodeficiency 

syndrome-defining malignancies. 

CANCER SCI 2010 Nov 15;116(22):5306-15 

IF: 3,846 

Reekie, J; Mocroft, A; Ledergerber, B; Beniowski, M; Clotet, B; van Lunzen, J; Chiesi, A; Pradier, C; 

Machala, L; Lundgren, JD 

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure 

after a treatment change 

HIV MED 2010 Aug;11(7):469-78. Epub 2010 Feb 22. 

IF: 3,575 

Romeu J, Clotet B. 

HIV sexual transmission. Should we review the risk among individuals with long-term viral supression? 

MED CLIN-BARCELONA 2010 Feb 13;134(4):158-60 

IF: 1,413 

Ruiz-Hernandez, R et al. 

Distribution of CD31 on CD4 t-cells from cord blood, peripheral blood and tonsil at different stages of 

differentiation 

THE OPEN IMMUNOLOGY JOURNAL 2010;3 

Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung 

RT, Rockstroh JK, Spengler U. GB virus C coinfection in advanced HIV type-1 disease is associated with 

low CCR5 and CXCR4 surface expression on CD4(+) T-cells 

ANTIVIR THER 2010;15(5):745-52. 

IF: 4,322 


Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte A, Flisiak R, 

Lundgren J; EuroSIDA. (R. Paredes as member of the EuroSIDA Study Group) 

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in 

Europe. J ANTIMICROB CHEMOTH 2010 Mar;65(3):548-55 

IF: 4,659 

Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama 

C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Clotet B, Zhao J, Wan H, Rhodes RR, 

Strohmaier KM, Barnard RJ, Isaacs RD, Nguyen BY; BENCHMRK Study Teamsa. 

Long-term efficacy and safety of Raltegravir combined with optimizedbackground therapy in treatmentexperienced 

patients with drugresistantHIV infection: week 96 results of the BENCHMRK 1 and 2Phase 

III trials. 

CLIN INFECT DIS 2010 Feb 15;50(4):605-12. 

IF: 8,186 

Van den Eynde, E; Tiraboschi, JM; Tural, C; Sola, R; Mira, JA; Podzamczer, D; Jou, A; Canete, N; Pineda, 

JA; Pahissa, A; Crespo, M 

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C 

virus/HIV coinfected patients 

AIDS 2010; APR 24, 24 (7) 975-982 

IF: 6,348 

Vieira, CR; Munoz-Olaya, JM; Sot, J; Jimenez-Baranda, S; Izquierdo-Useros, N; Abad, JL; Apellaniz, B; 

Delgado, R; Martinez-Picado, J; Alonso, A; Casas, J; Nieva, JL; Fabrias, G; Manes, S; Goni, FM 

Dihydrosphingomyelin Impairs HIV-1 Infection by Rigidifying Liquid-Ordered Membrane Domains 

CHEM BIOL 2010; jul-30, 17 (7) 766-775 

IF: 5,838 

Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, El-Sadr W, Phillips 

A, Lundgren J, Sabin C; D:A:D study group. (R. Paredes as member of the EuroSIDA Study Group) 

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of 

the metabolic syndrome. 

AIDS 2010 Jan 28;24(3):427-35 

IF: 6,348 

Projectes 

BLANCO ARBUES, JULIAN MIGUEL 


Herramientas para la cuantificación de la respuesta humoral protectiva contra las proteínas gp120 y gp41 

del VIH. Análisis de indicadores de protección y diseño racional de inmunógenos. 

Durada: 3 anys - (2008-2011) 


BLANCO ARBUES, JULIAN MIGUEL 

FIPSE - Núm. Exp.: 36750/08 

Evaluación de la adenosina desaminasa como molécula coestimuladora de la actividad linfocitaria en una 

vacuna terapéutica del VIH. 

Durada: 3 anys - (2008-2011) 



BOFILL SOLIGUER, MARGARITA 


Impacto de la infección por el VIH sobre acción de la IL-12 e IL-18 sobre monocitos y macrófagos: 

relevancia sobre el control de Mycobacterium tuberculosis y Mycobacterium avium. 

Durada: 3 anys - (2008-2011) 


BRANDER, CHRISTIAN 

FIPSE - Núm. Exp.: 36-0737-09 

Caracterización de los factores inmunológicos, genéticos y virales que determinan la pérdida del control 

de la infección por el VIH en la población de progresores lentos (LTNP) 

Durada: 3 anys - (2009-2012) 


CABRERA NAVARRO, CECILIA 


Efecto del tratamiento con T-20 en las funciones de la envuelta viral: relaciones de fusogenicidad, 

patogenicidad e infectividad en virus T-20-resistentes. 

Durada: 3 anys - (2007-2010) 


CABRERA NAVARRO, CECILIA 

FIPSE - Núm. Exp.: 36725/08 

Caracterización de los factores virales e inmunológicos que protegen las células CD4 en pacientes VIH+ sin 

tratamiento que presentan niveles de CD4 constantes y replicación viral elevada. 

Durada: 3 anys - (2008-2011) 


CLOTET SALA, BONAVENTURA 


Interacciones farmacológicas entre echinacea Purpurea y etravirina 

Durada: 1 anys - (2010-2011) 


LLANO MONTERO, ANUSKA 

FIS - Núm. Exp.: PS09/00283 

Definition of protective immunity to HIV using Toggled peptides 

Durada: 3 anys - (2009-2012) 


MARTINEZ DE LA SIERRA, MIGUEL ANGEL 


Mutagénesis letal del VIH-1 como una nueva estrategia antirretroviral. 

Durada: 3 anys - (2007-2010) 



FUNDACIÓ DE 

LLUITA CONTRA 

LA SIDA 





Treatment Failure in HCV/HIV-1 Coinfected Patients PLOS ONE 2010; oct-29, 5 (10) -e13771 

IF: 4,411 





IF: 4,439 




cohort study. 

AIDS 2010 Nov 27;24(18):2827-33 

IF: 6,348 



B. 



(Lake Study) 


IF: 4,439 





IF: 1,656 

Macías J, González J, Ortega E, Tural C, Cabrero E, Burgos A, Pineda JA; GRAFIHCO Study Team. 

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical 

practice. 

HIV MED 2010 Aug;11(7):439-47 

IF: 3,575 

Martínez E, Larrousse M, Podzamczer D, Pérez I, Gutiérrez F, Loncá M, Barragán P, Deulofeu R, 


Casamitjana R, 

Mallolas J, Pich J, Gatell JM; BICOMBO Study Team. 

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular 

dysfunction. 

AIDS 2010 Jan 28;24(3):F1-9. 

IF: 6,348 

Massanella M, Tural C, Papagno L, Garcia E, Jou A, Bofill M, Autran B, Clotet B, Blanco J. 

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha 2a plus 

ribavirin treatment 

ANTIVIR THER 2010;15(3):333-42 

IF: 4,322 

Massanella, M; Negredo, E; Perez-Alvarez, N; Puig, J; Ruiz-Hernandez, R; Bofill, M; Clotet, B; Blanco, J 

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during 

suppressive 

HAART AIDS 2010; APR 24, 24 (7) 959-968 

IF: 6,348 





IF: 3,127 




IF: 4,672 





IF: 2,082 


Clotet B. 



ANTIVIR THER 2010;15(2):219-25 

IF: 4,322 






IF: 2,243 







IF: 1,413 

Negredo E, Romeu J, Rodríguez-Santiago B, Miró O, Garrabou G, Puig J, Pérez-Alvarez N, Moren C, Ruiz L, 

Bellido R,Miranda C, Clotet B. 

Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite 

persistent impairment of mitochondrial DNA content 

CURR HIV RES 2010 Jul;8(5):379-85 

IF: 1,923 

Negredo, E; Massanella, M; Puig, J; Perez-Alvarez, N; Gallego-Escuredo, JM; Villarroya, J; Villarroya, F; 

Molto, J; Santos, JR; Clotet, B; Blanco, J 

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor 

CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications 

CLIN INFECT DIS 2010; may-01, 50(9)1300-1308 

IF: 8,186 


Negredo E. 




IF: 1,923 





IF: 3,502 

Poveda E, Alcamí J, Paredes R, Córdoba J, Gutiérrez F, Llibre JM, Delgado R, Pulido F, Iribarren JA, García 

Deltoro M, Hernández Quero J, Moreno S, García F. 

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the 

therapeutic use of CCR5 antagonists. 

AIDS REV 2010 Jul-Sep;12(3):135-48 

IF: 4,786 





AIDS 2010; APR 24, 24 (7) 975-982 

IF: 6,348 


Projectes 

MOLTO MARHUENDA, JOSE 


Interacciones farmacológicas entre Echinacea Purpurea y Darunavir/Ritonavir. 

Durada: 1 anys - (2009-2010) 


MOLTO MARHUENDA, JOSE 


Interacciones farmacológicas entre la silimarina y darunavir/ritonavir 

Durada: 1 anys - (2010-2011) 



HEMATOLOGIA I 

HEMOTERÀPIA 



Alvarez-Larran, A; Cervantes, F; Pereira, A; Arellano-Rodrigo, E; Perez-Andreu, V; Hernandez-Boluda, JC; 

Ayats, R; 

Salvador, C; Muntanola, A; Bellosillo, B; Vicente, V; Hernandez-Nieto, L; Burgaleta, C; Xicoy, B; Besses, C 

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential 

thrombocythemia 

BLOOD 2010 Aug 26;116(8):1205-10; quiz 1387. Epub 2010 May 27. 

IF: 10,558 

Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, 

Benoit Y, Biondi A, Cavé H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze 

G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli 

O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ. 

Standardized MRD quantification in European ALL trials: Proceedings of the Second International 

Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. 

LEUKEMIA 2010 Mar;24(3):521-35. Epub 2009 Dec 24. 

IF: 8,966 

E Carreras, L Rosiñol, MJ Terol, A Alegre, F de Arriba, J García-Laraña, JL Bello, R García, A León, R 

Martínez, MJ Peñarrubia, C Poderós, P Ribas, JM Ribera, JF San Miguel, J Bladé, JJ Lahuerta 

Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan 

for autologous blood stem-cell transplantation in multiple myeloma patients. 

BIOL BLOOD MARROW TR 

IF: 3,275 

Espinet, B; Salaverria, I; Bea, S; Ruiz-Xiville, N; Balague, O; Salido, M; Costa, D; Carreras, J; Rodriguez- 

Vicente, AE; Garcia, JL; Hernandez-Rivas, JM; Calasanz, MJ; Siebert, R; Ferrer, A; Salar, A; Carrio, A; Polo, 

N; Garcia-Marco, JA; Domingo, A; Gonzalez-Barca, E; Romagosa, V; Marugan, I; Lopez-Guillermo, A; 

Milla, F; Mate, JL; Luno, E; Sanzo, C; Collado, R; Oliver, I; Monzo, S; Palacin, A; Gonzalez, T; Sant, F; 

Salinas, R; Ardanaz, MT; Font, L; Escoda, L; Florensa, L; Serrano, S; Campo, E; Sole, F 

Incidence and Prognostic Impact of Secondary Cytogenetic Aberrations in a Series of 145 Patients with 

Mantle Cell Lymphoma. 

GENE CHROMOSOME CANC 2010; MAY, 49 (5) 439-451 

IF: 3,99 

Ferra, C; Sanz, J; de la Camara, R; Sanz, G; Bermudez, A; Valcarcel, D; Rovira, M; Serrano, D; Caballero, D; 

Espigado, I; Morgades, M; Heras, I; Solano, C; Duarte, R; Barrenetxea, C; Garcia-Noblejas, A; Diez-Martin, 

JL; Iriondo, A; Carreras, E; Sierra, J; Sanz, MA; Ribera, JM 

Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term 

Outcome Analysis and Study of the Impact of Hematopoietic Graft Source 

BIOL BLOOD MARROW TR 2010 Jul;16(7):957-66. Epub 2010 Feb 7. 

IF: 3,275 

Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N, Hoelzer D, Doubek M, Mayer J, 


Piatkowska-Jakubas B, Skotnicki AB, Dombret H, Ribera JM, Piccaluga PP, Czerw T, Kyrcz-Krzemien S, 

Holowiecki J.Status of minimal residual disease determines outcome of autologous hematopoietic stem 

cell transplantation in adult acute lymphoblastic leukemia. 

BONE MARROW TRANSPL 2010 Jun;45(6):1095-101. Epub 2009 Oct 26. 

IF: 3,66 

Hernández JM, Granada I, Solé F; Grupo Cooperativo Español de Citogenética Hematólogica From 

conventional cytogenetics to microarrays. 

Fifty years of Philadelphia chromosome 

MED CLIN-BARCELONA 2010 Jun 29. [Epub ahead of print] 

IF: 1,413 

Juncà J, Moreno M, Mate JL, Milla F 

Concomitant diagnosis of acute mieloide leucemia and chronic lymphoproliferative disorder with AA 

amiloidosis as a final event 

MED CLIN-BARCELONA 2010 Jun 19;135(3):136-7 

IF: 1,413 

M Batlle, Quesada MD, Moreno M, JM Ribera. 

Outbreak of blastoschysomics spp infection in a haematology unit: study of 6 cases and finding of the 

source of infection. 

MED CLIN-BARCELONA 2010 Nov 13;135(14):672-4. Epub 2009 Jun 11. 

IF: 1,413 

MA. Sanz, P Montesinos, C Rayón, A Holowiecka, J de la Serna, G Milone, E de Lisa, S Brunet, V Rubio, 

JM. Ribera, C Rivas, I Krsnik, J Bergua, J González, J Díaz-Mediavilla, R Rojas, F Manso, G Ossenkoppele, 

JD González, B Lowenberg, on behalf of the PETHEMA and HOVON Groups 

Risk-adapted Treatment of Acute Promyelocytic Leukemia Based on All-trans Retinoic Acid and 

Anthracycline with Addition of Cytarabine in Consolidation Therapy for High-risk Patients: Further 

Improvements in Treatment Outcome. 

BLOOD 2010; 5137-46 

IF: 10,558 

Mateos MV, Oriol A, Martínez-López J, Gutiérrez N, Teruel AI, de Paz R,García-Laraña J, Bengoechea E, 

Martín A, Mediavilla JD, Palomera L, de Arriba F, González Y, Hernández JM, Sureda A, Bello JL, Bargay J, 

Peñalver FJ, Ribera JM, Martín-Mateos ML, García-Sanz R, Cibeira MT, Ramos ML, Vidriales MB, Paiva 

B,Montalbán MA, Lahuerta JJ, Bladé J, Miguel JF. 

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction 

therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and 

prednisone in elderly patients with untreated multiple myeloma: a randomised trial 

LANCET ONCOL 2010; 934-941 

IF: 17,764 

Mateos, MV; Cibeira, MT; Richardson, PG; Prosper, F; Oriol, A; de la Rubia, J; Lahuerta, JJ; Garcia-Sanz, R; 

Extremera, S; Szyldergemajn, S; Corrado, C; Singer, H; Mitsiades, CS; Anderson, KC; Blade, J; San Miguel, 

J 

Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or 

with Dexamethasone in Relapsed and Refractory Multiple Myeloma 

CLIN CANCER RES 2010; jun-15, 16 (12) 3260-3269 

IF: 7,338 


Miralles P, J Berenguer, JM Ribera. 

El diagnóstico, la profilaxis y el tratamiento de sistema nervioso central por el linfoma no Hodgkin en 

pacientes infectados por VIH 

MED CLIN-BARCELONA 2010 Sep 18;135(9):417-22. Epub 2009 Jul 22. 

IF: 1,413 

Moreno M, Sancho JM, Gardella S, Coll R, García O, Gallardo D, Ribera JM. 

Non-pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine, prednisone 

and rituximab for the treatment of non-Hodgkin's lymphoma: study of 26 patients. 

MED CLIN-BARCELONA 2010 Jan 30;134(2):72-5. Epub 2009 Nov 12. 

IF: 1,413 

Motlló C, Grau J, Juncà J, Ruiz N, Mate JL, Orna E, Navarro JT, Vives S, Sancho JM, Esteban D, Granada I, 

Feliu E, Ribera JM, Millá F 

Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. 

CANCER GENET CYTOGEN 2010 Dec;203(2):328-32. 

IF: 1,551 

Motlló C, Xicoy B, Sancho JM, Ribera JM. 

Infiltación cutánea masiva seguida de infiltración del sistema nervioso central en un paciente con 

leucemia mielomonocítica crónica. 

MED CLIN-BARCELONA 2010 Jul 3;135(4):186-7. Epub 2009 Jul 31. 

IF: 1,413 






IF: 1,413 

Oriol A, Vives S, Hernandez-Rivas JM, Tormo M, Heras I, Rivas C, Bethencourt C, MoscardÃ³ F, Bueno J, 

Grande C, del Potro E, Guardia R, Brunet S, Bergua J,Bernal T, Moreno MJ, Calvo C, Bastida P, Feliu E, 

Ribera JM; Programa Español de Tratamiento en Hematologia Group. 

Outcome after relapse of acute lymphoblasticleukemia in adult patients included in four consecutive 

risk-adapted trials bythe PETHEMA Study Group. 

HAEMATOL-HEMATOL J 2010 Apr;95(4):589-96. Epub 2010 Feb 9. 

IF: 6,532 

P Montesinos, JD González, J González, C Rayón, E de Lisa, ML Amigo, GJ Ossenkoppele, MJ Peñarrubia, 

M Pérez-Encinas, J Bergua, G Debén, MJ Sayas, J de la Serna, JM Ribera, J Bueno, G Milone, C Rivas, S 

Brunet, B Lowenberg,MA Sanz. 

Therapy-related Myelodysplastic Syndrome or Acute Leukemia in Patients with Acute Promyelocytic 

Leukemia Treated with All-trans Retinoic Acid and Anthracycline-based Chemotherapy 

J CLIN ONCOL 2010; 3872-79 

IF: 18,97 

Pérez-Montaña A, Navarro JT, Juncà J, Ribera JM 

Remisión completa espontánea en dos pacientes con leucemia linfática crónica 

MED CLIN-BARCELONA 2010 Dec 10 [Epub ahead of print] 

IF: 1,413 


Ribera JM, Oriol A, González M, Vidriales B, Brunet S, Esteve J, Del Potro E, Rivas C, Moreno MJ, Tormo 

M, Martín-Reina V, Sarrá J, Parody R, de Oteyza JP, Bureo E, Bernal MT; Programa Español de 

Tratamiento en Hematología; Grupo Español de Trasplante Hemopoyético Groups. 

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly 

diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. 

HAEMATOL-HEMATOL J 2010 Jan;95(1):87-95. Epub 2009 Oct 1. 

IF: 6,532 

Salido, M; Baro, C; Oscier, D; Stamatopoulos, K; Dierlamm, J; Matutes, E; Traverse-Glehen, A; Berger, F; 

Felman, P; Thieblemont, C; Gesk, S; Athanasiadou, A; Davis, Z; Gardiner, A; Milla, F; Ferrer, A; Mollejo, 

M; Calasanz, MJ; Florensa, L; Espinet, B; Luno, E; Wlodarska, I; Verhoef, G; Garcia-Granero, M; Salar, A; 

Papadaki, T; Serrano, S; Piris, MA; Sole, F 

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell 

lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group 

BLOOD 2010 Sep 2;116(9):1479-88. Epub 2010 May 17. 

IF: 10,558 

Sancho, JM; Orfao, A; Quijano, S; Garcia, O; Panizo, C; Perez-Ceballos, E; Deben, G; Salar, A; Gonzalez- 

Barca, E; Alonso, N; Garcia-Vela, JA; Capote, J; Penalver, FJ; Provencio, M; Arias, J; Plaza, J; Caballero, D; 

Morado, M; Feliu, E; Ribera, JM 

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non- 

Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era 

EUR J HAEMATOL 2010 Oct;85(4):321-8. doi: 10.1111/j.1600-0609.2010.01478.x. Epub 2010 Jul 28. 

IF: 2,785 

Xicoy, B; Ribera, JM; Mate, JL; Tapia, G; Morgades, M; Navarro, JT; Sanz, C; Ariza, A; Feliu, E 

Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma 

with or without human immunodeficiency virus infection 

LEUKEMIA LYMPHOMA 2010; NOV, 51 (11) 2063-2069 

IF: 2,492 

Projectes 

FERRA COLL, CHRISTELLA MARIE 


Relación de los valores séricos de la procalcitonina (PCT) y otros reactantes de fase aguda con las 

complicaciones y supervivencia de pacientes con hemopatías malignas que requieren ingreso en Unidad 

de Cuidados Intensivos. 

Durada: 3 anys - (2007-2010) 


RIBERA SANTASUSANA, JOSEP MARIA 


Estudio de la frecuencia y significado pronóstico de las deleciones/mutaciones del gen IKZF1 y del estado 

de hipermetilación de los genes hsa-miR-375, HDPR1 (DACT1), SHP1 (PTPN6), P16 (CDKN2A), hsa-miR-9-3 

y DBC1 en pacientes adultos con leucemia aguda linfoblástica sin reordenamiento BCR-ABL1 incluidos en 

protocolos de tratamiento adaptado al riesgo del Grupo PETHEMA 

Durada: 3 anys - (2010-2013) 



SERRANO MAESTRO, ALFONS 

Fundación Española de Hematología y Hemoterapia 

Análisis de los eventos a largo plazo relacionados con el tratamiento en pacientes adultos con leucemia 

aguda linfoblástica en remisión completa y su comparación con la población general. 

Durada: 1 anys - (2009-2010) 


ZAMORA PLANA, LURDES 

Fundación Caja Navarra - Núm. Exp.: 16281 

Caracterización de los síndromes mielodisplásicos: pronósticos y evolución. 

Durada: 2 anys - (2010-2012) 



HEMODINÀMICA 


Albarrán A, Mauri J, Pinar E, Baz JA. 

Update on interventional cardiology. 

REV ESP CARDIOL 2010 Jan;63 Suppl 1:86-100. 

IF: 2,157 


Chieffo A, Hoye A, Mauri F, Mikhail G, Ammerer M, Grines C, Grinfeld L, Madan M, Presbitero P, Skelding 

KA, Weiner BH, Mehran R. 

Gender-based issues in interventional cardiology: a consensus statement from the Women in 

Innovations (WIN) initiative. 


IF: 2,157 

Chieffo A, Hoye A, Mauri F, Mikhail GW, Ammerer M, Grines C, Grinfeld L, Madan M, Presbitero P, 

Skelding KA, Weiner BH, Mehran R; WIN Group. 


Innovations (WIN) initiative. 

EuroIntervention 2010 Feb;5(7):773-9. 

Chieffo A, Hoye A, Mauri F, Mikhail GW, Ammerer M, Grines C, Grinfeld L, Madan M, Presbitero P, 

Skelding KA, Weiner BH, Mehran R; WIN Group; Women in Innovations Initiative. 


Innovations (WIN) Initiative. 

CATHETER CARDIO INTE 2010 Feb 1;75(2):145-52. 

IF: 2,398 

Ciompi F, Pujol O, Gatta C, Rodríguez-Leor O, Mauri-Ferré J, Radeva P. 

Fusing in-vitro and in-vivointravascular ultrasound data for plaque characterization. 

INT J CARDIOVAS IMAG 2010 Oct;26(7):763-79. Epub 2009 Nov 29. 

IF: 2,539 

F.Ciompi, O.Pujol, E.Fernandez-Nofrerias, J.Mauri, P.Radeva 

Conditional Random Fields for image segmentation in Intravascular Ultrasound 

MICCAT 2010 

Moreno R, Garcia E, Teles RC, Almeida MS, Carvalho HC, Sabate M, Martin-Reyes R, Rumoroso JR, 

Galeote G, Goicolea FJ, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Perez de Prado A, Martin-Yuste 

V, Jimenez-Valero S,Sanchez-Recalde A, Calvo L, Lopez de Sa E, Macaya C, Lopez-Sendon JL. 

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic 

coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by 

EveroLimus-Eluting Stent) trial. 

EuroIntervention 2010 May;6(1):112-6. doi: 10.4244/. 


Teis-Soley, A; Fernandez-Nofrerias, E; Rodriguez-Leor, O; Tizon, H; Salvatella, N; Valle, V; Mauri, J 

Coronary Artery Perforation by Intracoronary Guide Wires: Risk Factors and Clinical Outcomes 

REV ESP CARDIOL 2010; JUN, 63 (6) 730-734 

IF: 2,157 

Valdesuso, R; Karjalainen, P; Garcia, J; Diaz, J; Portales, JF; Masotti, M; Pico, F; Serra, A; Burgos, JM; Insa, 

L; Mauri,F; Collado, JR; Nammas, W 

The EXTREME Registry: Titanium-Nitride-Oxide Coated Stents in Small Coronary Arteries 

CATHETER CARDIO INTE 2010; AUG 1, 76 (2) 281-287 

IF: 2,398 

Vallejo N, Ferrer E, Fernández-Nofrerías E, Mauri J. 

Postpneumonectomy dyspnea: improvement after transcatheter closure. 

REV ESP CARDIOL 2010 Apr;63(4):498-9 

IF: 2,157 


INSTITUT 

GUTTMANN 



Benito Penalva J, Opisso E, Medina J, Corrons M, Kumru H, Vidal J, Valls-Solé J. 

H reflex modulation by transcranial magnetic stimulation in spinal cord injury subjects affer gait training 

with electromechanical systems 

SPINAL CORD 2010 May;48(5):400-6. Epub 2009 Nov 24. 

IF: 1,826 

Castaño B, Capdevila E 

Eating disorders in patients with traumatic brain injury: a report of four cases 

NEUROREHABILITATION 2010 Jan 1;27(2):113-6. 

Cohen DA, Freitas C, Tormos JM, Oberman L, Eldaief M, Pascual-Leone A 

Enhancing plasticity through repeated rTMS sessions 

CLIN NEUROPHYSIOL 2010 Dec;121(12):2159-64. Epub 2010 Jun 11. 

IF: 2,786 

Domenech J, Tormos JM, Barrios C, Pascual-Leone A. 

Motor cortical hyperexcitability in idiopathic scoliosis: could foca1 dystonia be a subclinical etiological 

factor? 

EUR SPINE J 2010 Feb;19(2):223-30. Epub 2009 Dec 24. 

IF: 1,994 

Fecteau S, Tormos JM, Gangitano M, Théoret H, Pascual-Leone A. 

Modulation of cortical motor outputs by the symbolic meaning of visual stimuli. 

EUR J NEUROSCI 2010 Jul;32(1):172-7. Epub 2010 Jun 18 

IF: 3,658 

Fernández-Espejo D, Junque C, Bernabeu M, Roig-Rovira T, Vendrell P, Mercader JM. 

Reductions of Thalamic Volume and Regional Shape Changes in the Vegetative and the Minimally 

Conscious States. 

J NEUROTRAUM 2010 Jul;27(7):1187-93. 

IF: 3,426 

García-Molina A, Bernabeu Guitart M, Roig-Rovira T. 

Traumatic brain injury and daily life: The role of executive function. 

PSICOTHEMA 2010 Aug;22(3):430-5. 

García-Molina A. 

Phineas Gage and the enigma of the prefrontal cortex. 

NEUROLOGIA 2010 Dec 16. [Epub ahead of print] 

IF: 0,589 

Kaplan E, Naeser MA, Martin PI, Ho M, Wang Y, Baker E, Pascual-Leone A. 

Horizontal portion of arcuate fasciculus fibers track to pars opercularis, not pars triangularis, in right and 


left hemispheres: a DTI study. 

NEUROIMAGE 2010 Aug 15;52(2):436-44. Epub 2010 May 8 

IF: 5,932 

Kumru H, Murillo N, Samso JV, Valls-Sole J, Edwards D, Pelayo R, Valero-Cabre A, Tormos JM, Pascual- 

Leone A. 

Reduction of spasticity with repetitive transcranial magnetic stimulation in patients with spinal cord 

injury. 

NEUROREHAB NEURAL RE 2010 Jun;24(5):435-41. Epub 2010 Jan 6. 

IF: 3,772 

Kumru H, Stetkarova I, Schindler C, Vidal J, Kofler M. 

Neurophysiological evidence for muscle tone reduction by intrathecal baclofen at the brainstem level. 

CLIN NEUROPHYSIOL 2010 Oct 1. [Epub ahead of print] 

IF: 2,786 

Kumru H, Vidal J, Kofler M, Portell E, Valls-Solé J. 

Alterations in excitatory and inhibitory brainstem interneuronal circuits after severe spinal cord injury. 

J NEUROTRAUM 2010 Apr;27(4):721-8. 

IF: 3,426 

Lima FP, Lima MO, León D, Falcon C, Cogo JC, Lucareli PR, Bargalló N, Vidal J, Bernabeu-Guitart M, León- 

Álvarez N,Lucareli JG, Junqué C. 

Changes in the functional magnetic resonance imaging of the sensorimotor cortex in traumatic brain 

injury after intensive rehabilitation. 

REV NEUROL-FRANCE 2010 Oct 1;51(7):403-11. 

IF: 0,528 

Murillo N, Kumru H, Vidal-Samso J, Benito J, Medina J, Navarro X, Valls-Sole J 

Decrease of spasticity with muscle vibration in patients with spinal cord injury 

CLIN NEUROPHYSIOL 2010 Dec 18. [Epub ahead of print] 

IF: 2,786 

Naeser MA, Martin PI, Treglia E, Ho M, Kaplan E, Bashir S, Hamilton R, Coslett HB, Pascual-Leone A. 

Research with rTMS in the treatment of aphasia. 

RESTOR NEUROL NEUROS 2010;28(4):511-29. 

IF: 3,349 

Pascual-Leone A 

The importance of recognizing paradoxes (Commentary on Madhavan et al.). 

EUR J NEUROSCI 2010 Sep;32(6):1030-1. 

IF: 3,658 

Pérez R., Costa Ú., Torrent M., Solana J., Opisso E., Cáceres C., Tormos J.M., Medina J., Gómez E.J. 

Upper Limb Portable Motion Analysis System Based on Inertial Technology for Neurorehabilitation 

Purposes 

SENSORS-BASEL 2010; 10(12):10733-10751 

IF: 1,771 

Soler MD, Kumru H, Pelayo R, Vidal J, Tormos JM, Fregni F, Navarro X, Pascual-Leone A. 

Effectiveness of transcranial direct current stimulation and visual illusion on neuropathic pain in spinal 


cord injury. 

BRAIN 2010 Sep;133(9):2565-77. Epub 2010 Aug 4. 

IF: 9,23 

Soler MD, Kumru H, Vidal J, Pelayo R, Tormos JM, Fregni F, Navarro X, Pascual-Leone A. 

Referred sensations and neuropathic pain following spinal cord injury. 

PAIN 2010 Jul;150(1):192-8. Epub 2010 May 14. 

IF: 5,355 

Soto O, Valls-Solé J, Kumru H. 

Paired-pulse transcranial magnetic stimulation during preparation for simple and choice reaction time 

tasks 

J NEUROPHYSIOL 2010 Sep;104(3):1392-400. Epub 2010 Jun 30. 

IF: 3,114 

Terré-Boliart R, Portell-Soldevila E. 

Oropharyngeal dysphagia secondary to post-polio síndrome 

REV NEUROLOGIA 2010 May 1;50(9):570-1. 

IF: 1,218 

Vallès M, Benito J, Pelayo R, Vidal J. 

Prognosis of polyneuropathy associated to intermittent acute porphyria 

MED CLIN-BARCELONA 2010 Nov 22. [Epub ahead of print] 

IF: 1,413 


Laboratori 

d'Immunobiologia 

per a la Recerca i les Aplicacions 

Diagnòstiques (LIRAD) 



Alonso N, Granada ML, Soldevila B, Salinas I, Joaquin C, Reverter JL, Juncà J, Martínez Cáceres EM, 

Sanmartí A. 

Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 

diabetes mellitus: a 5-year prospective study. 

J ENDOCRINOL INVEST 2010 Jun 4. [Epub ahead of print] 

IF: 1,476 

Balibrea Del Castillo JM, Puig Piña R, Planas Bas R, Vives Pi M. 

Tropical pancreatitis: ex-juvantibus diagnosis and multidiciplinary management in the globalization era. 


IF: 1,413 

Balibrea del Castillo, JM; Arias-Diaz, J; Martin, MCG; Vives-Pi, M; Perez, JCG; Cid, RC; Ameigeiras, EV; 

Cantero, JLB 

Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation 

by acute rejection cytokines 

Cirugía Española 2010 Jun;87(6):372-7. Epub 2010 May 10. 

Blanco Y, Hankiewicz K, Llufriu S, Sabater L, Graus F, Saiz A; Grupo Español de Neuromielitis Optica. 

(Ramo C. in collaborators) 

Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG) 

NEUROLOGIA 2010 Jan-Feb;25(1):5-12. 

IF: 0,589 

Brckalo T, Calzetti F, Pérez-Cabezas B, Borràs FE, Cassatella MA, López-Botet M. 

Functional analysis of the CD300e receptor in human monocytes and myeloid dendritic cells. 

EUR J IMMUNOL 2010 Mar;40(3):722-32 

IF: 4,942 

Colobran R, Pedrosa E, Carretero-Iglesia L, Juan M. 

Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health 

and disease. 

CLIN EXP IMMUNOL 2010 Oct;162(1):41-52. doi: 10.1111/j.1365-2249.2010.04224.x. Epub 2010 Aug 19 

IF: 3,134 

Ferrer, A; Formiga, F; Almeda, J; Alonso, J; Brotons, C; Pujol, R 

Health-related quality of life in nonagenarians: gender, functional status and nutritional risk as 

associated factors 

MED CLIN-BARCELONA 2010 Mar 13;134(7):303-6. Epub 2010 Jan 22. 


IF: 1,413 

Francesc E. Borràs 

Ilusion y determinacion 

INMUNOLOGÍA 2010; 29 :113-4 

Laura Bover, Mar Naranjo-Gómez, Shino Hanabuchi, Begoña Pérez-Cabezas, and Francesc E. Borràs 

Biological aspects of human plasmacytoid dendritic cells and their leukemic counterparts; similarities 

and differences 

INMUNOLOGIA 2010;29(4):125-134 





IF: 1,373 





IF: 3,134 

Montoya M, Borràs FE 

Influenza outbreak, a year after the pandemic, what have we learned? 

INMUNOLOGÍA 2010;29(4):141-143 

Ortiz-Santamaria V, Olive A, Martinez-Cáceres E, Coll M, Codina X, Surís X. 

Neonatal lupus erythematosus: a possible role for anti-Sm antibodies. 

LUPUS 2010 Apr;19(5):659-61. Epub 2010 Feb 4. 

IF: 2,6 

Parera, E; Gallardo, F; Toll, A; Gil, I; Sanchez-Schmidt, J; Pujol, R 

Inflammatory Linear Verrucous Epidermal Nevus Successfully Treated with Methyl-Aminolevulinate 

Photodynamic Therapy 

DERMATOL SURG 2010; FEB, 36 (2) 253-256 

IF: 2,264 

Planas R, Carrillo J, Sanchez A, de Villa MC, Nuñez F, Verdaguer J, James RF, Pujol-Borrell R, Vives-Pi M. 

Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at 

clinical onset and in long-standing diabetes. 

CLIN EXP IMMUNOL 2010 Jan;159(1):23-44. Epub 2009 Nov 11. 

IF: 3,134 

Planas, R; Pujol-Borrell, R; Vives-Pi, M 

Global gene expression changes in type 1 diabetes: Insights into autoimmune response in the target 

organ and in the periphery 

IMMUNOL LETT 2010 Oct 30;133(2):55-61. Epub 2010 Aug 11. 

IF: 2,511 




TRANSPL P 2010 Oct;42(8):2896-8 

IF: 0,993 


EM. 


regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during 

pegylated interferon alpha2a plus ribavirin treatment. 


IF: 3,502 

Trallero-Araguás E, Labrador-Horrillo M, Selva-O'Callaghan A, Martínez MA, Martínez-Gómez X, Palou E, 

Rodriguez-Sanchez JL, Vilardell-Tarrés M. 

Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic 

inflammatory myopathy. 

MEDICINE 2010 Jan;89(1):47-52. 

IF: 4,256 

VanZyl B, Planas R, Ye Y, Foulis AK, deKrijger RR, Butler PC, Nelson JL, Gale EAM, Vives-Pi M, Gillespie KM 

Why are levels of maternal microchimerism higher in type 1 diabetes pancreas? 

CHIMERISM 2010 Oct;1(2):45-50 

Projectes 

BORRAS SERRES, FRANCESC ENRIC 

FIS - Núm. Exp.: PS09/00229 

Estrategias para la inducción de tolerancia y prevención de la Nefropatía Crónica del Transplante. 

SUBPROYECTO 2: Evaluación del uso de exosomas obtenidos de fluidos biológicos como aloantígenos para 

la inducción de tolerancia en trasplante 

Durada: 3 anys - (2009-2012) 


MARTINEZ CACERES, EVA MARIA 


TOLERVIP-MS: inducció de tolerància en esclerosi múltiple amb cèl·lules dendrítiques tractades amb 

pèptid intestinal vasoactiu i carregades amb pèptids de la mielina. 

Durada: 3 anys - (2007-2010) 



Fundació GAEM - Núm. Exp.: 01032007 

Tolervip-MS: Inducció de tolerància en Esclerosi múltiple amb cèl·lules dendrítiques tractades amb pèptid 

intestinal vasoactiu i carregades amb pètids de la mielina. 

Durada: 3 anys - (2007-2010) 





Reprogramacion del sistema inmune para tratar la esclerosis multiple. Proyecto “TOLERVIT” 

Durada: 1 anys - (2011-2012) 

Import Concedit: 265,01 € 

PUJOL BORRELL, RICARDO 


Fisiopatología y diagnóstico de las enfermedades autoinmunes: Tiroiditis, Diabetes y Esclerosis Múltiple, 

un abordaje inspirado en la biologia de sistemas. 

Durada: 3 anys - (2008-2011) 


VIVES PI, MARTA 

FIS - Núm. Exp.: PS09/00253 

Prevención y remisión de la diabetes tipo 1 mediante inmunoterapia con células dendríticas autólogas 

pulsadas con cuerpos apoptoticos antígeno específicos 

Durada: 3 anys - (2009-2012) 


VIVES PI, MARTA 


Inmunoterapia preventiva con células dendríticas tolerogénicas en diabetes tipo 1 

Durada: 1 anys - (2011-2012) 

Import Concedit: 539,64 € 


IMMUNOLOGIA 

IGTP 

Projectes 

SARRIAS FORNÉS, MARIA ROSA 

FIS - Núm. Exp.: CP08/00124 

Papel de las proteínas scavenger Spalpha/AIM en la respuesta del huésped a la infección bacteriana. 

Durada: 3 anys - (2008-2011) 




Estudio de las propiedades inmunoreguladoras de la proteína scavenger Sp_ en la respuesta antiinfecciosa. 

Durada: 3 anys - (2007-2010) 




Mecanismes moleculars implicats en la prevenció de l'aterosclerosi mediada per LXR I RXR. subprojecte 3: 

Paper d´aim en l´activació del macròfag i desenvolupament de cèl.lules espumoses. 

Durada: 4 anys - (2008-2012) 




Estudio funcional de la proteína scavenger Spalpha en inflamación, y valor diagnóstico/pronóstico de los 

niveles en plasma en daño hepático 

Durada: 3 anys - (2010-2013) 



IMPPC 



IMPPC 

Abate-Daga D, Garcia-Rodríguez L, Sumoy L, Fillat C 

Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells 

BIOCHIMIE 2010 Oct;1803(10):1175-85 

IF: 3,787 

Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, 

Peinado MA, Moreno V, Esteller M, Capellá G 

Novel methylation panel for the early detection of colorectal tumors in stool DNA 

CLIN COLORECTAL CANC 2010 Jul;9(3):168-76 

IF: 2,632 

Bilbao C, Lara PC, Ramírez R, Henríquez-Hernández LA, Rodríguez G, Falcón O, León L, Perucho M, Díaz- 

Chico BN, Díaz-Chico JC 

Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer 

INT J RADIAT ONCOL 2010 Jan 1;76(1):9-13 

IF: 4,503 

Bilbao C, Ramírez R, Rodríguez G, Falcón O, León L, Díaz-Chico N, Perucho M, Díaz-Chico JC 

Double strand break repair components are frequent targets of microsatellite instability in endometrial 

cancer 

EUR J CANCER 2010 Oct;46(15):2821-7 

IF: 4,944 

Buschbeck M, Di Croce L 

Approaching the molecular and physiological function of macroH2A variants. 

EPIGENETICS-US 2010 Feb 16;5(2):118-23. Epub 2010 Feb 20 

IF: 4,622 

Gil V, Bichler Z, Lee JK, Seira O, Llorens F, Bribian A, Morales R, Claverol-Tinture E, Soriano E, Sumoy L, 

Zheng B, Del Río JA. 

Developmental Expression of the Oligodendrocyte Myelin Glycoprotein in the Mouse Telencephalon. 

CEREB CORTEX 2010 Aug;20(8):1769-79 

IF: 6,844 

González E, Fernández MR, Marco D, Calam E, Sumoy L, Parés X, Dequin S, Biosca JA 

Role of oxidoreductases Bdh1p and Ara1p, from Saccharomyces cerevisiae in the metabolism of acetoin 

and 2, 3butanediol 

APPL ENVIRON MICROB 2010 Feb;76(3):670-9. Epub 2009 Dec 4. 

IF: 3,778 

Gonzalez Fernandez Beatriz, Lauren J. Schwimmer, Roberta P. Fuller, Yongjun Ye, Lily 

Asawapornmongkol, and Carlos F. Barbas III 


System for the Construction of Zinc-Finger Libraries and Proteins 

NAT PROTOC 2010;5(4):791-810. Epub 2010 Apr 1. 

IF: 8,362 

Javierre, BM; Fernandez, AF; Richter, J; Al-Shahrour, F; Martin-Subero, JI; Rodriguez-Ubreva, J; Berdasco, 

M; Fraga, MF; O'Hanlon, TP; Rider, LG; Jacinto, FV; Lopez-Longo, FJ; Dopazo, J; Forn, M; Peinado, MA; 

Carreno, L; Sawalha, AH; Harley, JB; Siebert, R; Esteller, M; Miller, FW; Ballestar, E 

Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus 

erythematosus 

GENOME RES 2010; FEB, 20 (2) 170-179 

IF: 13,588 

Jordà M, Peinado MA 

Methods for DNA methylation analysis and applications in colon cancer 

MUTAT RES-FUND MOL M 2010 Nov 10;693(1-2):84-93 

IF: 3,204 

Lee I, Lehner B, Vavouri T, Shin J, Fraser AG, Marcotte E. (Perucho M. in collaborators) 

Predicting genetic modifier loci using functional gene networks. 

GENOME RES 2010 Aug;20(8):1143-53. Epub 2010 Jun 9 

IF: 13,588 

Martí E, Pantano L, Bañez-Coronel M, Llorens F, Miñones-Moyano E, Porta S, Sumoy L, Ferrer I, Estivill X. 

A myriad of miRNA variants in control and Huntington’s disease brain regions detected by massively 

parallel sequencing 

NUCLEIC ACIDS RES 2010 Nov 1;38(20):7219-35. Epub 2010 Jun 30. 

IF: 7,836 

Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V, Marquez VE, Valente S, Mai A, 

Forcales SV, Sartorelli V, Puri PL 

TNF/p38Œ±/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic 

control of muscle regeneration 

CELL STEM CELL 2010 Oct 8;7(4):455-69 

IF: 25,943 

Pros E, Fernández-Rodríguez J, Benito L, Ravella A, Capellá G, Blanco I, Serra E, Lázaro C. 

Modulation of aberrant NF1 pre-mRNA splicing by kinetin treatment. 

EUR J HUM GENET 2010 May;18(5):614-7 

IF: 4,38 

Samuelsson, J.K., Alonso, S., Yamamoto, F., and Perucho, M 

DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer. 

MUTAT RES-FUND MOL M 2010 Nov 10;693(1-2):61-76 

IF: 3,204 

Yamamoto F, Yamamoto M, Blancher A. 

Generation of histo-blood group B transferase by replacing the N-acetyl-d-galactosamine recognition 

domain of human A transferase with the galactose-recognition domain of evolutionarily related murine 

alpha1,3 galactosyltransferase. 

TRANSFUSION 2010 Mar;50(3):622-30. Epub 2009 Nov 20. 

IF: 3,3 


MEDICINA 

INTENSIVA 



Alvarez-Lerma F, Mariscal F, Quintana E, Rialp G, Diaz-Reganon J, Pérez San José MJ, Alvarez-Sanchez B; 

Liposomal Amphotericin B in the ICU Study Group. (Mesalles E. in collaborators) 

Impact of the administration of liposomal amphotericin B in patients with renal function impairment at 

initiation of treatment. 

J CHEMOMETR 2010 Aug;22(4):285-7. 

IF: 1,377 

Arméstar F, Moreno JA, Cladellas JM, Puyalto P. 

Hemorrhagic stroke in basal ganglia treated with decompressive hemicraniectomy. 

REV NEUROLOGIA 2010 Apr 16;50(8):511. 

IF: 1,218 

Montejo JC, Miñambres E, Bordejé L, Mesejo A, Acosta J, Heras A, Ferré M, Fernandez-Ortega F, 

Vaquerizo CI, Manzanedo R. 

Gastric residual volume during enteral nutrition in ICU patients: the REGANE study 

INTENS CARE MED 2010 Aug;36(8):1386-93. Epub 2010 Mar 16. 

IF: 4,996 

Subirà C, Pérez H, Anglada M, López J. 

Austrian syndrome 

MED INTENSIVA 2010 Mar;34(2):155-6. Epub 2009 Sep 23. 

IF: 1,496 




IF: 3,008 


MEDICINA INTERNA 



Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp 

S, Sokurenko G, Leizorovicz A; CALISTO Study Group. 

Fondaparinux for the treatment of superficial-vein thrombosis in the legs. 

NEW ENGL J MED 2010 Sep 23;363(13):1222-32 

IF: 53,484 

EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing 

AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen 

A, Davidson BL, Piovella F, Schellong S. (Monreal M. in collaborators) 

Oral rivaroxaban for symptomatic venous thromboembolism. 

NEW ENGL J MED 2010 Dec 23;363(26):2499-510. Epub 2010 Dec 3. 

IF: 53,484 

Fuenzalida, L; Blanco, S; Prat, C; Vivancos, M; Dominguez, MJ; Modol, JM; Rodrigo, C; Ausina, V Utility of 

the rapid antigen detection BinaxNOW Influenza A& B test for detection of novel influenza A (H1N1) virus 

CLIN MICROBIOL INFEC 2010; OCT, 16 (10) 1574-1576 

IF: 4,784 

Tudela P., Lacoma A., Prat C., Mòdol JM., Giménez M., Barallat J., Tor J. 

Prediction of bacteremia in patients with suspicion of infection in emergency room. 


IF: 1,413 



DESINTOXICACIÓ 







2008]. 


IF: 1,413 

Lodi S, Phillips A, Touloumi G, Pantazis N, Bucher HC, Babiker A, Chêne G, Vanhems P, Porter K; CASCADE 

Collaboration. (Muga R.) 

CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral 

therapy era. 

AIDS 2010 Nov 13;24(17):2697-704. 

IF: 6,348 

Rivas I, Martinez E, Sanvisens A, Bolao F, Tor J, Torrens M, Pujol R, Fuster D, Rey-Joly C, Muñoz A, Muga 

R. 

Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 

1987-2006. 

DRUG ALCOHOL DEPEN 2010 Aug 1;110(3):234-9. Epub 2010 Apr 24. 

IF: 3,365 

Tudela P., Lacoma A., Prat C., Mòdol JM., Giménez M., Barallat J., Tor J.Prediction of bacteremia in 

patients with suspicion of infection in emergency room. 


IF: 1,413 

Vallecillo G, Sanvisens A, Martinez E, Torrens M, Bolao F, Tor J, Muga R. 

Use of highly active antiretroviral therapy is increasing in HIV positive severe drug users. 

CURR HIV RES 2010 Dec;8(8):641-8. 

IF: 1,923 


Projectes 

MUGA BUSTAMANTE, ROBERT 


Vacuna preventiva del VIH: Anclaje de una cohorte de individuos a riesgo. Análisis de la aceptación y 

predisposición a participar en un ensayo de vacuna en fase II-III. 

Durada: 4 anys - (2007-2011) 


MUGA BUSTAMANTE, ROBERT 

FIPSE - Núm. Exp.: 36781/08 

Grupo de estudio multicéntrico español de seroconvertores (GEMES): Estudio del período de incubación 

del SIDA y la supervivencia de la infección por VIH en cohortes de seroconvertores. 

Durada: 3 anys - (2008-2011) 




HOSPITALITZACIÓ 


Blanco-Molina A, Monreal M. 

Venous thromboembolism in women taking hormonal contraceptives. 

Expert Rev Cardiovasc Ther 2010 Feb;8(2):211-5 


Blanco-Molina, A; Rota, L; Di Micco, P; Brenner, B; Trujillo-Santos, J; Ruiz-Gamietea, A; Monreal, M 

Venous thromboembolism during pregnancy, postpartum or during contraceptive use Findings from the 

RIETE Registry 

THROMB HAEMOSTASIS 2010; FEB, 103 (2) 306-311 

IF: 4,701 

Bueno H, Bardají A, Patrignani P, Martín-Merino E, García-Rodríguez LA; Spanish Case-Control Study to 

Assess NSAID-Associated ACS Risk Investigators. (Muga R.) 

Use of non-steroidal antiinflamatory drugs and type-specific risk of acute coronary syndrome. 

AM J CARDIOL 2010 Apr 15;105(8):1102-6. Epub 2010 Feb 20. 

IF: 3,68 

Esteban, C; Perez, P; Fernandez-Llamazares, J; Surinach, JM; Camafort, M; Martorell, A; Monreal, M 

Clinical Outcome in Patients With Peripheral Artery Disease and Renal Artery Stenosis 

ANGIOLOGY 2010 Feb-Mar;61(1):58-65. Epub 2008 Dec 18. 

IF: 0,992 

Gadelha T, Roldán V, Lecumberri R, Trujillo-Santos J, del Campo R, Poggio R, Monreal M; RIETE 

Investigators. 

Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of 

venous thromboembolism. Findings from the RIETE Registry. 

THROMB RES 2010 Oct;126(4):283-6. Epub 2010 Jul 13. 

IF: 2,372 

Guijarro R, Montes J, San Román C, Arcelus JI, Barillari G, Granero X, Monreal M. 

Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish 

National Discharge Database. 

THROMB HAEMOSTASIS 2010 Dec 21;105(4). [Epub ahead of print] 

IF: 4,701 

Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Nicol P, Vicaut E, Turpie AG, Yusen RD; 

EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With 

Prolonged Immobilization) study. 

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently 

reduced mobility: a randomized trial. 

ANN INTERN MED 2010 Jul 6;153(1):8-18. 

IF: 16,729 

Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD; 


RIETE Investigators. 

Simplification of the pulmonary embolism severity index for prognostication in patients with acute 

symptomatic pulmonary embolism. 

ARCH INTERN MED 2010 Aug 9;170(15):1383-9. 

IF: 10,639 

Jimenez, D; Aujesky, D; Diaz, G; Monreal, M; Oteros, R; Marti, D; Marin, E; Aracil, E; Sueiro, A; Yusen, RD 

Prognostic Significance of Deep Vein Thrombosis in Patients Presenting with Acute Symptomatic 

Pulmonary Embolism 

AM J RESP CRIT CARE 2010 May 1;181(9):983-91. Epub 2010 Jan 28. 

IF: 10,191 

Maestre A, Sánchez R, Rosa V, Aujesky D, Lorenzo A, Barillari G, Monreal M; RIETE Investigators. 

Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: 

findings from the RIETE Registry. 

EUR J INTERN MED 2010; OCT, 21 (5) 377-382 

IF: 1,657 

Monreal M, López-Jiménez L. 

Pulmonary embolism in patients over 90 years of age. 

CURR OPIN PULM MED 2010 Sep;16(5):432-6. 

IF: 2,906 




IF: 1,413 

Nieto JA, Solano R, Ruiz-Ribó MD, Ruiz-Gimenez N, Prandoni P, Kearon C, Monreal M; Riete 


Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from 

the RIETE registry. 

J THROMB HAEMOST 2010 Jun;8(6):1216-22. Epub 2010 Mar 12. 

IF: 5,439 






IF: 2,157 

Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, 

Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD; VALIANT 

Investigators. (Lupon J., ValleV.) 

Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and 

left ventricular dysfunction, heart failure, or both. 

CIRCULATION 2010 Aug 10;122(6):597-602. Epub 2010 Jul 26 

IF: 14,429 

Prandoni P, Trujillo-Santos J, Sanchez-Cantalejo E, Dalla Valle F, Piovella C, Pesavento R, Nieto Rodríguez 


JA, Monreal M; RIETE Group. 

Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the 

RIETE Registry. 

J THROMB HAEMOST 2010 Nov;8(11):2575-7. doi: 10.1111/j.1538-7836.2010.04039.x. 

IF: 5,439 

Recio-Iglesias J, Grau-Amorós J, Formiga F, Camafort-Babkowski M, Trullàs-Vila JC, Rodríguez A; en 

nombre de los investigadores del Grupo para el Estudio y Significado de la Anemia en la Insuficiencia 

Cardíaca (GESAIC). (UrrutiaA) 

[Chronic obstructive pulmonary disease on inpatients with heart failure.GESAIC study results]. 

MED CLIN-BARCELONA 2010 Apr 10;134(10):427-32. Epub 2010 Feb 9. 

IF: 1,413 

Rivas I, Martinez E, Sanvisens A, Bolao F, Tor J, Torrens M, Pujol R, Fuster D, Rey-Joly C, Muñoz A, Muga 

R. 

Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 

1987-2006. 

DRUG ALCOHOL DEPEN 2010 Aug 1;110(3):234-9. Epub 2010 Apr 24. 

IF: 3,365 

Roa, L; Monreal, M; Carmona, JA; Aguilar, E; Coll, R; Suarez, C 

Treatment inertia in secondary prevention of cardiovascular disease. FRENA registry 

MED CLIN-BARCELONA 2010; JAN 30, 134 (2) 57-63 

IF: 1,413 

Romero, R; Rey-Joly, C 

Cardiorenal syndrome 

MED CLIN-BARCELONA 2010 May 15;134(14):630-2. Epub 2010 Apr 8. 

IF: 1,413 

Rosón B, Monte R, Gamallo R, Puerta R, Zapatero A, Fernández-Solá J, Pastor I, Girón JA, Laso J; ASMI 

Study Group. (Rey-Joly C) 

Prevalence and routine assessment of unhealthy alcohol use in hospitalized patients. 

EUR J INTERN MED 2010 Oct;21(5):458-64. Epub 2010 May 20 

IF: 1,657 

Shin SH, Hung CL, Uno H, Hassanein AH, Verma A, Bourgoun M, Køber L, Ghali JK, Velazquez EJ, Califf 

RM, Pfeffer MA, Solomon SD; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. 

Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Mechanical dyssynchrony after 

myocardial infarction in patients with left ventricular dysfunction, heart failure, or both. 

CIRCULATION 2010 Mar 9;121(9):1096-103. Epub 2010 Feb 22. 

IF: 14,429 

Soto MJ, Grau E, Gadelha T, Palareti G, Bounameaux H, Villalta J, Monreal M; RIETE Investigators 

Clinical significance of a negative D-dimer level in patients with confirmed venous thromboembolism: 

findings from the RIETE Registry. 

J THROMB HAEMOST 2010 Nov 16. doi: 10.1111/j.1538-7836.2010.04143.x. 

IF: 5,439 

Trujillo-Santos J, Nieto JA, Ruíz-Gamietea A, López-Jiménez L, García-Bragado F, Quintavalla R, Monreal 

M; RIETE Investigators. 


Bleeding complications associated with anticoagulant therapy in patients with cancer. 

THROMB RES 2010 Apr;125 Suppl 2:S58-61 

IF: 2,372 

Tsoran I, Saharov G, Brenner B, Barrón M, Valdés V, de la Roca Toda M, Monreal M. 

Prolonged travel and venous thromboembolism findings from the RIETE registry 


IF: 2,372 

Urrutia A, Sacanella E, Mascaro J, Formiga F. 

Anemia in the elderly. 

Rev Esp Geriatr Gerontol 2010 Sep-Oct;45(5):291-7. Epub 2010 Aug 7 

Urrutia A, Santesmases J, Benítez RM, Areal J. 

Adrenal gland abscess due to Streptococcus pneumoniae 

J INFECTION 2010 Jan;60(1):88-9. Epub 2009 Oct 31. 

IF: 3,805 




IF: 2,157 

Projectes 

MONREAL BOSCH, MANEL 


Predicción de la muerte por embolia pulmonar en España. 

Durada: 3 anys - (2008-2011) 



MEDICINA 

INTERNA 

MALALTIES INFECCIOSES 



Barrabeig, I; Rovira, A; Garcia, M; Oliva, JM; Vilamala, A; Ferrer, MD; Sabria, M; Dominguez, A 

Outbreak of Legionnaires' disease associated with a supermarket mist machine 

EPIDEMIOL INFECT 2010; DEC, 138 (12) 1823-1828 

IF: 2,257 

Marin A, Monsó E, Garcia-Nuñez M, Sauleda J, Noguera A, Pons J, Agustí A, Morera J. 

Variability and effects of bronchial colonisation in patients with moderate COPD. 


IF: 5,922 

Miravitlles, M; Marin, A; Monso, E; Vila, S; de la Roza, C; Hervas, R; Esquinas, C; Garcia, M; Millares, L; 

Morera, J; Torres, A 

Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease airway 

RESP RES 2010; may-14, 11 () -58 

IF: 2,859 




IF: 1,413 

Projectes 

PEDRO-BOTET MONTOYA, MARIA LUISA 


Estudio de la utilidad de la técnica “Sequence-based Typing” en brotes de Legionelosis 

Durada: 3 anys - (2010-2013) 


SABRIA LEAL, MIQUEL 


Descripción de factores de virulencia/competencia de L. pneumophila mediante técnicas de proteómica. 

Durada: 4 anys - (2008-2012) 



MEDICINA 

INTERNA - VIH 





Treatment Failure in HCV/HIV-1 Coinfected Patients 

PLOS ONE 2010; oct-29, 5 (10) -e13771 

IF: 4,411 





IF: 4,439 




cohort study. 

AIDS 2010 Nov 27;24(18):2827-33 

IF: 6,348 

Bruguera M, Barrio JL, Bayas JM, Campins M, Esteban R, Gatell JM, Martínez M, Monés J, Plans A, Planas 

R, Segura A, Serra C, Torres M, Tural C, Villalbí JR 

Com actuar quan un metge és portador del virus de la immunodeficiència humana o dels virus de 

l’hepatitis B o C (Segona Edició del Quadern de la Bona Praxi, núm. 7). 

QUADERNS DE LA BONA PRAXI 2006;21:1-14. 

Buzón MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, 

Sharkey M, Palmer S, Stevenson M, Clotet B, Blanco J, Martinez-Picado J. 

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed 

subjects. 

NAT MED 2010 Apr;16(4):460-5 

IF: 25,43 





IF: 4,023 







IF: 3,268 


Group. 



IF: 4,784 





2008]. 


IF: 1,413 



B. 



(Lake Study) 


IF: 4,439 

Ferreira MA, Mangino M, Brumme CJ, Zhao ZZ, Medland SE, Wright MJ, Nyholt DR, Gordon S, Campbell 

M, McEvoyBP, Henders A, Evans DM, Lanchbury JS, Pereyra F; International HIV Controllers Study, 

Walker BD, Haas DW, Soranzo N, Spector TD, de Bakker PI, Frazer IH, Montgomery GW, Martin NG. 

(Llibre JM in collaborators) 

Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV- 

1 immune control. 

AM J HUM GENET 2010 Jan;86(1):88-92. Epub 2009 Dec 31. 

IF: 11,68 

Ghosn J, Flandre P, Cohen-Codar I, Girard PM, Chaix ML, Raffi F, Dellamonica P, Ngovan P, Norton M, 

Delfraissy JF;MONARK Study Group. (Llibre JM) 

Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line 

lopinavir/ritonavir monotherapy in the MONARK trial. 

HIV MED 2010 Feb;11(2):137-42. Epub 2009 Aug 13. 

IF: 3,575 

International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, 

Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge 

RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, 

Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, 

Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, 

Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, 

Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, 

Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos 

K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, 

Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch 


C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, 

Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, 

Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, 

Cornelson B, Cox DT, Cristofano MV, Cuchural G Jr, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, 

Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo 

H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant 

JE, Gandhi RT, Garcia E, Garmon D, Gathe JC Jr, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, 

Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins 

TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert 

MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, 

Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, 

Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, 

Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, 

Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin 

HL Jr, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, 

Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, 

Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, 

Oldfield EC 3rd, Olender SA, Ostrowski M, Owen WF Jr, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, 

Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch 

M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC 3rd, Rosenberg 

ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, 

Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM 

Jr, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, 

Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, 

Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, 

Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, 

Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, 

Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M 

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. The 

International HIV Controllers Study. 

SCIENCE 2010 Dec 10;330(6010):1551-7. Epub 2010 Nov 4. 

IF: 31,364 

Latorre I, Martínez-Lacasa X, Font R, Lacoma A, Puig J, Tural C, Lite J, Prat C, Cuchi E, Ausina V, 

Domínguez J. 

IFN-gamma response on T-cell based assays in HIV infected patients for detection of tuberculosis 

infection 

BMC INFECT DIS 2010 Dec 10;10:348 

IF: 2,825 





IF: 1,656 

Llibre JM, Schapiro JM, Clotet B. 

Clinical Implications of Genotypic Resistance to the Newer Antiretroviral Drugs in HIV-1-Infected 

Patients with Virological Failure. 

CLIN INFECT DIS 2010 Mar 15;50(6):872-81 

IF: 8,186 


Llibre JM. 

Do we need genotypic weighted resistance scores for antiretrovirals? 

The curious case of tipranavir. 

ANTIVIR THER 2010;15(7):959-61. 

IF: 4,322 

Macías J, González J, Ortega E, Tural C, Cabrero E, Burgos A, Pineda JA; GRAFIHCO Study Team. 

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical 

practice. 

HIV MED 2010 Aug;11(7):439-47 

IF: 3,575 





IF: 2,631 

Martinez, E; Larrousse, M; Llibre, JM; Gutierrez, F; Saumoy, M; Antela, A; Knobel, H; Murillas, J; 

Berenguer, J; Pich, J; Perez, I; Gatell, JM 

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL 

study 

AIDS 2010; JUL, 24 (11) 1697-1707 

IF: 6,348 

Massanella M, Tural C, Papagno L, Garcia E, Jou A, Bofill M, Autran B, Clotet B, Blanco J. 

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha 2a plus 

ribavirin treatment 

ANTIVIR THER 2010;15(3):333-42 

IF: 4,322 

Massanella, M; Negredo, E; Perez-Alvarez, N; Puig, J; Ruiz-Hernandez, R; Bofill, M; Clotet, B; Blanco, J 

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during 

suppressive HAART 

AIDS 2010; APR 24, 24 (7) 959-968 

IF: 6,348 





IF: 3,127 




IF: 4,672 






IF: 2,082 


Clotet B. 



ANTIVIR THER 2010;15(2):219-25 

IF: 4,322 

Moreno S, López Aldeguer J, Arribas JR, Domingo P, Iribarren JA, Ribera E, Rivero A, Pulido F; HIV 2020 

Project (Llibre JM) 

The future of antiretroviral therapy: challenges and needs 

J ANTIMICROB CHEMOTH 2010 May;65(5):827-35 

IF: 4,659 






IF: 2,243 




IF: 1,413 

Negredo E, Romeu J, Rodríguez-Santiago B, Miró O, Garrabou G, Puig J, Pérez-Alvarez N, Moren C, Ruiz L, 

Bellido R, Miranda C, Clotet B. 

Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite 

persistent impairment of mitochondrial DNA content 

CURR HIV RES 2010 Jul;8(5):379-85 

IF: 1,923 

Negredo, E; Massanella, M; Puig, J; Perez-Alvarez, N; Gallego-Escuredo, JM; Villarroya, J; Villarroya, F; 

Molto, J; Santos, JR; Clotet, B; Blanco, J 

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor 

CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications 

CLIN INFECT DIS 2010; may-01, 50(9)1300-1308 

IF: 8,186 


Negredo E. 




IF: 1,923 






IF: 3,502 

Poveda E, Alcamí J, Paredes R, Córdoba J, Gutiérrez F, Llibre JM, Delgado R, Pulido F, Iribarren JA, García 

Deltoro M, Hernández Quero J, Moreno S, García F. 

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the 

therapeutic use of CCR5 antagonists. 

AIDS REV 2010 Jul-Sep;12(3):135-48 

IF: 4,786 

Romeu J, Clotet B. 

HIV sexual transmission. Should we review the risk among individuals with long-term viral supression? 

MED CLIN-BARCELONA 2010 Feb 13;134(4):158-60 

IF: 1,413 

Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung 

RT, Rockstroh JK, Spengler U. 

GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface 

expression on CD4(+) T-cells 

ANTIVIR THER 2010;15(5):745-52. 

IF: 4,322 





AIDS 2010; APR 24, 24 (7) 975-982 

IF: 6,348 

Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, 

Navarro G, Holguín A; Cohort of Spanish AIDS Research Network (CoRIS). 

Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of 

naïve HIV-infected patients (CoRIS). 

ANTIVIR RES 2010 Nov 9. [Epub ahead of print] 

IF: 4,439 


Projectes 

ROMEU FONTANILLAS, JOAN 

FIS - Núm. Exp.: EC07/90672 

Tratamiento antirretroviral una vez al día en pacientes con infección por el VIH-1 no tratados previamente 

y con cifras de linfocitos CD$+ inferioresa 100 cel/MM3. Estudio prospectivo aleatorizado, multicéntrico y 

abierto. Estudio ADVANZ-3. 

Durada: 3 anys - (2007-2010) 


TURAL LLACHER, CRISTINA 

FIPSE - Núm. Exp.: 36702/07 

Cohorte de GESIDA de pacientes coinfectados por VIH y virus de Hepatitis C que reciben tratamiento para 

la Hepatitis C (2008-2010). 

Durada: 3 anys - (2007-2010) 



MEDICINA 

NUCLEAR 



Candell-Riera J, Romero-Farina G, Milá M, Aguadé-Bruix S, Cuberas G, García-Dorado D; RECAVA 

Research Team. 

Negative contractile reserve with low-dose dobutamine in patients with ischemic cardiomyopathy 

investigated by gated myocardial perfusion SPECT. 


IF: 2,157 

Martorell, A; Vallejos, V; Esteban, C; Mila, M; Callejas, JM; Fraile, M 

Lymphoscintigraphy study of oedema after femoropopliteal segment surgery 

Cirugía Española 2010 Jul;88(1):36-40. Epub 2010 May 8. 

Milà López M, Fraile López-Amor M, Bechini Bernard J, Vallejos Arroyo V, Guasch Arriaga I, Riba Jofré J. 

Findings of lung ventilation-perfusion SPECT-CT study in a case of pulmonary thromboembolism in a 

child 

REV ESP MED NUCL 2010 May-Jun;29(3):142-3. Epub 2010 Feb 2. 

IF: 0,77 

Solà M, Fraile M. 

Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario. 

REV ESP MED NUCL 2010 Nov-Dec;29(6):316-8 

IF: 0,77 


Fraile M. 




Projectes 

SOLA SUAREZ, MONTSERRAT 


Predicción de la SPECT-CT ósea en la eficacia analgésica de la vertebroplastia percutánea 

Durada: 3 anys - (2010-2013) 



MICROBIOLOGIA 



Altet-Gómez N, De Souza-Galvao M, Latorre I, Milá C, Jiménez MA, Solsona J, Cantos A, Zamora JJ, Ruiz- 

Manzano J, Ausina V, Domínguez J. 

Diagnosing TB infection in children: analysis of discordances using in vitro tests and tuberculin skin test 

EUR RESPIR J 2010 Aug 20. [Epub ahead of print] 

IF: 5,922 

Andreo F, Ruiz-Manzano J, Prat C, Lores L, Blanco S, Malet A, Gallardo X, Domínguez J. 

Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients. 

RESP MED 2010 Mar;104(3):397-403. Epub 2009 Nov 5. 

IF: 2,525 

Andreu A., Matas L. 

Laboratory unification: advantages and disadvantages for clinical microbiology. 

ENFERM INFEC MICR CL 2010 Oct;28 Suppl 3:63-8. Spanish 

IF: 1,656 

Ausina V., Mirelis B., Prats G. 

La docencia de la microbiología y parasitología en los estudios de grado de medicina y su adaptación al 

Espacio Europeo de Educación Superior. 

ENFERM INFEC MICR CL 2010; 28: 8-15 

IF: 1,656 

Bru A, Cardona PJ. 

Mathematical modeling of tuberculosis bacillary counts and cellular populations in the organs of 

infected mice. 

PLOS ONE 2010 Sep 23;5(9):e12985 

IF: 4,411 

Calmet M., Juvé R., Alberny M., Andreu A., Loureiro E., Matas L., Vilamala A. Casabona J. 

Recursos diagnósticos para las infecciones de transmisión sexual en los laboratorios de Cataluña 

(España). 

GAC SANIT 2009 348-350 

IF: 1,114 

Cardona PJ. 

Revisiting the natural history of tuberculosis the inclusion of constant reinfection, host tolerance, and 

damage response frameworks leads to a better understanding of latent infection and its evolution 

towards active disease 

ARCH IMMUNOL THER EX 2010 Feb;58(1):7-14. Epub 2010 Jan 5. 

IF: 2,385 

Corbeto EL, Lugo R, Martró E, Falguera G, Ros R, Avecilla A, Coll C, Saludes V, Casabona J. 

Epidemiological features and determinants for Chlamydia trachomatis infection among women in 


Catalonia, Spain. 

INT J STD AIDS 2010 Oct;21(10):718-22 

IF: 1,082 

Domínguez J., Blanco S., Lacoma A., García-Sierra N., Prat C., Ausina V. 

Utilidad de la biología molecular en el diagnóstico microbiológico de las infecciones por micobacterias. 

ENFERM INFEC MICR CL 2008 

IF: 1,656 

Fuenzalida, L; Blanco, S; Prat, C; Vivancos, M; Dominguez, MJ; Modol, JM; Rodrigo, C; Ausina, V 

Utility of the rapid antigen detection BinaxNOW Influenza A& B test for detection of novel influenza A 

(H1N1) virus 


IF: 4,784 

Fuenzalida, L; Fabrega, J; Blanco, S; del Mar Martinez, M; Prat, C; Perez, M; Ramil, C; Dominguez, J; 

Ausina, V; Rodrigo, C 

Usefulness of two new methods for diagnosing metapneumovirus infections in children 

CLIN MICROBIOL INFEC 2010 Nov;16(11):1663-8 

IF: 4,784 


Cardona, PJ 


PLOS ONE 2010; APR 6, 5 (3) -e10030 

IF: 4,411 

Guio H, Vilaplana C, Cardona PJ. 

Inmunodiagnosis and Biomarkers in Tuberculosis. 


IF: 1,413 

Lacoma, A; Prat, C; Ausina, V 

Importance of biomarkers in diagnosis, prognosis and new therapies in infectious diseases 

ENFERM INFEC MICR CL 2010 May;28(5):263-5. Epub 2010 Apr 8. 

IF: 1,656 

Latorre I, De Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Altet N, Ausina V, Domínguez J. 

Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. 

EUR RESPIR J 2010 Feb;35(2):338-42 

IF: 5,922 

Latorre I, Martínez-Lacasa X, Font R, Lacoma A, Puig J, Tural C, Lite J, Prat C, Cuchi E, Ausina V, 

Domínguez J. 

IFN-gamma response on T-cell based assays in HIV infected patients for detection of tuberculosis 

infection 

BMC INFECT DIS 2010 Dec 10;10:348. 

IF: 2,825 

Latorre I., De Souza-Galva M., Ruiz-Manzano J., Lacoma A., Prat C., Altet N., Ausina V., Domínguez J. 


Discordance between tuberculin skin tests and interferon-gamma release assays: the role of nontuberculous 

mycobacteria and the relevance of mycobacterial sensitins. 

EUR RESPIR J 2010; 36:215-6 

IF: 5,922 

M Batlle, Quesada MD, Moreno M, JM Ribera. 

Outbreak of blastoschysomics spp infection in a haematology unit: study of 6 cases and finding of the 

source of infection. 


IF: 1,413 

Marshall, V; Martro, E; Labo, N; Ray, A; Wang, DA; Mbisa, G; Bagni, RK; Volfovsky, N; Casabona, J; 

Whitby, D 

Kaposi Sarcoma (KS)-Associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European 

AIDS-KS Case Control Study 

J INFECT DIS 2010; oct-01, 202 (7) 1126-1135 

IF: 6,288 





IF: 2,631 

Menendez, R; Torres, A; Aspa, J; Capelastegui, A; Prat, C; de Castro, FR 

Community Acquired Pneumonia. New Guidelines of the Spanish Society of Chest Diseases and Thoracic 

Surgery (SEPAR) 

ARCH BRONCONEUMOL 2010 Oct;46(10):543-58. Epub 2010 Sep 15. 






IF: 1,413 

Pérez-Trallero E, Martín-Herrero JE, Mazón A, García-Delafuente C, Robles P, Iriarte V, Dal-Ré R, Garcíade-Lomas 

J;Spanish Surveillance Group for Respiratory Pathogens. (Ausina V. in collaborators) 

Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years 

(1996-1997 to 2006-2007). 

ANTIMICROB AGENTS CH 2010 Jul;54(7):2953-9. Epub 2010 May 3. 

IF: 4,672 

Prat C., Haas PJ., Bestebroer J., de Haas CJ., van Strijp JA., van Kessel KP. 

A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 

inhibitory protein) that inhibits FPRL1 and FPR1. 

J IMMUNOL 2009 6569-6578 

IF: 5,745 

Quesada MD, Giménez M, Molinos S, Fernández G, Sánchez MD, Rivelo R, Ramírez A, Banqué G, Ausina 

V. 


Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and 

susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. 

CLIN MICROBIOL INFEC 2010 Feb;16(2):137-40 

IF: 4,784 

Rodriguez-Bano, J; Picon, E; Gijon, P; Hernandez, JR; Cisneros, JM; Pena, C; Almela, M; Almirante, B; Grill, 

F; Colomina, J; Molinos, S; Oliver, A; Fernandez-Mazarrasa, C; Navarro, G; Coloma, A; Lopez-Cerero, L; 

Pascual, A 

Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-beta- 

Lactamase-Producing Escherichia coli 

J CLIN MICROBIOL 2010 May;48(5):1726-31. Epub 2010 Feb 24. 

IF: 4,22 

Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, 

Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A; Spanish Network for 

Research in Infectious Diseases (REIPI). 

Community-onset bacteremia due to extended-spectrum b-lactamase-producing Escherichia coli: risk 

factors and prognosis. 

CLIN INFECT DIS 2010 Jan 1;50(1):40-8 

IF: 8,186 

Rullas J, García JI, Beltrán M, Cardona PJ, Cáceres N, García-Bustos JF, Angulo-Barturen I. 

Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis. 

ANTIMICROB AGENTS CH 2010 May;54(5):2262-4 

IF: 4,672 

Saludes V, Bracho MA, Valero O, Ardèvol M, Planas R, González-Candelas F, Ausina V, Martró E. 

Baseline prediction of combination therapy outcome in Hepatitis C Virus 1b infected patients by 

discriminant analysis using viral and host factors. 

PLOS ONE 2010 Nov 30;5(11):e14132 

IF: 4,411 

Tudela P., Lacoma A., Prat C., Mòdol JM., Giménez M., Barallat J., Tor J. 

Prediction of bacteremia in patients with suspicion of infection in emergency room. 


IF: 1,413 



vaccine RUTI. 


IF: 3,572 




IF: 2,726 


Projectes 

AUSINA RUIZ, VICENÇ 

Ministerio de Ciencia e Innovación - Núm. Exp.: TRA2009_0370_02 

Validación de la encapsulación de principios activos en micro- y nanopartículas y su uso para la fabricación 

en desinfectantes de larga duración. 

Durada: 3 anys - (2010-2013) 


CARDONA IGLESIAS, PERE JOAN 

BILL & MELINDA GATES FOUNDATION - Núm. Exp.: 37885 

Preclinical and clinical evaluation of a post-exposure TB vaccine (proposal no.82) 

Durada: 5 anys - (2005-2010) 



COMISSIÓ EUROPEA - Núm. Exp.: 200999 

LATENT TUBERCULOSIS: New tools for the detection and clearance of dormant Mycobacterium 

tuberculosis. (StopLATENT-TB) 

Durada: 3 anys - (2007-2010) 




Demostración de la hipótesis dinámica de la infección tuberculosa latente. 

Durada: 3 anys - (2008-2011) 



Comissió Europea - Núm. Exp.: NEWTBVAC 241745 

NEWTBVAC: Discovery and preclinical development of new generation tuberculosis vaccines. 

Durada: 4 anys - (2010-2014) 



Comissió Europea - Núm. Exp.: NOPERSIST 232188 

NOPERSIST: Novel strategies for the prevention and control of persistent infections. 

Durada: 3 anys - (2010-2013) 



Unitat de Tuberculosi Experimental - Núm. Exp.: GRANLATHU 

GRANLATHU: Study of LTBI by high ressolution scanner. 

Durada: 3 anys - (2009-2012) 

Import Concedit: 0 € 

DOMINGUEZ BENITEZ, JOSE ANTONIO 


Detección, identificación de Mycobacterium tuberculosis, caracterización molecular de la resistencia a los 

principales antituberculosos en muestra clínica directa mediante pirosecuenciación. Aplicabilidad en el 


estudio de la clonalidad de las cepas. 

Durada: 3 anys - (2007-2010) 



SEPAR - Núm. Exp.: 47 

Utilidad de la pirosecuenciación en la detección, identificación de Mycobacterium tuberculosis y 

caracterización molecular de la resistencia a los principales antituberculosos en muestra clínica directa. 

Durada: 3 anys - (2007-2010) 



FUCAP - Núm. Exp.: -- 

Utilidad de la cuantificación de linfócitos T sensibilizados frente a antígenos específicos de mycobacterium 

tuberculosis presentes en lavado broncoalveolar para el diagnóstico de la tuberculosis pulmonar. 

Durada: 3 anys - (2007-2010) 



B•R•A•H•M•S Aktiengesellschaft - Núm. Exp.: --- 

Clinical Evaluation of the In Vitro Diagnostic Product BRAHMS PCT direct 

Durada: 2 anys - (2008-2010) 




Estudio de la utilidad de la estimulación in vitro de linfocitos T sensibilizados y detección posterior de IFNy 

mediante antígenos específicos de latencia y análisis de las discordancias entre la tuberculina y las 

técnicas in vitro de diagnóstico de la infección tuberculosa 

Durada: 3 anys - (2010-2013) 


MARTRO CATALA, ELISA 

Instituto de Salud Carlos III - Núm. Exp.: CP09/00044 

Impacto de la variabilidad genética del VHC-1 y de los cofactores del hospedador basales en la 

probabilidad de respuesta a la terapia antivírica combinada de la hepatitis C crónica. 

Durada: 3 anys - (2009-2012) 


MARTRO CATALA, ELISA 


Secuenciacion de hemigenomas y pirosecuenciación ultraprofunda de aislados clínicos del virus de la 

hepatitis C 

Durada: 3 anys - (2010-2013) 



NEFROLOGIA 



Bajo, MA; Selgas, R; Remon, C; Arrieta, J; Alvarez-Ude, F; Arenas, MD; Borras, M; Coronel, F; Garcia- 

Ramon, R; Minguela, I; Perez-Banasco, V; Perez-Contreras, J; Fontan, MP; Teixido, J; Tornero, F; Vega, N 

Scientific-technical quality and ongoing quality improvement plan in peritoneal dialysis 

NEFROLOGIA 2010;30(1):28-45. doi: 10.3265/Nefrologia.pre2010.Jan.10205. 

IF: 0,738 





IF: 4,439 

Hernández AA, Moreso F, Bayés B, Lauzurica R, Sánz-Guajardo D, Gómez-Huertas E, Pereira P, Paul J, 

Crespo J, Amenábar JJ, Oliver J, Serón D. 

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in 

renal transplantation between 1990 and 2002 in Spain. 

NDT PLUS 2010 Jun;3(Suppl_2):ii21-ii25. 





IF: 3,134 

Moreso F, Alonso A, Gentil MA, González-Molina M, Capdevila L, Marcén R, Pascual J, Serón D; Spanish 

Late Allograft Dysfunction Study Group. (Bayés B, Lauzurica R) 

Improvement in late renal allograft survival between 1990 and 2002 in Spain: results from a multicentre 

case-control study 

TRANSPL INT 2010 Sep;23(9):907-13. Epub 2010 Mar 11. 

IF: 3,211 

Pérez V, Sánchez A, Bayés B, Navarro-Muñoz M, Lauzurica R, Pastor MC, Romero R. 

Effect of paricalcitol on the urinary peptidome of kidney transplant patients. 

TRANSPL P 2010 Oct;42(8):2924-7. 

IF: 0,993 

Perez-Romero, N; Serra, A; Granada, ML; Rull, M; Alastrue, A; Navarro-Diaz, M; Romero, R; Fernandez- 

Llamazares, J 

Effects of Two Variants of Roux-en-Y Gastric Bypass on Metabolism Behaviour: Focus on Plasma Ghrelin 

Concentrations Over a 2-Year Follow-up 


OBES SURG 2010; MAY, 20 (5) 600-609 

IF: 3,078 

Ricardo Lauzurica, Mari Cruz Pastor, Beatriz Bayés, Cristian Morales, Maribel Troya, Susana Malumbres, 

María Doladé, Ramón Romero. Immflamation, Metalloproteinases and Growth Factors in the 

development of Carotid Atherosclerosis in Renal transplant (RT) Patients. 

AM J TRANSPLANT 2010 (S4), 10: 242. 

IF: 6,048 

Romero, R; Rey-Joly, C 

Cardiorenal syndrome 

MED CLIN-BARCELONA 2010 May 15;134(14):630-2. Epub 2010 Apr 8. 

IF: 1,413 



TRANSPL P 2010 Oct;42(8):2896-8 

IF: 0,993 

Projectes 

BAYES GENIS, BEATRIU 


Papel de la autoinmunidad en el desarrollo de la diabetes mellitus postrasplante renal (DMPT): 

Marcadores humorales, genéticos y linfocitos T reguladores. 

Durada: 3 anys - (2007-2010) 


BAYES GENIS, BEATRIU 


Efecto de la vitamina D sobre los linfocitos T reguladores y las alteraciones de la glucosa en el paciente 

trasplantado renal. Influencia de las adipocitocinas 

Durada: 3 anys - (2010-2013) 


LAUZURICA VALDEMOROS, RICARDO 

FIS - Núm. Exp.: EC07/90472 

Estudio piloto de selección del regimen inmunosupresor basado en anti-calcineurinico o libre de anticalcineurinico 

dependiendo de la aloreactividad celular donante-específica mediante técnica de elispot en 

receptores de un injerto redal de bajo riesgo. 

Durada: 3 anys - (2007-2010) 


ROMERO GONZALEZ, RAMÓN 


Aplicaciones clínico-diagnósticas de la proteómica en las nefropatías glomerulares proteinúricas. 

Durada: 4 anys - (2006-2010) 



ROMERO GONZALEZ, RAMÓN 


Perfil de genotipado del podocito y estudio de la resistencia farmacológica en el síndrome nefrotico 

corticoresistente 

Durada: 3 anys - (2010-2013) 



NEUROCIRURGIA 





IF: 1,218 

Teixidor, P; Garcia, R; Alamar, M; Gonzalez, M; Llasera, R; Dura, MJ; Munoz, J; Florensa, R 

Intraoperative complications of corticosubcortical mapping 

NEUROCIRUGIA 2010; APR, 21 (2) 99-107 

IF: 0,366 

Projectes 


TEIXIDOR RODRIGUEZ, Ma. DEL PILAR 


Estudio observacional multicéntrico de seguimiento de una cohorte de pacientes con glioma de alto grado 

con resección quirúrgica guiada con ácido 5-aminolevulínico. 

Durada: 2 anys - (2009-2011) 



NEUROLOGIA 



Ahmed N, Dávalos A, Eriksson N, Ford GA, Glahn J, Hennerici M, Mikulik R, Kaste M, Lees KR, Lindsberg 

PJ, Toni D; SITS Investigators. 

Association of Admission Blood Glucose and Outcome in Patients Treated With Intravenous 

Thrombolysis 

ARCH NEUROL-CHICAGO 2010; SEP, 67 (9) 1123-1130 

IF: 7,108 

Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R, Parsons M, Roine RO, Toni D, Ringleb 

P; SITS investigators. (Dávalos .A in collaborators) 

Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated 

analysis from SITS-ISTR 

LANCET NEUROL 2010 Sep;9(9):866-74. Epub 2010 Jul 26 

IF: 21,659 

Arroyo E, González M, Grau C, Arnal C, Bujanda M, de Castro P, Grau L, Martínez M, Ramo C, Sánchez V, 

Sánchez-Soliño O. 

Proposals to improve adherence to immunomodulatory therapies in patients with multiple sclerosis 

NEUROLOGIA 2010 Nov-Dec;25(9):544-51. Epub 2010 Oct 12. 

IF: 0,589 

Arroyo E, Grau C, Ramo C, Parra J, Sánchez-Soliño O; por el grupo espanol del estudio GAP 

Global adherence project to disease-modifying therapies in patients with relapsing multiple sclerosis: 2year 

interim results 

NEUROLOGIA 2010 Sep;25(7):435-42. 

IF: 0,589 

B. T. Jankowitz, A. Aleu, R. Lin, M. Jumaa, H. Kanaan, D. Kostov, M. Hammer, K. Uchino, L. R. Wechsler, 

M. Horowitz, et al 

Endovascular treatment of basilar artery occlusion by manual aspiration thrombectomy. 

J NEUROINTERV SURG June 1, 2(2): 110 – 114. 

IF: 1,069 

Blanco Y, Hankiewicz K, Llufriu S, Sabater L, Graus F, Saiz A; Grupo Español de Neuromielitis Optica. 

(Ramo C. in collaborators) 

Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG) 

NEUROLOGIA 2010 Jan-Feb;25(1):5-12. 

IF: 0,589 

Castaño C, Dorado L, Guerrero C, Millán M, Gomis M, Perez de la Ossa N, Castellanos M, García MR, 

Domenech S, Dávalos A. 

Mechanical Thrombectomy With the Solitaire AB Device in Large Artery Occlusions of the Anterior 

Circulation. A Pilot Study 

STROKE 2010 Aug;41(8):1836-40. Epub 2010 Jun 10. 

IF: 5,756 


Cobo E, Secades JJ, Miras F, González JA, Saver JL, Corchero C, Rius R, Dàvalos A. 

Boosting the chances to improve stroke treatment. 

STROKE 2010 Mar;41(3):e143-50. Epub 2009 Dec 24. 

IF: 5,756 

de la Ossa, NP; Sobrino, T; Silva, Y; Blanco, M; Millan, M; Gomis, M; Agulla, J; Araya, P; Reverte, S; 

Serena, J; Davalos, A 

Iron-Related Brain Damage in Patients With Intracerebral Hemorrhage 

STROKE 2010 Apr;41(4):810-3. Epub 2010 Feb 25. 

IF: 5,756 

de Noreña D, Ríos-Lago M, Bombín-González I, Sánchez-Cubillo I, García-Molina A, Tirapu-Ustárroz J. 

Effectiveness of neuropsychological rehabilitation in acquired brain injury (I): attention, processing 

speed, memory and language 

REV NEUROLOGIA 2010 Dec 1;51(11):687-98. 

IF: 1,218 

de Noreña D, Sánchez-Cubillo I, García-Molina A, Tirapu-Ustárroz J, Bombín-González I, Ríos-Lago M. 

Effectiveness of neuropsychological rehabilitation in acquired brain injury (II): executive functions, 

behavioural modification and psychotherapy, and the use of the new technologies. 

REV NEUROLOGIA 2010 Dec 16;51(12):733-44. 

IF: 1,218 

Dorado, L; Millan, M; de la Ossa, NP; Guerrero, C; Gomis, M; Lopez-Cancio, E; Ricciardi, AC; Davalos, A 

Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke 

after intravenous thrombolysis 

EUR J NEUROL 2010 Feb;17(2):301-6. Epub 2009 Nov 12. 

IF: 3,765 

Espinosa G, Mendizábal A, Mínguez S, Ramo-Tello C, Capellades J, Olivé A, Cervera R 

Transverse Myelitis Affecting More Than 4 Spinal Segments Associated with Systemic Lupus 

Erythematosus: and Radiological Characteristics of 22 Patients 

SEMIN ARTHRITIS RHEU 2010 Feb;39(4):246-56. Epub 2008 Nov 20 

IF: 4,744 

Fernández M, Gobartt AL, Balañá M; COOPERA Study Group. (Gomis M. in collaborators) 

Behavioural symptoms in patients with Alzheimer’s disease and their association with cognitive 

impairment 

BMC NEUROL 2010 Sep 28;10:87. 

IF: 2,797 

Fernàndez-Busquets X, Ponce J, Bravo R, Arimon M, Martianyez T, Gella A, Cladera J, Durany N. 

Modulation of Amyloid beta Peptide1-42 Cytotoxicity and Aggregation in Vitro by Glucose and 

Chondroitin Sulfate. 

CURR ALZHEIMER RES 2010 Aug;7(5):428-38. 

IF: 4,953 

Fuentes B, Ortega-Casarrubios MA, Sanjosé B, Castillo J, Leira R, Serena J, Vivancos J, Dávalos A, Gil- 

Nuñez A, Egido J, Díez-Tejedor E; Stroke Project of the Cerebrovascular Diseases Study Group Spanish 

Society of Neurology. 


Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it? : 

Implications for outcome. 

STROKE 2010 Oct;41(10):2362-5. Epub 2010 Aug 19. 

IF: 5,756 

Garcia-Molina A, Tirapu-Ustarroz J, Luna-Lario P, Ibañez J, Duque P. 

Are intelligence and executive functions the same thing? 

REV NEUROL-FRANCE 2010 Jun 16;50(12):738-46 

IF: 0,528 

Gomis M, Ois A, Rodríguez-Campello A, Cuadrado-Godia E, Jiménez-Conde J, Subirana I, Dávalos A, 

Roquer J. 

Outcome of intracerebral haemorrhage patients pre-treated with statins 

EUR J NEUROL 2010 Mar;17(3):443-8. Epub 2009 Nov 12. 

IF: 3,765 

Jumaa MA, Zhang F, Ruiz-Ares G, Gelzinis T, Malik AM, Aleu A, Oakley JI, Jankowitz B, Lin R, Reddy V, 

Zaidi SF, Hammer MD, Wechsler LR, Horowitz M, Jovin TG. 

Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for 

proximal middle cerebra artery occlusion with intubation and general anesthesia versus the 

nonintubated state. 

STROKE 2010 Jun;41(6):1180-4. Epub 2010 Apr 29. 

IF: 5,756 

Kanaan H, Jankowitz B, Aleu A, Kostov D, Lin R, Lee K, Panipitiya N, Gologorsky Y, Sandhu E, Rissman L, 

Crago E, Chang YF, Kim SR, Jovin T, Horowitz M. 

In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial 

aneurysms. 

NEUROSURGERY 2010 Dec;67(6):1523-32; discussion 1532-3. 

IF: 3,298 

Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton 

SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, 

Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, 

Byrnes G. (Davalos A. in collaborators) 

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of 

ECASS, ATLANTIS, NINDS, and EPITHET trials 

LANCET 2010 May 15;375(9727):1695-703. 

IF: 33,633 

Lin R, Aleu A, Jankowitz B, Kostov D, Kanaan H, Horowitz M, Jovin T 

Endovascular Revascularization of Chronic Symptomatic Vertebrobasilar Occlusion. 

J NEUROIMAGING 2010 Dec 1. doi: 10.1111/j.1552-6569.2010.00554.x. [Epub ahead of print] 

IF: 1,287 

Martínez S, Cáceres C, Mataró M, Escudero D, Latorre P, Dávalos A. 

Is there progressive cognitive dysfunction in Sjögren Syndrome? A preliminary 

ACTA NEUROL SCAND 2010 Sep;122(3):182-8. Epub 2010 Jan 21. 

IF: 2,153 

Masjuan J, Alvarez-Sabín J, Arenillas J, Calleja S, Castillo J, Dávalos A, Tejedor ED, Freijo M, Gil-Núñez A, 


Fernández JC, Maestre JF, Vila EM, Morales A, Purroy F, Ramírez JM, Segura T, Serena J, Tejada J, Tejero 

C. 

Stroke health care plan (ICTUS II. 2010). 

NEUROLOGIA 2010 Nov 3. [Epub ahead of print] 

IF: 0,589 

Matilla-Dueñas A, Sánchez I, Corral-Juan M, Dávalos A, Alvarez R, Latorre P. 

Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias 

CEREBELLUM 2010 Jun;9(2):148-66 

IF: 3,288 

Millán M, Dorado L, Dávalos A 

Fibrinolytic therapy in acute stroke 

CURR CARDIOL REV 6:218-226. 

Miralbell J, Soriano JJ, López-Cancio E, Arenillas JF, Dorado L, Barrios M, Cáceres C, Alzamora MT, Torán 

P, Pera G, Dávalos A, Mataró M. 

Vascular risk factors and cognitive performance in patients 50 to 5 years-old. 

NEUROLOGIA 2010 Sep;25(7):422-9. 

IF: 0,589 

Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, Wahlgren NG, Lees KR; VISTA 

collaborators; SITS collaborators. (Davalos A) 

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis 

Registry and Virtual International Stroke Trials Archive 

BMJ 2010 Nov 23;341:c6046. doi: 10.1136/bmj.c6046. 

Otero S, Batlle J, Bonaventura I, Brieva L, Bufill E, Cano A, Carmona O, Escartín A, Marco M, Moral E, 

Munteis E, Nos C, Pericot I, Perkal H, Ramió-Torrentà L, Ramo-Tello C, Saiz A, Sastre-Garriga J, Tintoré M, 

Vaqué J, MontalbanX; Grupo de Trabajo del Registro de Esclerosis Múltiple de Cataluña 

Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry 

of new cases in Catalonia 

REV NEUROLOGIA 2010 May 16;50(10):623-33. 

IF: 1,218 

Pérez de La Ossa N, Dávalos A. 

Transient ischemic attack: the end justifies the means. 

MED CLIN-BARCELONA 2010 Sep 11;135(8):360-1. Epub 2010 Jul 1. 

IF: 1,413 

Ponce, J; Brea, D; Carrascal, M; Guirao, V; DeGregorio-Rocasolano, N; Sobrino, T; Castillo, J; Davalos, A; 

Gasull, T 

The effect of simvastatin on the proteome of detergent-resistant membrane domains: Decreases of 

specific proteins previously related to cytoskeleton regulation, calcium homeostasis and cell fate 

PROTEOMICS 2010; MAY, 10 (10) 1954-1965 

IF: 4,815 

Sobrino, T; Millan, M; Castellanos, M; Blanco, M; Brea, D; Dorado, L; Rodriguez-Gonzalez, R; Rodriguez- 

Yanez, M; Serena, J; Leira, R; Davalos, A; Castillo, J 

Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic 


stroke treated with tPA 

J THROMB HAEMOST 2010 Jul;8(7):1567-74. Epub 2010 Apr 30. 

IF: 5,439 




IF: 0,366 

Viteri, C; Codina, M; Cobaleda, S; Lahuerta, J; Barriga, J; Morales, MD 

Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine 

or valproic acid 

SEIZURE-EUR J EPILEP 2010; SEP, 19 (7) 432-438 

IF: 1,649 

Projectes 

ARENILLAS LARA, JUAN FRANCISCO 


Mecanismos básicos implicados en el desarrollo y la progresión de la aterosclerosis intracraneal 

asintomática: estudio de base poblacional. 

Durada: 3 anys - (2007-2010) 


COLL CANTI, JAUME 


Paràlisi del malalt crític: Estudi Clínic, electrofisiològic, bioquímic i patològic. 

Durada: 3 anys - (2007-2010) 


DAVALOS ERRANDO, ANTONI 

CIDEM - Núm. Exp.: RDITSCON07-4-2006 

Disseny de models per al desenvolupament de noves Teràpies Neuro reparadores e Ictus. 

Durada: 3 anys - (2007-2010) 


GASULL DALMAU, TERESA 

MEC - Núm. Exp.: SAF2007-62559 

Papel de los rafts lipídicos en la neurodegeneración producida por la excesiva activación de los receptores 

glutamatérgicos: protección por estatinas. 

Durada: 3 anys - (2007-2010) 



Ministerio de Ciencia e Innovación - Núm. Exp.: SAF2010-22122 

Efectores de la muerte neuronal excitotóxica: Intervención sobre la señalización de los receptores 

extrasinápticos de N-METIL-D ASPARTATO 

Durada: 3 anys - (2010-2013) 




Agència de Gestió d'Ajuts Universitaris i de Recerca - Núm. Exp.: 2010ACDC00155 

Taller didàctic: Que passa dins del nostre cos quan patim un infart cerebral? 

Durada: 1 anys - (2010-2011) 


MATILLA DUEÑAS, ANTONI 

Ministerio de Educación y Ciencia - Núm. Exp.: BFU2008-00527 

Identificación de genes y rutas moleculares directamente reguladas por ataxina_1. 

Durada: 3 anys - (2008-2011) 



FIS - Núm. Exp.: CP08/00027 

Investigación de las bases moleculares neurodegenerativas en la ataxia espinocerebelosa tipo 1 (SCA1) 

Durada: 3 anys - (2008-2011) 




Estudis clínics, genètics, epidemiològics, patofisiològics i translacionals a les atàxies espinocerebel·loses. 

Durada: 3 anys - (2010-2013) 


MILLAN TORNE, MONICA 

FIS - Núm. Exp.: EC07/90325 

Estudio doble ciego, aleatorizado, controlado con placebo de dosis escaladas de deferoxamina 

intravenosa en pacientes con ictus isquémico agudo tratado con activador tisular del plasminógeno. 

Durada: 3 anys - (2007-2010) 


MILLAN TORNE, MONICA 

FIS - Núm. Exp.: PS09/01638 

Efecto de la recanalización arterial y del postcondicionamiento isquémico sobre el daño por reperfusión 

en pacientes con oclusión proximal de la arteria cerebral media 

Durada: 3 anys - (2009-2012) 


PEREZ DE LA OSSA, NATALIA 


Estudio de la sensibilidad del sistema sanitario y de los diferentes niveles asistenciales en la detección de 

pacientes candidatos a activación de código ictus. Análisis de factores clínicos y organizativos relacionados 

con la negligencia de tratamiento específico en el ictus agudo 

Durada: 3 anys - (2010-2013) 


RAMO TELLO, CRISTINA 

FIS - Núm. Exp.: EC07/90278 

Ensayo clínico, multicéntrico, con asignación aleatoria y doble ciego, para comparar la eficacia clínica y 

radiológica de dosis equivalentes de metilprednisolona administradas por vía oral o vía intravenosa en 

pacientes en brote de esclerosis múltiple. 


Durada: 3 anys - (2007-2010) 


RAMO TELLO, CRISTINA 


Trasplante de Células Troncales Mesenquimales Autólogas Derivadas de Médula Ósea como Estrategia 

Terapéutica Potencial para el tratamiento de la Esclerosis Múltiple. 

Durada: 1 anys - (2010-2011) 



OBSTETRÍCIA I 

GINECOLOGIA 







IF: 4,023 

Gadelha T, Roldán V, Lecumberri R, Trujillo-Santos J, del Campo R, Poggio R, Monreal M; RIETE 


Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of 

venous thromboembolism. Findings from the RIETE Registry. 


IF: 2,372 




IF: 1,413 




IF: 3,008 


OFTALMOLOGIA 



Angi M, Romano V, Valldeperas X, Romano F, Romano MR 

Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patientInt 

Ophthalmol 2010 Apr;30(2):195-7. Epub 2009 Jan 23. 

López R, Salgado M, Reboredo M, Grande C, Méndez JC, Jorge M, Romero C, Quintero G, de la Cámara J, 

Candamio S. 

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab 

combined with FOLFIRI in metastatic colorectal cancer. 

BRIT J CANCER 2010 Nov 9;103(10):1536-41. Epub 2010 Oct 12. 

IF: 4,831 

Loscos-Arenas J, Blázquez-Albisú A, de-la-Cámara J. 

Blindness in the work by Jorge Luis Borges: "Seven nights: Blindness" 

Arch Soc Esp Oftalmol 2010 Jun;85(6):220-1. Epub 2010 Oct 12. 

Romano MR, Vinciguerra P, Valldeperas X, Romano V, Angi M, Furgiuele D, Costagliola C. 

Inferior pseudophakic retinal detachment 

OPHTHALMOLOGY 2010 Nov;117(11):2233.e3-4. 

IF: 5,017 


ONCOLOGIA 

MÈDICA 



Alba, E; Ruiz-Borrego, M; Margeli, M; Rodriguez-Lescure, A; Sanchez-Rovira, P; Ruiz, A; Mel-Lorenzo, JR; 

Ramos-Vazquez, M; Ribelles, N; Calvo, E; Casado, A; Marquez, A; Vicente, D; Garcia-Saenz, JA; Martin, M 

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction 

chemotherapy for metastatic breast cancer: GEICAM 2001-01 study 

BREAST CANCER RES TR 2010 Jul;122(1):169-76. Epub 2010 Apr 2. 

IF: 4,859 

Auperin, A; Le Chevalier, T; Le Pechoux, C; Pignon, JP; Tribodet, H; Burdett, S; Stewart, LA; Tierney, JF; 

Stephens, RJ; Arriagada, R; Higgins, JP; Johnson, DH; van Meerbeeck, J; Parmar, MKB; Souhami, RL; 

Bergman, B; Dautzenberg, B; Douillard, JY; Dunant, A; Endo, C; Girling, DJ; Imaizumi, M; Kato, H; Keller, 

SM; Kimura, H; Knuuttila, A; Kodama, K; Komaki, R; Kris, MG; Lad, T; Mineo, T; Park, JH; Piantadosi, S; 

Pyrhonen, S; Rosell, R; Scagliotti, GV; Seymour, LW; Shepherd, FA; Spiro, SG; Strauss, GM; Sylvester, R; 

Tada, H; Tanaka, F; Torri, V; Wada, H; Waller, D; Xu, GC 

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung 

cancer: two meta-analyses of individual patient data 

LANCET 2010 Apr 10;375(9722):1267-77. Epub 2010 Mar 24. 

IF: 33,633 

Borras, E; Pineda, M; Blanco, I; Jewett, EM; Wang, F; Teule, A; Caldes, T; Urioste, M; Martinez-Bouzas, C; 

Brunet, J;Balmana, J; Torres, A; Cajal, TRY; Sanz, J; Perez-Cabornero, L; Castellvi-Bel, S; Alonso, A; Lanas, 

A; Gonzalez, S; Moreno, V; Gruber, SB; Rosenberg, NA; Mukherjee, B; Lazaro, C; Capella, G 

MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families 

CANCER RES 2010 Oct 1;70(19):7379-91. Epub 2010 Sep 21. 

IF: 8,234 

Cabezon, O; Rosell, R; Velarde, R; Mentaberre, G; Casas-Diaz, E; Lavin, S; Marco, I 

Border disease virus shedding and detection in naturally infected Pyrenean chamois (Rupicapra 

pyrenaica) 

J VET DIAGN INVEST 2010; SEP, 22 (5) 744-747 

IF: 1,381 

Cabezon, O; Velarde, R; Rosell, R; Lavin, S; Segales, J; Marco, I 

Experimental infection of lambs with Border disease virus isolated from a Pyrenean chamois 

VET REC 2010; oct-16, 167 (16) 619-621 

IF: 1,482 

Camps C, Jantus-Lewintre E, Cabrera A, Blasco A, Sanmartín E, Gallach S, Caballero C, Del Pozo N, Rosell 

R, Guijarro R, Sirera R. 

The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced 

non-small cell lung cancer patients. 

LUNG CANCER 2010 Nov 11. [Epub ahead of print] 

IF: 3,356 


Carcereny E, Ramirez J. L, Sanchez-Ronco M, Isla D, Cobo M, Moran T, de Aguirre I, Okamoto T, Wei J, 

Provencio M, Lopez-Vivanco G, Camps C, Domine M, Alberola V, Sanchez J. M, Massuti B, Mendez P, 

Taron M, Rosell R. 

Blood-based CHRNA3 single nucleotide polymorphisms and outcome in advanced non-small-cell lung 

cancer patients. 

LUNG CANCER 2010 Jun;68(3):491-7. Epub 2009 Sep 5. 

IF: 3,356 

Colomer, R; Alba, E; Gonzalez-Martin, A; Paz-Ares, L; Martin, M; Llombart, A; Lescure, AR; Salvador, J; 

Albanell, J; Isla, D; Lomas, M; Rodriguez, CA; Trigo, JM; Germa, JR; Bellmunt, J; Tabernero, J; Rosell, R; 

Aranda, E; Cubedo, R; Baselga, J 

Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology 

(SEOM) 

ANN ONCOL 2010 Feb;21(2):195-8. 

IF: 6,452 

Douillard, JY; Tribodet, H; Aubert, D; Shepherd, FA; Rosell, R; Ding, KY; Veillard, AS; Seymour, L; Le 

Chevalier, T; Spiro, S; Stephens, R; Pignon, JP 

Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer Subgroup 

Analysis of the Lung Adjuvant Cisplatin Evaluation 

J THORAC ONCOL 2010; FEB, 5 (2) 220-228 

IF: 4,04 

Estévez LG, Alvarez I, Seguí MÁ, Muñoz M, Margelí M, Miró C, Rubio C, Lluch A, Tusquets I. 

Current perspectives of treatment of ductal carcinoma in situ 

CANCER TREAT REV 2010 Nov;36(7):507-17 

IF: 6,811 

Felip E, Rosell R, Maestre JA, Rodríguez-Paniagua JM, Morán T, Astudillo J, Alonso G, Borro JM, 

González-Larriba JL, Torres A, Camps C, Guijarro R, Isla D, Aguiló R, Alberola V, Padilla J, Sánchez- 

Palencia A, Sánchez JJ, Hermosilla E,Massuti B; Spanish Lung Cancer Group. 

Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery 

Alone in Early-Stage Non-Small-Cell Lung Cancer 

J CLIN ONCOL 2010; jul-01, 28 (19) 3138-3145 

IF: 18,97 





IF: 5,922 

Gironés Sarrió R, Torregrosa MD, López P, Gómez-Codina J, Rosell R 

Smoking habits in elderly lung cancer patients: still no changes in epidemiology? A single-center 

experience. 

CLIN TRANSL ONCOL 2010 Oct;12(10):686-91 

IF: 1,254 

Gridelli C, Ardizzoni A, Douillard J. Y, Hanna N, Manegold C, Perrone F, Pirker R, Rosell R, Shepherd F. A, 

De Petris L, Di Maio M, de Marinis F. 

Recent issues in first-line treatment of advanced non-small cell lung cancer: results of an International 


Expert Panel Meeting of the Italian Association of Thoracic Oncology 

LUNG CANCER 2010 Jun;68(3):319-31 

IF: 3,356 




Cancer 

PLOS ONE 2010; mar-03, 5 (3) -e9499 

IF: 4,411 

Martinez-Balibrea E, Abad A, Martinez-Cardus A, Gines A, Valladares M, Navarro M, Aranda E, Marcuello 

E, Benavides M, Massuti B, Carrato A, Layos L, Manzano JL, Moreno V. 

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated 

with first-lineirinotecan and fluorouracil combination therapy. 

BRIT J CANCER 2010 Aug 10;103(4):581-9. Epub 2010 Jul 13. 

IF: 4,831 

Mazieres J, Cappuzzo F, Fruh M, Sorensen J. B, Blackhall F, Taron M, Gridelli C, O’Byrne K, Rosell R. 

Meeting Report: 2nd meeting of the European Thoracic Oncology Platform (ETOP). 

LUNG CANCER 2010 68, 121-124 

IF: 3,356 

Paz-Ares L, Soulieres D, Melezínek I, Moecks J, Keil L, Mok T, Rosell R, Klughammer B. 

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis 

J CELL MOL MED 2010 Jan;14(1-2):51-69 

IF: 4,608 

Pirker R, Herth F, Kerr K, Filipits M, Taron M, Gandara D, Hirsch F, Grunenwald D, Popper H, Smit E, 

Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R. 

Consensus for EGFR mutation testing in non-small cell lung cancer (NSCLC): Results from a European 

workshop 

J THORAC ONCOL 2010 Oct;5(10):1706-13 

IF: 4,04 

Provencio M, de las Peñas R, Camps C, Artal A, Massuti B, Cobo M, Perez J. F, Sanchez A, Rosell R. 

Cisplatin plus vinorelbine as first-line treatement for advanced non-small-cell lung cancer: is a 

hemogram on day 8 essential? 

LUNG CANCER 2010 June; 18. 68;415-419 

IF: 3,356 

Provencio M, Molina M. A, Méndez M, Rosell R. 

Screening for epidermal growth factor receptor mutations in lung cancer and tyrosine-kinase inhibitors. 

EUR J CLIN MED ONCOLOGY 2010 (in press) Epub ahead of print October 2010 

Reguart N, Cardona AF, Rosell R. 

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer. 

Cancer Manag Res 2010 Jun 1;2:143-56. 


Rosell R, Moran T, Carcereny E, Quiroga V, Molina M. A, Costa C, Benlloch S, Taron M 

Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain. 


IF: 1,254 

Rosell R, Moran T, Cardenal F, Porta R, Viteri S, Molina M. A, Benlloch S, Taron M. 

Predictive biomarkers in the management of EGFR-mutant lung cancer. 

ANN NY ACAD SCI 2010 Oct;1210:45-52 

IF: 2,847 

Rosell R, Moran T, Viteri S, Carcereny E, Gasco A, Quiroga V, Wei J, Camps C, Massuti B 

Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer. 

EXPERT OPIN PHARMACO 2010 Jul;11(10):1683-93 

IF: 2,403 

Rosell R, Vergenegre A, Lui B, Cobo M, Massuti B, Wei J, Molina M. A, Costa C, Queralt C, Taron M. 

Biomarkers in lung oncology 

PULM PHARMACOL THER 2010 Dec;23(6):508-14 

IF: 2,093 

Rosell R, Viteri S, Molina M. A, Benlloch S, Taron M. 

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall 

cell lung cancer. 

CURR OPIN ONCOL 2010 Mar;22(2):112-20 

IF: 4,386 

Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R, Fárez-Vidal ME. 

Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. 

INT J CANCER 2010 Sep 28. Epub ahead of print 

IF: 4,926 





Simonetti S, Molina MA, Queralt C, de Aguirre I, Mayo C, Bertran-Alamillo J, Sanchez JJ, Gonzalez-Larriba 

JL, Jimenez U, Isla D, Moran T, Viteri S, Camps C, Garcia-Campelo R, Massuti B, Benlloch S, Y Cajal SR, 

Taron M, Rosell R. 

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer. 

J TRANSL MED 2010 Dec 18;8:135 

IF: 3,508 

Souquet P. J, Krzakowski M, Ramlau R, Sun X. S, Lopez-Vivanco G, Puozzo C, Pouget J. C, Pinel M. C, 

Rosell R. 

Phase I/II and pharmacokinetic study of IV vinflunine in combination with cisplatin for treatment of 

advanced nonsmall cell lung cancer in chemonaive patients. 

CLIN LUNG CANCER 2010 11;2 105-113 

IF: 2,362 


Tusquets, I; Garcia-Estevez, L; Adrover, E; Calvo, L; Alvarez, I; Mata, JG; Fernandez, Y; Margeli, M; Segui, 

MA; Rodriguez, C; Lescure, AR; Colomer, R; Gascon, P; Martin, M; Alba, E; Barnadas, A; Llombart, A; 

Albanell, J; Lluch, A 

Current controversies in the management of breast cancer 

CLIN TRANSL ONCOL 2010; APR, 12 (4) 278-286 

IF: 1,254 


Fraile M. 




Wei J, Xie L, Taron M, Rosell R, Lui B. 

Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies. 

DRUG NEWS PERSPECT 2010 Dec;23(10):655-61 

IF: 2,598 

Yin M, Yan J, Voutsina A, Tibaldi C, Chistiani D, Rosell R, Booton R, Wei Q. 

No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinumbased 

chemotherapies in non-small-cell lung cancer: a meta-analysis 

LUNG CANCER 2010 Nov 12. [Epub ahead of print] 

IF: 3,356 

Projectes 

ABAD ESTEVE, ALBERT 


Polimorfismos genéticos (Opmr-1, βarrestina 2, stat6 y COMT) y su influencia en la tolerancia al 

tratamiento con opiáceos mayores. Papel en la selección de rotación individualizada de opiáceos. 

Durada: 4 anys - (2007-2011) 


ABAD ESTEVE, ALBERT 

FIS - Núm. Exp.: PS09/01463 

Implicación de los TLRS en la tumorogénesis intestinal: Determinación de biomarcadores humanos, 

validación del modelo animal y análisis de perfiles genéticos por micromatrices. 

Durada: 3 anys - (2009-2012) 


BALAÑA QUINTERO, CARMEN 

FIS - Núm. Exp.: EC08/00071 

Estudio abierto, fase II aleatorizado de tratamiento neo-adyuvante con 3 ciclos de temozolamida a dosis 

extendidas, previos al tratamiento con temozolamida más irradiación, versus mismo tratamiento con 

bevacizumab bisemanal en pacientes con Glioblastoma clase V-VI de la RPA EORTC y sólo biopsia. 

Durada: 3 anys - (2008-2011) 



MARTINEZ BALIBREA, EVA 

Fundación Privada Olga Torres - Núm. Exp.: FOT 2009-2011 

Estudio del papel de la isoforma M2 de Piruvato quinasa (PK-M2) en la respuesta y resistencia a 

oxaliplatino en líneas celulares y pacientes con cáncer colorrectal avanzado. 

Durada: 3 anys - (2008-2011) 


MARTINEZ BALIBREA, EVA 

FIS - Núm. Exp.: PS09/01334 

Estudio de la expresión de genes relacionados con resistencia a quimioterapia basada en oxaliplatino en 

líneas celulares y tejido de pacientes con cáncer colorrectal avanzado. 

Durada: 3 anys - (2009-2012) 


ROSELL COSTA, RAFAEL 

National Cancer Institut - Núm. Exp.: 1 U01 CA114771 

Firmas moleculares en cáncer de pulmon. 

Durada: 4 anys - (2006-2010) 



ONCOLOGIA 

RADIOTERÀPICA 



Manchon P, Borràs JM, Ferro T, Espinàs JA; Breast Cancer OncoGuia Group. (Arellano A, Llatjós M) 

Breast Cancer OncoGuia 


IF: 1,254 

TD. Nguyen, D. Ariza, D. Brochon, P. Poortmans, RC Miller, L. Scandolaro, W. Majewski, M. Krengli, U. 

Abacioglu, L. Moretti, S. Villà, et al. 

Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: A 

retrospective rare cancer network study. 

CRIT REV ONCOL HEMAT 2010 Apr;74(1):66-71. Epub 2009 May 5. 

IF: 4,689 


PEDIATRIA 



Alcalde-Martin C, Muro-Tudelilla JM, Cancho-Candela R, Gutierrez-Solana LG, Pintos-Morell G, Martin- 

Herrero M, Munguira-Aguado P, Galan-Gomez E. 

First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter 

syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS). 

EUR J MED GENET 2010 Nov-Dec;53(6):371-7. Epub 2010 Aug 10. 

IF: 2,335 

Amaya-Villar R, García-Cabrera E, Sulleiro-Igual E, Fernández-Viladrich P, Fontanals-Aymerich D, Catalán- 

Alonso P, Rodrigo-Gonzalo de Liria C, Coloma-Conde A, Grill-Díaz F, Guerrero-Espejo A, Pachón J, Prats- 

Pastor G. 

Three-year multicenter surveillance of community-acquired listeria monocytogenes meningitis in adults. 

BMC INFECT DIS 2010;10:324 (1-8) 

IF: 2,825 

Burton BK, Guffon N, Roberts J, van der Ploeg AT, Jones SA; HOS investigators, Pintos-Morell G. 

Home treatment with intravenous enzyme replacement therapy with idursulfase for 

mucopolysaccharidosis type II-data from the Hunter Outcome Survey. 

MOL GENET METAB 2010;101:123-9 

IF: 3,539 

Calvo Rey C, Soler-Palacín P, Merino Muñoz R, Saavedra Lozano J, Antón López J, Aróstegui JI, Blázquez 

Gamero D, Martín-Nalda A, Juan M, Méndez M, Piñeiro Perez R, Calvo I. 

Documento de Consenso de la Sociedad de Infectología Pediatrica y la Sociedad de Reumatología 

Pediatrica sobre el diagnóstico diferencial y el abordaje terapéutico de la fiebre recurrente. 

An Pediatr (Barc) 2010. doi:10.1016/j.anpedi.2010.09.022. 

Carrascosa A, Audí L, Fernández-Cancio M, Yeste D, Gussinye M, Albisu MA, Clemente M, Fábregas A, Bel 

J, Nosás R, Rabanal M, del Pozo C, Gómez JM, Mesa J, Catalan Group for Short Stature Study. 

Growth Hormone Secretory Status Evaluated by Growth Hormone Peak after Two Pharmacological 

Growth Hormone Release Stimuli Did Not Significantly Influence the Two-Year Catch-Up Growth Induced 

by Growth Hormone Therapy in 318 Prepubertal Short Children with Idiopathic Growth Retardation. 

HORM RES PAEDIAT 2010. DOI: 10.1159/000318782 

Cortès Saladelafont E, Roguera M, del Alcázar R, Benítez S, Montraveta M. 

Nen de 4 anys amb esplenomegàlia i circulació colateral abdominal. 

PEDIATRIA CATALANA 2010 Vol 70, N1; 23-24 

Costa Pagès J, Polanco Allué I, Rodrigo Gonzalo de Liria C. 

Guía de práctica clínica: Gastroenteritis aguda en el niño. Guía multidisciplinar. 

SEGNHP-SEIP 2010 

Couce ML, Aldamiz-Echevarria L, Baldellou A, Blasco J, Bueno MA, Dalmau J, De La Vega A, Del Toro M, 

Diaz C, Lama R, Leao E, Marrero M, Navas VM, Pintos G. 

Recommendations and management of Type I hereditary or hepatorenal Tyrosinemia. 


An Pediatr (Barc) 2010 Nov;73(5):279.e1-4. Epub 2010 Sep 1. 

Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A, Casado-Flores J, Taskin E, Leclerc 

F, Rodrigo C, Gervaix A, Gendrel D, Bréart G, Chalumeau M. 

Distinguishing between bacterial and aseptic meningitis in children: European 

comparison of two clinical decision rules. 

ARCH DIS CHILD 2010 2010;95:963-7 

IF: 2,616 

Fuenzalida, L; Blanco, S; Prat, C; Vivancos, M; Dominguez, MJ; Modol, JM; Rodrigo, C; Ausina, V 

Utility of the rapid antigen detection BinaxNOW Influenza A& B test for detection of novel influenza A 

(H1N1) virus 


IF: 4,784 

Fuenzalida, L; Fabrega, J; Blanco, S; del Mar Martinez, M; Prat, C; Perez, M; Ramil, C; Dominguez, J; 

Ausina, V; Rodrigo, C 

Usefulness of two new methods for diagnosing metapneumovirus infections in children 

CLIN MICROBIOL INFEC 2010 Nov;16(11):1663-8 

IF: 4,784 

Giménez-Sánchez F, Delgado-Rubio A, Martinón-Torres F, Bernaola-Iturbe E; Rotascore Research Group 

Rodrigo C. 

Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain. 

ACTA PAEDIATR 2010 May;99(5):738-42. Epub 2010 Jan 21. 

IF: 1,955 

Lidove O, West ML, Pintos-Morell G, Reisin R, Nicholls K, Figuera LE, Parini R, Carvalho LR, Kampmann C, 

Pastores GM, Mehta A. 

Effects of enzyme replacement therapy in Fabry disease: a comprehensive review of the medical 

literature. 

GENET MED 2010 Nov;12(11):668-79. 

IF: 5,28 

Marés J, Rodrigo C, Moreno-Pérez D, Cilleruelo MJ, Barrio F, Buñuel JC, González MP, González de Dios J, 

Aparicio M, Arístegui J, Hernández-Sampelayo T. 

Recomendaciones para el manejo de la gripe en niños (2009-2010). 

An Pediatr (Barc) 2010; 72:144.e1-e12 

Meeths, M; Entesarian, M; Al-Herz, W; Chiang, SCC; Wood, SM; Al-Ateeqi, W; Almazan, F; Boelens, JJ; 

Hasle, H; Ifversen, M; Lund, B; van den Berg, JM; Gustafsson, B; Hjelmqvist, H; Nordenskjold, M; 

Bryceson, YT; Henter, JI 

Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with 

mutations in STXBP2 

BLOOD 2010 Oct 14;116(15):2635-43. Epub 2010 Jun 17. 

IF: 10,558 

Mehta A, West ML, Pintos-Morell G, Reisin R, Nicholls K, Figuera LE, Parini R,Carvalho LR, Kampmann C, 

Pastores GM, Lidove O. 

Therapeutic goals in the treatment of Fabry disease. 


GENET MED 2010 Nov;12(11):713-20. 

IF: 5,28 

Méndez M, Azuara M, Rodrigo C. 

Celulitis orbitaria bacteriémica por Haemophilus influenzae tipo b en una niña no vacunada. 

Vacunas 2010;11(4):155-7 

Modesto C, Antón J, Rodriguez B, Bou R, Arnal C, Ros J, Tena X, Rodrigo C, Rotés I, Hermosilla E, Barceló 

P. 

Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). 

SCAND J RHEUMATOL 2010 2010;39:472-9 

IF: 2,594 

Moreno-Pérez D, Andrés Martín A, Altet Gómez N, Baquero-Artigao F, Escribano Montaner A, Gómez- 

Pastrana Durán D, González Montero R, Mellado Peña MJ, Rodrigo-Gonzalo-de-Liria C, Ruiz Serrano MJ. 

Diagnóstico de la tuberculosis en la edad pediátrica. Documento de consenso de la Sociedad española 

de infectología pediátrica (SEIP) y la Sociedad española de neumología pediátrica (SENP). 

An Pediatr (Barc) 2010; 72:283.e1-283.e14. 

Murillo M, Bel J. 

Avenços en el diagnòstic i el tractament de la talla baixa a la infància. 

PEDIATRIA CATALANA 2010; 70: 113-118 

Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, Arkwright PD, McDonald D, Geha RS, Takada H, 

Krause JC, Creech CB, Ku CL, Ehl S, Maródi L, Al-Muhsen S, Al-Hajjar S, Al-Ghonaium A, Day-Good NK, 

Holland SM, Gallin JI, Chapel H, Speert DP, Rodriguez-Gallego C, Colino E, Garty BZ, Roifman C, Hara T, 

Yoshikawa H, Nonoyama S, Domachowske J, Issekutz AC, Tang M, Smart J, Zitnik SE, Hoarau C, 

Kumararatne DS, Thrasher AJ, Davies EG, Bethune C, Sirvent N, de Ricaud D, Camcioglu Y, Vasconcelos J, 

Guedes M, Vitor AB, Rodrigo C, Almazán F, Méndez M, Aróstegui JI, Alsina L, Fortuny C, Reichenbach J, 

Verbsky JW, Bossuyt X, Doffinger R, Abel L, Puel A, Casanova JL. 

Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency. 

MEDICINE 2010;89:403-425 

IF: 4,256 

Rodrigo C, Salman N, Tatochenko V, MÃ©szner Z, Giaquinto C. 

Recommendations for rotavirus vaccination: A worldwide perspective. 

VACCINE 2010 Jul 12;28(31):5100-8. Epub 2010 May 14. 

IF: 3,572 

Rodrigo C. 

Use of antibiotics in the paediatric population. 

ENFERM INFEC MICR CL 2010 May;28(5):310-20. Epub 2010 Apr 22. 

IF: 1,656 

Santiago EB, Garau J, Crespo RZ, Gonzalo de Liria CR. 

Relationships with microbiology: the view from other specialties. 

ENFERM INFEC MICR CL 2010 Oct;28 Suppl 3:39-44 

IF: 1,656 

Van Esso Arbolave DL, Rodrigo Gonzalo de Liria C. 

Profilaxis antimicrobiana y postexposición. 


PEDIATR INT 2010; 14: 66-74 

IF: 0,755 

Projectes 

ESTEBAN OLIVA, DOLORS 

Fundación Santiago DEXEUS Font - Núm. Exp.: 

Estudio del patrón proteómico urinario en recién nacidos con anomalías nefro-urológicas de detección 

prenatal: búsqueda de biomarcadores predictores de la evolución. 

Durada: 2 anys - (2008-2010) 



PNEUMOLOGIA 



Almirall J, Bolíbar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, 

Torres A; Community-Acquired Pneumonia in Catalan Countries. (Costa J; Ruiz-Manzano J. in 

collaborators) 

Inhaled drugs as risk factors for community-acquired pneumonia. 

EUR RESPIR J 2010 Nov;36(5):1080-7. Epub 2010 Jun 4. 

IF: 5,922 

Altet-Gómez N, De Souza-Galvao M, Latorre I, Milá C, Jiménez MA, Solsona J, Cantos A, Zamora JJ, Ruiz- 

Manzano J, Ausina V, Domínguez J. 

Diagnosing TB infection in children: analysis of discordances using in vitro tests and tuberculin skin test 

EUR RESPIR J 2010 Aug 20. [Epub ahead of print] 

IF: 5,922 

Andreo F, Ruiz-Manzano J, Prat C, Lores L, Blanco S, Malet A, Gallardo X, Domínguez J. 

Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients. 

RESP MED 2010 Mar;104(3):397-403. Epub 2009 Nov 5. 

IF: 2,525 

Calverley PM, Kuna P, Monsó E, Costantini M, Petruzz, Sergio F, Varoli G, Papi A, Brusasco V. 

Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. 

RESP MED 2010 Dec;104(12):1858-68. Epub 2010 Oct 20. 

IF: 2,525 

Fiz, JA; Jane, R; Sola-Soler, J; Abad, J; Garcia, MA; Morera, J 

Continuous Analysis and Monitoring of Snores and Their Relationship to the Apnea-Hypopnea Index 

LARYNGOSCOPE 2010; APR, 120 (4) 854-862 

IF: 2,096 

García Melchor E, Grados Casanovas D, Ruiz Manzano J, Olivé Marqués A 

Takayasu's arteritis: infrequent or underdiagnosed? 


IF: 1,413 

Garcia-Aymerich J, Gómez FP, Benet M, Farrero E, Basagaña X, Gayete A, Paré C, Freixa X, Ferrer J, Ferrer 

A, Roca J,Gáldiz JB, Sauleda J, Monsó E, Gea J, Barberà JA, Agustí A, Antó JM; on behalf of the PAC-COPD 

Study Group. 

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease 

(COPD) subtypes. 

THORAX 2010 Dec 21. [Epub ahead of print] 

IF: 6,525 






IF: 5,922 

Garcia-Olive I, Sanz-Santos J, Andreo F, Monsó E. 

Application of real time endobronchial ultrasound-guided transbronchial needle aspiration for lung 

cancer staging 

Zhongguo Fei Ai Za Zhi 2010 May;13(5):406-9. 

Gonzalez-Martin, J; Garcia-Garcia, JM; Anibarro, L; Vidal, R; Esteban, J; Blanquer, R; Moreno, S; Ruiz- 

Manzano, J 

Consensus document on diagnosis, treatment and prevention of tuberculosis 

ENFERM INFEC MICR CL 2010; MAY, 28 (5) 297-297 

IF: 1,656 

Gonzalez-Martin, J; Garcia-Garcia, JM; Anibarro, L; Vidal, R; Esteban, J; Blanquer, R; Moreno, S; Ruiz- 

Manzano, J 

Consensus document on diagnosis, treatment and prevention of tuberculosis 

ARCH BRONCONEUMOL 2010 May;46(5):255-74. Epub 2010 May 5. 

Ignasi Garcia-Olivé, José Sanz-Santos, Felipe Andreo & Eduard Monsó 

Application of real-time endobronchial ultrasound-guided transbronchial needle aspiration for lung 

cancer staging. 

THORACIC CANCER 2010; 1:23-27 

Ignasi Garcia-Olivé, José Sanz-Santos, Felipe Andreo and Eduard Monsó 

Detection of Epidermal Growth Factor Receptor Mutations in Samples obtained with Endobronchial 

Ultrasound-Guided Transbronchial Needle Aspiration: A Short Review 

ANNALS OF RESPIRATORY MEDICINE 2010 

Jiménez Ruiz CA, Ruiz Manzano J. 

The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the new law on smoking in Spain 

ARCH BRONCONEUMOL 2010 Aug;46(8):402-4. Epub 2010 Jun 9. 

Latorre I, De Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Altet N, Ausina V, Domínguez J. 

Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. 

EUR RESPIR J 2010 Feb;35(2):338-42 

IF: 5,922 

Latorre I., De Souza-Galva M., Ruiz-Manzano J., Lacoma A., Prat C., Altet N., Ausina V., Domínguez J. 

Discordance between tuberculin skin tests and interferon-gamma release assays: the role of nontuberculous 

mycobacteria and the relevance of mycobacterial sensitins. 

EUR RESPIR J 2010; 36:215-6 

IF: 5,922 

Marin A, Monsó E, Garcia-Nuñez M, Sauleda J, Noguera A, Pons J, Agustí A, Morera J. 

Variability and effects of bronchial colonisation in patients with moderate COPD. 


IF: 5,922 


Mesquita J, Fiz JA, Sola-Soler J, Morera J, Jane R. 

Regular and non regular snore features as markers of SAHS 

IEEE ENG MED BIOL 2010;2010:6138-41. 

IF: 2,828 

Miravitlles, M; Marin, A; Monso, E; Vila, S; de la Roza, C; Hervas, R; Esquinas, C; Garcia, M; Millares, L; 

Morera, J; Torres, A 

Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease airway 

RESP RES 2010; may-14, 11 () -58 

IF: 2,859 

Murio C, Soler X, Pérez M, Calero G, Ruiz-Manzano J. 

Acute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: the 

EPOCAP study 

THER ADV RESPIR DIS 2010 Aug;4(4):215-23. Epub 2010 Jul 12. 

Núñez B, Sauleda J, Antó JM, Julià MR, Orozco M, Monsó E, Noguera A, Gómez FP, Garcia-Aymerich J, 

Agustí A; onbehalf of the PAC-COPD investigators listed in Appendix. 

Anti-Tissue Antibodies are Related to Lung Function in Chronic Obstructive Pulmonary Disease. 

AM J RESP CRIT CARE 2010 Apr 15;183(8):1025-1031. Epub 2010 Nov 19. 

IF: 10,191 

Portillo Carroz K, Roldán Sánchez J, Morera Prat J. 

Combined pulmonary fibrosis and emphysema. 

ARCH BRONCONEUMOL 2010 Dec;46(12):646-51 

Portillo K, Santos S, Madrigal I, Blanco I, Paré C, Borderías L, Peinado VI, Roca J, Milà M, Barberà JA. 

Study of the BMPR2 gene in patients with pulmonary arterial hypertension] 

ARCH BRONCONEUMOL 2010 Mar;46(3):129-34. Epub 2010 Jan 21. 

Ruiz-Manzano, J; Altet-Gomez, N 

Treatment of tuberculous infection: Where we are? 

MED CLIN-BARCELONA 2010 Sep 4;135(7):310-1. Epub 2010 Jun 18. 

IF: 1,413 

Sánchez-Martínez E, Garcia-Olivé I, Ruiz-Manzano J. 

Shortness of breath and cyanosis in a patient with dermatitis herpetiformis. 

ARCH BRONCONEUMOL 2010 Mar;46(3):153. Epub 2009 Oct 17. 





Sarlabous L, Torres A, Fiz JA, Gea J, Martinez-Llorens JM, Morera J, Jane R 

Interpretation of the approximate entropy using fixed tolerance values as a measure of amplitude 

variations in biomedical signals 

IEEE ENG MED BIOL 2010;2010:5967-70. 

IF: 2,828 

Torres A, Sarlabous L, Fiz JA, Gea J, Martinez-Llorens JM, Morera J, Jane R. 


Noninvasive measurement of inspiratory muscle performance by means of diaphragm muscle 

mechanomyographic signals in COPD patients during an incremental load respiratory test. 

IEEE ENG MED BIOL 2010;2010:2493-6 

IF: 2,828 

Projectes 

ABAD CAPA, JORGE 


Análisis de polimorfismos genéticos en el fenotipo SAHS-Obesidad. 

Durada: 3 anys - (2009-2012) 


ANDREO GARCIA, FELIPE CRISTOBAL 


Rentabilidad diagnóstica de la ultrasonografía endobronquial en el diagnóstico y estadificación del 

carcinoma pulmonar no microcítico. 

Durada: 3 anys - (2007-2010) 


ANDREO GARCIA, FELIPE CRISTOBAL 

SOCAP - Núm. Exp.: 

Rentabilitat diagnòstica de la ultrasonografia endobronquial en el diagnòstic i estadificació de carcinoma 

de pulmó no cèl·lula petita. 

Durada: 3 anys - (2008-2011) 


MARTINEZ RIVERA, CARLOS 

FIS - Núm. Exp.: PI08/90251 

AUDIPOC: Auditoría Clínica Nacional sobre exacerbaciones de la EPOC en España. Proyecto Coordinado. 

Subproyecto AUDIPOC Cataluña. 

Durada: 2 anys - (2008-2010) 


MONSO MOLAS, EDUARD 

FUCAP - Núm. Exp.: Beca Oscar Ravà 

Detección de displasia bronquial y carcinoma in situ a nivel molecular y endoscópico en una población de 

riesgo de cáncer de pulmón por enfermedad pulmonar obstructiva crónica (EPOC). 

Durada: 3 anys - (2009-2012) 


MONSO MOLAS, EDUARD 

FIS - Núm. Exp.: PS09/01612 

Estadificación nodal sistemática con ultrasonografía endobronquial lineal en el carcinoma pulmonar no 

microcítico 

Durada: 3 anys - (2009-2012) 


MORERA PRAT, JOSEP 



Estudio de la vía de señalización de la prostaglandina E2 en cáncer de pulmón y su relación con en 

receptor del factor de crecimiento epidérmico. 

Durada: 2 anys - (2009-2011) 


ROLDAN SANCHEZ, JUAN 


Mecanismos Genéticos y Celulares en Fibrosis Pulmonar. 

Durada: 3 anys - (2007-2010) 


RUIZ MANZANO, JOAN 

SOCAP 

Estudi de la utilitat de la determinació dual del número de cèl•lules T productores d’interferó gamma i 

interleuquina 2 en la monitorització del tractament de la tuberculosi i de la profilaxi de la infecció 

tuberculosa. 

Durada: 3 anys - (2008-2011) 



PSIQUIATRIA 








IF: 2,157 


RADIODIAGNÒSTIC 





IF: 1,218 

Capel, MD; Mourelo, S; Cannata, PA 

38-year-old woman with polyglobulia and a abdominal mass. 

MED CLIN-BARCELONA 2010 Feb 6;134(3):116-22. Epub 2009 Jun 5. 

IF: 1,413 

Luque, AF; Urra, I; Lopez-Martos, RA 

41 year old woman with renal insufficiency and a mass in the liver 

MED CLIN-BARCELONA 2010 Oct 9;135(11):519-26. Epub 2010 May 27 

IF: 1,413 


Milà López M, Fraile López-Amor M, Bechini Bernard J, Vallejos Arroyo V, Guasch Arriaga I, Riba Jofré J. 

Findings of lung ventilation-perfusion SPECT-CT study in a case of pulmonary thromboembolism in a 

child 

REV ESP MED NUCL 2010 May-Jun;29(3):142-3. Epub 2010 Feb 2. 

IF: 0,77 

Roca, JM; Alonso, V; Pericay, C; Escudero, P; Salud, A; Losa, F; Lopez, LJ; Guasch, I; Mendez, M; Quintero- 

Aldana, G; Grande, C; Vicente, P; Arrivi, A; Martin, C; Moreno, I; Garcia, P; Anton, I; Constenla, M; 

Yubero, A; Cirera, L 

Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated 

Patients with Metastatic Colorectal Cancer 

CHEMOTHERAPY 2010;56(2):142-6. Epub 2010 Apr 21. 

IF: 2,108 






REHABILITACIÓ 








IF: 2,157 




IF: 0,366 


RESSONÀNCIA 

MAGNÈTICA 





Erythematosus: Clinical, Immunological, and Radiological Characteristics of 22 Patients 


IF: 4,744 


REUMATOLOGIA 





Erythematosus: Clinical, Immunological, and Radiological Characteristics of 22 Patients 


IF: 4,744 

Fernandez-Nebro, A; Olive, A; Castro, MC; Varela, AH; Riera, E; Irigoyen, MV; de Yebenes, MJG; Garcia- 

Vicuna, R 

Long-term TNF-alpha Blockade in Patients with Amyloid A Amyloidosis Complicating Rheumatic Diseases 

AM J MED 2010; MAY, 123 (5) 454-461 

IF: 5,115 

García-Casares E, Mateo Soria L, García-Melchor E, Riera Alonso E, Olivé Marqués A, Holgado Pérez S, 

Tena Marsà X, Molinos Abós S. 

Necrotizing fasciitis and myositis caused by streptococcal flesh-eating bacteria. 

CLIN RHEUMATOL 2010 Dec;16(8):382-4. 

IF: 1,687 

González Wellens N, Minguez S, Lozano M, Olivé A. 

Trigeminal neuropathy and dermatomyositis. 

MED CLIN-BARCELONA 2010 Jun 19;135(3):140-1. Epub 2009 Jun 10. 

IF: 1,413 

Martínez-Morillo M, López R, Ibernón M, Olivé A. 

Renal p-ANCA vasculitis in patients with systemic lupus erythematosus. 

MED CLIN-BARCELONA 2010 Dec 7. [Epub ahead of print] 

IF: 1,413 

Modesto C, Antón J, Rodriguez B, Bou R, Arnal C, Ros J, Tena X, Rodrigo C, Rotés I, Hermosilla E, Barceló 

P. 

Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). 

SCAND J RHEUMATOL 2010 2010;39:472-9 

IF: 2,594 

Moltó A, Holgado S, Mateo L, Olivé A 

Osteoporosis transitoria de la cadera y embarazo 

MED CLIN-BARCELONA 2010 Nov 13;135(14):678-9. Epub 2009 Oct 22. 

IF: 1,413 

Molto A, Olive A. 

Anti-IL-1 molecules: new comers and new indications. 

JOINT BONE SPINE 2010 Mar;77(2):102-7. Epub 2009 Dec 31. 

IF: 2,46 


Molto, A; Mateo, L; Lloveras, N; Olive, A; Minguez, S 

Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under 

treatment with adalimumab 

JOINT BONE SPINE 2010 May;77(3):271-3. Epub 2010 Apr 7. 

IF: 2,46 

Naredo E, Batlle-Gualda E, García-Vivar ML, García-Aparicio AM, Fernández-Sueiro JL, Fernández-Prada 

M, Giner E, Rodriguez-Gomez M, Pina MF, Medina-Luezas JA, Toyos FJ, Campos C, Gutiérrez-Polo R, 

Ferrer MA, Martínez O, Díaz-Torne C, Gonzalez T, Campos S, Queiro R, Castaño-Sánchez M, Aznar JJ, 

Bustabad S, Paez-Camino M, Tuneu R, Ruiz T, Mateo L, Pujol M, Ponce A, Ros I, Gallegos A, Moreno J, 

Gumbau D, Sianes M, Poveda-Elices MJ, Romero-Gómez M, Raya E; Ultrasound Group of the Spanish 

Society of Rheumatology. 

Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy 

of entheseal abnormalities. 

J RHEUMATOL 2010 Oct;37(10):2110-7. Epub 2010 Sep 1. 

IF: 3,551 

Olivé A, Garcia Melchor E 

On Raynaud's phenomenon. 

MED CLIN-BARCELONA 2010 Apr 10;134(10):470 

IF: 1,413 

Ortiz-Santamaria V, Olive A, Martinez-Cáceres E, Coll M, Codina X, Surís X. 

Neonatal lupus erythematosus: a possible role for anti-Sm antibodies. 

LUPUS 2010 Apr;19(5):659-61. Epub 2010 Feb 4. 

IF: 2,6 

Reverter, JL; Colome, E; Holgado, S; Aguilera, E; Soldevila, B; Mateo, L; Sanmarti, A 

Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine 

treatment for differentiated thyroid carcinoma 

ENDOCRINE 2010 Jun;37(3):467-72. Epub 2010 Apr 16. 

IF: 1,373 


UNITAT FUNCIONAL 

INTERDISCIPLINÀRIA 

SOCIOSANITÀRIA 



Monteserin, R; Brotons, C; Moral, I; Altimir, S; Jose, AS; Santaeugenia, S; Sellares, J; Padros, J 

Effectiveness of a geriatric intervention in primary care: a randomized clinical trial 

FAM PRACT 2010 Jun;27(3):239-45. Epub 2010 Jan 6. 

IF: 1,709 






IF: 2,157 

Urrutia A, Santesmases J, Altimir S, Rey-Joly C. 

Outcome prediction in patients in acute geriatric units 

Rev Esp Geriatr Gerontol 2010 Mar-Apr;45(2):111-2. Epub 2009 Dec 1. 


UNITAT 

D'AL·LÈRGIA 



Garcia-Ortega, P; Marin, A 

Usefulness of the basophil activation test (BAT) in the diagnosis of life-threatening drug anaphylaxis 

ALLERGY 2010 Sep;65(9):1204. Epub 2010 Feb 10. 

IF: 6,297 


UNITAT 

D’INNOVACIÓ 


Marí-Buyé N, & Semino C.E. 

Differentiation of mouse embryonic stem cells in self-assembling peptide scaffolds. 

Methods Mol. Biol 2010; 690: 217-237 

Wu, J, Marí-Buyé, M., SanMarti, T., Fernandez N, Gutierrez J, Favia P, Lopez L & Semino, CE. 

A thin self-assembling peptide nanofiber-modified membrane maintain hepatospecific functions in a 

sandwich culture system. 

J. Nanobiotech 2010; 8: 29 


UNITAT DE 

GENÒMICA 



Colobran R, Pedrosa E, Carretero-Iglesia L, Juan M. 

Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health 

and disease. 

CLIN EXP IMMUNOL 2010 Oct;162(1):41-52. doi: 10.1111/j.1365-2249.2010.04224.x. Epub 2010 Aug 19. 

IF: 3,134 


UNITAT DE 

GENÒMICA 

FUNCIONAL 

Projectes 

PEDROSA TAPIAS, ELISABET 

Asociación Española de Gastroenterología 

Perfiles genéticos de miARN en plasma de pacientes con enfermedad inflamatoria intestinal 

Durada: 2 anys - (2010-2012) 



UNITAT 

D'URGÈNCIES 


Amestoy Torre E, Segura Egea A, Guardiola Ponti H, Carreres Molas A. 

Ovarian hyperstimulation syndrome in a 19-years-old woman 

MED CLIN-BARCELONA 2010 Nov 20;135(15):723-4. Epub 2009 Nov 13. 

IF: 1,413 



UNITAT DE 

PATOLOGIA 

MAMÀRIA 



Alba, E; Ruiz-Borrego, M; Margeli, M; Rodriguez-Lescure, A; Sanchez-Rovira, P; Ruiz, A; Mel-Lorenzo, JR; 

Ramos-Vazquez, M; Ribelles, N; Calvo, E; Casado, A; Marquez, A; Vicente, D; Garcia-Saenz, JA; Martin, M 

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction 

chemotherapy for metastatic breast cancer: GEICAM 2001-01 study 

BREAST CANCER RES TR 2010 Jul;122(1):169-76. Epub 2010 Apr 2. 

IF: 4,859 

Azambuja, E., McCaskill-Stevens, W, Francis P, Quinaux E, Crown JPA, Vicente M, Giuliani R, 

Nordenskjöld B, Gutiérrez J, Andersson M, Margelí M, Jakesz R, Demol J; Dewar J, Santoro A, Lluch A, 

Olsen S, Gelber RD, Di Leo A, Piccart-Gelbert M. 

The effect of body mass index on overall and disease-free survival in node-positive breast cancer 

patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of 

the BIG 02-98 trial. 

BREAST CANCER RES TR 2010 Jan;119(1):145-53. 

IF: 4,859 

Climent, F; Soler, MT; Catala, I; Castella, E; Corominas, JM; Walsh, PM 

Breast Cancer OncoGuia: surgical pathology report guidelines 

CLIN TRANSL ONCOL 2010; FEB, 12 (2) 138-141 

IF: 1,254 

Estévez LG, Alvarez I, Seguí MÁ, Muñoz M, Margelí M, Miró C, Rubio C, Lluch A, Tusquets I. 

Current perspectives of treatment of ductal carcinoma in situ 

CANCER TREAT REV 2010 Nov;36(7):507-17 

IF: 6,811 




Cancer PLOS ONE 2010; mar-03, 5 (3) -e9499 

IF: 4,411 

Solà M, Fraile M. 

Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario. 

REV ESP MED NUCL 2010 Nov-Dec;29(6):316-8 

IF: 0,77 


Fraile M. 





UNITAT DE 

TUBERCULOSI 

EXPERIMENTAL (UTE) 


Guio H, Vilaplana C, Cardona PJ. 

Inmunodiagnosis and Biomarkers in Tuberculosis. 


IF: 1,413 




vaccine RUTI. 


IF: 3,572 




IF: 2,726 


UNITAT 

POLIVALENT 

D'INVESTIGACIÓ 

CLÍNICA (UPIC) 



Montané E, Barriocanal A, Portabella E, García F, Bel J, Just M, Lezcano C, Morató L, Muga R, Pintanel T, 

Santesmases J, Valls RM, Vilar D, Costa J. 

Farmacovigilancia: Reaccions adverses a medicaments (RAM). 

BUTLLETÍ DEL MEDICAMENT - HOSPITAL GERMANS TRIAS I PUJOL 12(53) 2010 



vaccine RUTI. 


IF: 3,572 


UROLOGIA 



Buisán O, Boix R, Areal J, Ruiz JM, Ibarz L, Bayona S, Saladié JM. 

Enucleación prostàtica con láser de holmio. Experiencia del Hospital Germans Trias i Pujol. 

ACTAS UROL ESP 2010; 34(8): 713-8 

Castella Domenench A, Ruiz caballero J, Tresserra Casas F, Ibarz Servio L, Graupera Nicolau B 

Carcinoma de células transicionales de vejiga en una paciente con incontinencia urinària 

SUELO PÉLVICO 2010; 6(2): 55-8 

Ibarz Servio L, Arzoz Fabregas M, Valverde Vilamala I 

Fitatos: Evidencia científica en el tartamiento de la litiasis renal 

JANO, NATURALEZA Y HUMANIDADES 2010; 1: 6-12 

Martinez-Rodriguez R, Areal Calama J, Buisan Rueda O, Gonzalez Satue C, Sanchez Macias J, Arzoz 

Fabregas M, Gago Ramos J, Bayona Arenas S, Ibarz Servio L, Saladie Roig JM. 

Practical treatment approach of radiation induced cystitis 

ACTAS UROL ESP 2010 Jul;34(7):603-9. 

Romero G., Conejero J., Planells I., Giménez M. 

Características de las infecciones urinarias en pacientes con vejiga neurógena según el sistema de 

vaciado vesical utilizado en comparación con pacientes sin vejiga neurógena. 

ACTAS UROL ESP 34: 251-257 

Urrutia A, Santesmases J, Benítez RM, Areal J. 

Adrenal gland abscess due to Streptococcus pneumoniae 

J INFECTION 2010 Jan;60(1):88-9. Epub 2009 Oct 31. 

IF: 3,805 


Projectes 

AREAL CALAMA, JOAN 

Asociación Española de Urología 

Estudio piloto para la identificación de marcadores de replicación de XMRV (xenotropic murine leukemia 

virusrelated virus) en tejido parafinado de pacientes con adenocarcinoma prostático sometidos a 

prostatectomía radical. 

Durada: 1 anys - (2010-2011) 


IBARZ SERVIO, LUIS 

Asociación Española de Urología 

El estrés crónico como factor etiológico de la litiasis renal oxalocálcica. Estudio de sus implicaciones 

psicológicas y posibles interacciones bioquímicas. 

Durada: 2 anys - (2008-2010)

Publicacions - Fundació Institut d'Investigació en Ciències de la

Create successful ePaper yourself

Delete template?

Save as template?